<?xml version="1.0"  ?><!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd"><pmc-articleset><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" article-type="review-article" xml:lang="en" dtd-version="1.4"><front><journal-meta><journal-id journal-id-type="nlm-ta">Int J Mol Sci</journal-id><journal-id journal-id-type="iso-abbrev">Int J Mol Sci</journal-id><journal-id journal-id-type="pmc-domain-id">808</journal-id><journal-id journal-id-type="pmc-domain">ijms</journal-id><journal-id journal-id-type="publisher-id">ijms</journal-id><journal-title-group><journal-title>International Journal of Molecular Sciences</journal-title></journal-title-group><issn pub-type="epub">1422-0067</issn><publisher><publisher-name>Multidisciplinary Digital Publishing Institute  (MDPI)</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">PMC7663252</article-id><article-id pub-id-type="pmcid-ver">PMC7663252.1</article-id><article-id pub-id-type="pmcaid">7663252</article-id><article-id pub-id-type="pmcaiid">7663252</article-id><article-id pub-id-type="pmid">33126494</article-id><article-id pub-id-type="doi">10.3390/ijms21218011</article-id><article-id pub-id-type="publisher-id">ijms-21-08011</article-id><article-version article-version-type="pmc-version">1</article-version><article-categories><subj-group subj-group-type="heading"><subject>Review</subject></subj-group></article-categories><title-group><article-title>CD4 T Helper Cell Subsets and Related Human Immunological Disorders</article-title></title-group><contrib-group><contrib contrib-type="author"><name name-style="western"><surname>Zhu</surname><given-names initials="X">Xiaoliang</given-names></name><xref rid="c1-ijms-21-08011" ref-type="corresp">*</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="true">https://orcid.org/0000-0002-0117-4745</contrib-id><name name-style="western"><surname>Zhu</surname><given-names initials="J">Jinfang</given-names></name><xref rid="c1-ijms-21-08011" ref-type="corresp">*</xref></contrib></contrib-group><aff id="af1-ijms-21-08011">Molecular and Cellular Immunoregulation Section, Laboratory of Immune System Biology, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892, USA</aff><author-notes><corresp id="c1-ijms-21-08011"><label>*</label>Correspondence: <email>xiaoliang.zhu@nih.gov</email> (X.Z.); <email>jfzhu@niaid.nih.gov</email> (J.Z.)</corresp></author-notes><pub-date pub-type="epub"><day>28</day><month>10</month><year>2020</year></pub-date><pub-date pub-type="collection"><month>11</month><year>2020</year></pub-date><volume>21</volume><issue>21</issue><issue-id pub-id-type="pmc-issue-id">368680</issue-id><elocation-id>8011</elocation-id><history><date date-type="received"><day>11</day><month>9</month><year>2020</year></date><date date-type="accepted"><day>26</day><month>10</month><year>2020</year></date></history><pub-history><event event-type="pmc-release"><date><day>01</day><month>11</month><year>2020</year></date></event><event event-type="pmc-live"><date><day>14</day><month>11</month><year>2020</year></date></event><event event-type="pmc-last-change"><date iso-8601-date="2024-08-02 21:25:27.163"><day>02</day><month>08</month><year>2024</year></date></event></pub-history><permissions><copyright-statement>&#169; 2020 by the authors.</copyright-statement><copyright-year>2020</copyright-year><license license-type="open-access"><ali:license_ref specific-use="textmining" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p>Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link>).</license-p></license></permissions><self-uri xmlns:xlink="http://www.w3.org/1999/xlink" content-type="pmc-pdf" xlink:href="ijms-21-08011.pdf"/><abstract><p>The immune system plays a critical role in protecting hosts from the invasion of organisms. CD4 T cells, as a key component of the immune system, are central in orchestrating adaptive immune responses. After decades of investigation, five major CD4 T helper cell (Th) subsets have been identified: Th1, Th2, Th17, Treg (T regulatory), and Tfh (follicular T helper) cells. Th1 cells, defined by the expression of lineage cytokine interferon (IFN)-&#947; and the master transcription factor T-bet, participate in type 1 immune responses to intracellular pathogens such as mycobacterial species and viruses; Th2 cells, defined by the expression of lineage cytokines interleukin (IL)-4/IL-5/IL-13 and the master transcription factor GA&#932;A3, participate in type 2 immune responses to larger extracellular pathogens such as helminths; Th17 cells, defined by the expression of lineage cytokines IL-17/IL-22 and the master transcription factor ROR&#947;t, participate in type 3 immune responses to extracellular pathogens including some bacteria and fungi; Tfh cells, by producing IL-21 and expressing Bcl6, help B cells produce corresponding antibodies; whereas Foxp3-expressing Treg cells, unlike Th1/Th2/Th17/Tfh exerting their effector functions, regulate immune responses to maintain immune cell homeostasis and prevent immunopathology. Interestingly, innate lymphoid cells (ILCs) have been found to mimic the functions of three major effector CD4 T helper subsets (Th1, Th2, and Th17) and thus can also be divided into three major subsets: ILC1s, ILC2s, and ILC3s. In this review, we will discuss the differentiation and functions of each CD4 T helper cell subset in the context of ILCs and human diseases associated with the dysregulation of these lymphocyte subsets particularly caused by monogenic mutations.</p></abstract><kwd-group><kwd>Th1</kwd><kwd>Th2</kwd><kwd>Th17</kwd><kwd>Treg</kwd><kwd>Tfh</kwd><kwd>ILCs</kwd><kwd>pathogens</kwd><kwd>immunological diseases</kwd></kwd-group><custom-meta-group><custom-meta><meta-name>pmc-status-qastatus</meta-name><meta-value>0</meta-value></custom-meta><custom-meta><meta-name>pmc-status-live</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-status-embargo</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-status-released</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-open-access</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-olf</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-manuscript</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-legally-suppressed</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-pdf</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-supplement</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-pdf-only</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-suppress-copyright</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-real-version</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-scanned-article</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-preprint</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-in-epmc</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-license-ref</meta-name><meta-value>CC BY</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec sec-type="intro" id="sec1-ijms-21-08011"><title>1. Introduction</title><p>To defend countless pathogen invasions, mammals have developed and evolved a rigorous and precise immune system, which is built upon various kinds of cells, cytokines, chemokines, antibodies et al. [<xref rid="B1-ijms-21-08011" ref-type="bibr">1</xref>,<xref rid="B2-ijms-21-08011" ref-type="bibr">2</xref>]. CD4 T helper cells, as a key component of this system, play a critical role in defending infections throughout life by coordinating the actions of other immune cells as well as non-immune cells. CD4 T cells originate from common lymphoid progenitors in the bone marrow, develop in the thymus, and execute their functions mainly in peripheral tissues and various lymphoid organs [<xref rid="B3-ijms-21-08011" ref-type="bibr">3</xref>]. The developmental process is precisely regulated so that CD4 T cells may efficiently recognize a very broad range of foreign antigens without eliciting auto-reactivity to self-antigens. For executing their effector functions, na&#239;ve CD4 T cells first need to be activated when receiving pathogen signals delivered by antigen-presenting cells (APCs), such as dendritic cells (DCs), and then differentiate into distinct T effector (Teff) populations based on the nature of infections. Effector CD4 T cells provide host defensive mechanisms against pathogens through the production of effector cytokines, which activate other immune cells such as macrophages and CD8 T cells in killing infected cells and help B cells in producing antibodies to mediate humoral immune responses [<xref rid="B4-ijms-21-08011" ref-type="bibr">4</xref>,<xref rid="B5-ijms-21-08011" ref-type="bibr">5</xref>,<xref rid="B6-ijms-21-08011" ref-type="bibr">6</xref>].</p><p>Based on the expression of signature cytokines and lineage-specific master transcription factors, CD4 T helper (Th) cells are typically categorized into five major subsets (<xref ref-type="fig" rid="ijms-21-08011-f001">Figure 1</xref>): Th1 (interferon (IFN)-&#947; and T-bet), Th2 (interleukin (IL)-4/IL-5/IL-13 and GATA3), Th17 (IL-17/IL-22 and ROR&#947;t), Tfh (IL-21 and Bcl6) and Treg (T regulatory) (IL-10/transforming growth factor (TGF)-&#946;/IL-35 and Foxp3) [<xref rid="B7-ijms-21-08011" ref-type="bibr">7</xref>]. Some labs have also described some other subsets, such as Th3 (TGF-&#946;) [<xref rid="B8-ijms-21-08011" ref-type="bibr">8</xref>], Tr1 (IL-10) [<xref rid="B9-ijms-21-08011" ref-type="bibr">9</xref>], Th9 (IL-9) [<xref rid="B10-ijms-21-08011" ref-type="bibr">10</xref>,<xref rid="B11-ijms-21-08011" ref-type="bibr">11</xref>], and Th22 (IL-22) [<xref rid="B12-ijms-21-08011" ref-type="bibr">12</xref>]. Since there are still controversial issues in defining them as unique lineage subsets (particularly because the lack of a master regulator associated with each of these &#8220;lineages&#8221;), we will not further discuss these CD4 T cell subsets in this review.</p><p>Through thymic selection, CD4/CD8 double positive T cells develop into either mature CD4 (helper) or CD8 (cytotoxic) T cells, which recognize major histocompatibility complex (MHC) class II (MHCII)/peptide and MHCI/peptide complexes, respectively (<xref ref-type="fig" rid="ijms-21-08011-f001">Figure 1</xref>). However, some mature CD4 T cells, cytotoxic CD4 T cells (CD4-CTLs or Th-CTLs), may act similarly as cytotoxic CD8 T cells in killing their target cells through the secretion of granzyme B and perforin but in an MHCII-restricted manner [<xref rid="B13-ijms-21-08011" ref-type="bibr">13</xref>,<xref rid="B14-ijms-21-08011" ref-type="bibr">14</xref>,<xref rid="B15-ijms-21-08011" ref-type="bibr">15</xref>]. The transcriptional factor Eomes (a T-box transcription factor critical for the development of functional natural killer (NK) and CD8 T cells), T-bet, and Blimp1 are critical for inducing the expression of cytotoxicity-associated genes in CD4-CTLs [<xref rid="B16-ijms-21-08011" ref-type="bibr">16</xref>,<xref rid="B17-ijms-21-08011" ref-type="bibr">17</xref>,<xref rid="B18-ijms-21-08011" ref-type="bibr">18</xref>]. Similar to CD8 T cells, CD4-CTLs display increased Runx3 but reduced ThPOK expression [<xref rid="B19-ijms-21-08011" ref-type="bibr">19</xref>,<xref rid="B20-ijms-21-08011" ref-type="bibr">20</xref>,<xref rid="B21-ijms-21-08011" ref-type="bibr">21</xref>,<xref rid="B22-ijms-21-08011" ref-type="bibr">22</xref>]. Furthermore, opposite to Tfh cells, CD4-CTLs express low levels of Bcl6 but high levels of Blimp-1 [<xref rid="B23-ijms-21-08011" ref-type="bibr">23</xref>]. Two important markers for CD4-CTLs are CRTAM [<xref rid="B24-ijms-21-08011" ref-type="bibr">24</xref>] and NKG2C/E [<xref rid="B25-ijms-21-08011" ref-type="bibr">25</xref>]. It has been shown that the cytotoxicity executed through CD4-CTLs becomes effective when CD8-CTL activity is impaired during infections in association with virus escape strategies [<xref rid="B14-ijms-21-08011" ref-type="bibr">14</xref>,<xref rid="B15-ijms-21-08011" ref-type="bibr">15</xref>]. Interestingly, more CD4-CTLs have been identified in severe COVID-19 patients than in mild symptomatic patients [<xref rid="B26-ijms-21-08011" ref-type="bibr">26</xref>], suggesting a possible inefficient CD8 response in viral control in patients with severe disease, which is an important question that needs to be tested in the future. In addition to protecting the host from viral infections, CD4-CTLs are also involved in anti-tumor responses as well as in various autoimmune conditions [<xref rid="B19-ijms-21-08011" ref-type="bibr">19</xref>,<xref rid="B27-ijms-21-08011" ref-type="bibr">27</xref>,<xref rid="B28-ijms-21-08011" ref-type="bibr">28</xref>]. Strikingly, CD4-CTLs are increased in people of exceptional longevity [<xref rid="B29-ijms-21-08011" ref-type="bibr">29</xref>]. The development and functions of CD4-CTLs have been recently reviewed [<xref rid="B15-ijms-21-08011" ref-type="bibr">15</xref>]. In consideration of the scope of this review, we will not further discuss this interesting population below in great detail.</p><p>Among the CD4 T subsets possessing helper functions (<xref ref-type="fig" rid="ijms-21-08011-f001">Figure 1</xref>), Th1 cells induce type 1 responses to protect against intracellular pathogens such as bacteria, viruses, and protozoa by activating type 1 macrophages (M1) [<xref rid="B5-ijms-21-08011" ref-type="bibr">5</xref>]. Th2 cells are involved in type 2 responses to fight infections by parasites such as helminths by activating type 2 microphages (M2), as well as the recruitment of eosinophils, basophils, and mast cells to the sites of infections [<xref rid="B30-ijms-21-08011" ref-type="bibr">30</xref>]. Th17 cells mediate type 3 responses for the clearance of extracellular bacteria and fungi by orchestrating sustained neutrophil recruitment and an induction of antimicrobial peptide production by epithelial cells of barrier tissues such as intestines, lungs, and skin [<xref rid="B31-ijms-21-08011" ref-type="bibr">31</xref>]. Tfh cells are found to be important in helping B cells make antibody responses by promoting germinal center formation, affinity maturation, and possibly immunoglobulin class switch recombination [<xref rid="B32-ijms-21-08011" ref-type="bibr">32</xref>], although Tfh-independent antibody responses have also been reported [<xref rid="B33-ijms-21-08011" ref-type="bibr">33</xref>]. Treg cells are critical for the preservation of immune tolerance and involved in preventing autoimmune diseases [<xref rid="B34-ijms-21-08011" ref-type="bibr">34</xref>,<xref rid="B35-ijms-21-08011" ref-type="bibr">35</xref>].</p><p>Innate lymphoid cells (ILCs) [<xref rid="B7-ijms-21-08011" ref-type="bibr">7</xref>,<xref rid="B36-ijms-21-08011" ref-type="bibr">36</xref>,<xref rid="B37-ijms-21-08011" ref-type="bibr">37</xref>] that do not express antigen receptors have been recently identified as the counterparts of T helper subsets within the innate arm of the immune system. While progenitors of ILCs are found both in bone marrow and tissue, mature ILCs are largely tissue-resident [<xref rid="B38-ijms-21-08011" ref-type="bibr">38</xref>]. Therefore, ILCs can act earlier and more quickly than CD4 T cells during an immune response and thus provide the first line of protection against pathogens through a rapid and local secretion of effector cytokines, which were previously thought to be largely produced by CD4 T helper cells. Similar to the classification of CD4 T effector subsets into three major subsets, Th1/Th2/Th17 cells, ILCs can also be categorized into three major groups (<xref ref-type="fig" rid="ijms-21-08011-f001">Figure 1</xref>), which produce similar effector cytokines and lineage-defining transcription factors. Thus, group 1 ILCs (ILC1s) secret IFN-&#947; and express T-bet; group 2 ILCs (ILC2s) secret IL-5 and IL-13, and express GATA3; group 3 ILCs (ILC3s) secret IL-17 and IL-22, and express ROR&#947;t [<xref rid="B7-ijms-21-08011" ref-type="bibr">7</xref>]. Functionally, group 1 ILCs, similar to Th1 cells, may participate in defending intracellular pathogens, such as bacteria, viruses, and protozoa; group 2 ILCs, just as Th2 cells, respond to large extracellular pathogens, such as parasites and allergens; group 3 ILCs, like Th17 cells, combat extracellular microbes, such as bacteria and fungi [<xref rid="B37-ijms-21-08011" ref-type="bibr">37</xref>]. ILCs, similar to Th cells, are also involved in many inflammatory diseases including autoimmunity, allergy, and asthma [<xref rid="B39-ijms-21-08011" ref-type="bibr">39</xref>]. It is worth pointing out that within the ROR&#947;t-expressing ILCs, there is a lymphoid tissue inducer (LTi) population, and they are involved in the formation of lymphoid structures as well as in host defense [<xref rid="B40-ijms-21-08011" ref-type="bibr">40</xref>]. Recently, ILCs were also found to be involved in non-immunological functions including tissue repair, metabolism regulation, and immune-neuronal interactions [<xref rid="B36-ijms-21-08011" ref-type="bibr">36</xref>].</p><p>A proper and effective response to a particular microorganism invasion through the activation and differentiation of T helper subsets and ILCs protects host from that pathogen without causing excessive inflammation that damages host tissues. However, when an immune response is out of balance, either too weak or too strong, it can cause chronic infection or inflammatory diseases [<xref rid="B5-ijms-21-08011" ref-type="bibr">5</xref>,<xref rid="B6-ijms-21-08011" ref-type="bibr">6</xref>,<xref rid="B32-ijms-21-08011" ref-type="bibr">32</xref>,<xref rid="B41-ijms-21-08011" ref-type="bibr">41</xref>,<xref rid="B42-ijms-21-08011" ref-type="bibr">42</xref>]. Inappropriate immune responses to harmless environmental agents or self-antigens may also lead to inflammation, allergy, and autoimmunity, such as inflammatory bowel disease (IBD). Immunodeficiency with reduced ILC and CD4 T cell numbers and/or diminished ILC and CD4 T cell functions can result in insufficient immune response, which may cause chronic or repeated infections. In fact, in human immunodeficiency virus (HIV)-infected patients, the CD4 T cell number is drastically reduced, which is the main cause of acquired immunodeficiency syndrome (AIDS). X-linked severe combined immune deficiency (SCID) patients have mutations in the <italic toggle="yes">IL2RG</italic> gene [<xref rid="B43-ijms-21-08011" ref-type="bibr">43</xref>], which results in a lack of T cells and ILCs; these boys suffer from severe infections of bacteria, viruses, and fungi, and they do not survive beyond infancy without treatment. In this review, we will discuss the differentiation and functions of major T helper subsets and their involvement in host defense and diseases in the context of ILCs.</p></sec><sec id="sec2-ijms-21-08011"><title>2. Th1 Cells and Related Diseases</title><sec id="sec2dot1-ijms-21-08011"><title>2.1. Th1 Cells</title><p>The Th1/Th2 dichotomy was first proposed by Robert Coffman and Tim Mosmann in 1986 when they reported that CD4 T helper cell clones from mice can be divided into two distinct types based on their cytokine production profile [<xref rid="B44-ijms-21-08011" ref-type="bibr">44</xref>]. Since then, the definition of a unique lineage has expanded to the expression of lineage-specific master transcription factors, cell surface markers, as well as transcriptomes and epigenomes, which is reflected by different epigenetic modifications to a certain degree [<xref rid="B5-ijms-21-08011" ref-type="bibr">5</xref>].</p><p>Upon TCR activation in a particular cytokine milieu, na&#239;ve CD4 T cells can differentiate into Th1 cells. IL-12 secreted by APCs activates the transcription factor STAT4, and IFN-&#947; produced by NK cells and/or T cells themselves activates another transcription factor, STAT1; both STAT1 and STAT4 activation are capable of inducing the expression of the Th1-inducing master transcription factor T-bet [<xref rid="B45-ijms-21-08011" ref-type="bibr">45</xref>,<xref rid="B46-ijms-21-08011" ref-type="bibr">46</xref>]. T-bet, by cooperating with Hlx [<xref rid="B47-ijms-21-08011" ref-type="bibr">47</xref>], Runx3 [<xref rid="B48-ijms-21-08011" ref-type="bibr">48</xref>,<xref rid="B49-ijms-21-08011" ref-type="bibr">49</xref>], Ets-1 [<xref rid="B50-ijms-21-08011" ref-type="bibr">50</xref>], and Bhlhe40 [<xref rid="B51-ijms-21-08011" ref-type="bibr">51</xref>], promotes IFN-&#947; production. While T-bet together with Runx3 may directly repress IL-4 transcription, T-bet also inhibits the expression of other master transcription factors including GATA3 and ROR&#947;t [<xref rid="B7-ijms-21-08011" ref-type="bibr">7</xref>,<xref rid="B45-ijms-21-08011" ref-type="bibr">45</xref>,<xref rid="B52-ijms-21-08011" ref-type="bibr">52</xref>], thereby antagonizing Th2 and Th17 cell differentiation.</p><p>While Th1 cells can directly differentiate from na&#239;ve CD4 T cells, they can also derive from other T helper CD4 subsets, including Th17, Treg, and Tfh cells as a result of CD4 T cell plasticity [<xref rid="B5-ijms-21-08011" ref-type="bibr">5</xref>,<xref rid="B53-ijms-21-08011" ref-type="bibr">53</xref>,<xref rid="B54-ijms-21-08011" ref-type="bibr">54</xref>]. Differentiated Th1 cells are capable of producing Th1 signature cytokine IFN-&#947;, which activates and/or stimulates other immune cells, including CD8 T cells, ILC1s, macrophages, and B cells during the process of eliminating pathogens [<xref rid="B6-ijms-21-08011" ref-type="bibr">6</xref>]. An important chemokine receptor expressed by Th1 cells is CXCR3, which plays an important role in Th1 cell migration toward the inflammation sites with pathogen invasion, and it is also widely used for the identification of human Th1 cells [<xref rid="B55-ijms-21-08011" ref-type="bibr">55</xref>].</p><p>In addition to Th1 cells, three other kinds of lymphocytes (ILC1s, CD8 T cells, and NK cells) are also involved in type 1 immunity [<xref rid="B6-ijms-21-08011" ref-type="bibr">6</xref>]. ILC1s, probably by producing IFN-&#947;, may participate in immune responses to the infection of protozoa and viruses [<xref rid="B56-ijms-21-08011" ref-type="bibr">56</xref>,<xref rid="B57-ijms-21-08011" ref-type="bibr">57</xref>]. However, the relative importance of IFN-&#947; production by ILC1s or NK cells during infection remains unclear partly because of the lack of reliable ILC1-deficient models. It has been recently reported that ILC1s are essential for limiting early viral replication, which cannot be compensated by NK cell-mediated anti-viral effects in response to mouse cytomegalovirus infection of hepatic cells [<xref rid="B57-ijms-21-08011" ref-type="bibr">57</xref>]. However, the transcription factor Zfp683 (Hobbit), which appeared to be specifically required for ILC1 development, may also have important functions in other immune cells including NK, CD8 T, and Th1 cells. Whether IFN-&#947; produced by ILC1s plays a role in promoting Th1 cell differentiation is currently unknown.</p><p>Whole genome analyses of Th1 cells generated both in vitro and in vivo, including RNA-Seq for assessing gene expression, ChIP-Seq of histone modifications, and transcription factor binding as well as ATAC-Seq (and/or DNase-Seq) for analyzing epigenetic status of specific gene loci, have not only confirmed the previously known Th1-related genes but also identified many more Th1-specific genes, which may help understand the mechanisms of Th1 cell differentiation as well as the heterogeneity and functions of Th1 cells after their differentiation [<xref rid="B58-ijms-21-08011" ref-type="bibr">58</xref>,<xref rid="B59-ijms-21-08011" ref-type="bibr">59</xref>,<xref rid="B60-ijms-21-08011" ref-type="bibr">60</xref>,<xref rid="B61-ijms-21-08011" ref-type="bibr">61</xref>].</p></sec><sec id="sec2dot2-ijms-21-08011"><title>2.2. Th1-Related Diseases</title><p>In addition to an essential protective effect in host defense, Th1 cells also play important roles in (or are associated with) different types of autoimmune diseases, such as rheumatoid arthritis, multiple sclerosis, Hashimoto thyroiditis, insulin-dependent diabetes mellitus, autoimmune gastritis, and other chronic inflammatory disorders, including inflammatory bowel diseases, atherosclerosis, and sarcoidosis [<xref rid="B62-ijms-21-08011" ref-type="bibr">62</xref>]. Since Th1 cells are responsible for orchestrating type 1 immunity against intracellular pathogens, deficiencies in the generation and functions of Th1 cells may result in chronic and/or recurrent infections. However, no monogenic mutations only related to Th1 cells have been found [<xref rid="B5-ijms-21-08011" ref-type="bibr">5</xref>]; this may reflect a complex connection and interaction network within our immune system.</p><p>Serving as the master regulator for Th1 cell differentiation and IFN-&#947; production, T-bet has recently been reported to be deficient in some patients with mycobacterial disease [<xref rid="B63-ijms-21-08011" ref-type="bibr">63</xref>]; these patients have reduced IFN-&#947; production by most of the innate-like lymphocytes including NK, invariant NKT (iNKT), mucosal-associated invariant T (MAIT), and V&#948;2<sup>+</sup> &#947;&#948; T cells. Interestingly, while non-mycobacterial reactive classic Th1 cells produced less IFN-&#947;, normal IFN-&#947; response was detected in mycobacterial reactive non-classic CCR6<sup>+</sup> Th1 (Th1*) cells, indicating that T-bet-independent Th1-related response may be elicited and/or preserved in a situation where innate and classic adaptive IFN-&#947; response is inadequate. &#924;utations in many other genes that are related to Th1 cell differentiation and/or functions, such as <italic toggle="yes">IFNGR1, IFNGR2, STAT1, IL12RB1, IL12B</italic> and <italic toggle="yes">NEMO</italic>, have also been found in patients [<xref rid="B64-ijms-21-08011" ref-type="bibr">64</xref>]. The vast majority of these abnormalities result in susceptibility to infections with mycobacterial species.</p><p>Since there is a similarity in the development and regulation of ILC1s, NK, and Th1 cells, some gene mutations that affect Th1 cell differentiation may also have an impact on the generation and functions of other type 1 lymphocytes. Indeed, T-bet deficiency has a broad impact on multiple lymphoid lineages in either development/maturation or IFN-&#947; production [<xref rid="B63-ijms-21-08011" ref-type="bibr">63</xref>]. Th1 cells may also be involved in tumor immunology. Interestingly, the epigenetic silencing of Th1-type chemokines has been reported as a novel immune-evasion mechanism of tumors [<xref rid="B65-ijms-21-08011" ref-type="bibr">65</xref>]; this indicates that a selective epigenetic reprogramming may enhance the clinical efficacy of cancer therapy.</p></sec></sec><sec id="sec3-ijms-21-08011"><title>3. Th2 Cells and Related Diseases</title><sec id="sec3dot1-ijms-21-08011"><title>3.1. Th2 Cells</title><p>Th2 cells are defined as IL-4-producing T cells when the Th1/Th2 model was proposed. Th2 cells are mainly involved in host defense against large extracellular pathogens, such as helminths. Na&#239;ve CD4 T cells after receiving signals from DCs may differentiate into Th2 cells after their activation [<xref rid="B30-ijms-21-08011" ref-type="bibr">30</xref>]. IL-2 and IL-4 are two important cytokines during Th2 cell differentiation, particularly in vitro. IL-2 and IL-4 activate STAT5 and STAT6, respectively, and the latter induce the expression of the Th2 master transcription factor GATA3 in activated CD4 T cells [<xref rid="B5-ijms-21-08011" ref-type="bibr">5</xref>]. IL-4-independent Th2 cell differentiation may occur in vivo [<xref rid="B66-ijms-21-08011" ref-type="bibr">66</xref>]; however, GATA3 is absolutely required for Th2 cell differentiation and functions both in vitro and in vivo [<xref rid="B67-ijms-21-08011" ref-type="bibr">67</xref>,<xref rid="B68-ijms-21-08011" ref-type="bibr">68</xref>]. GATA3 not only plays an essential role in inducing Th2 cell differentiation, it also represses the expression of other lineage transcription factors, such as T-bet and ROR&#947;t [<xref rid="B58-ijms-21-08011" ref-type="bibr">58</xref>,<xref rid="B69-ijms-21-08011" ref-type="bibr">69</xref>,<xref rid="B70-ijms-21-08011" ref-type="bibr">70</xref>]. In addition to GATA3, other transcription factors including c-Maf [<xref rid="B71-ijms-21-08011" ref-type="bibr">71</xref>], STAT3 [<xref rid="B72-ijms-21-08011" ref-type="bibr">72</xref>], and Notch/CSL [<xref rid="B73-ijms-21-08011" ref-type="bibr">73</xref>] may also regulate Th2 cell differentiation and functions.</p><p>Differentiated Th2 cells secret lineage cytokines including IL-4, IL-5, and IL-13. During a classic type 2 immune response, IL-4 promotes B cell antibody class switching to immunoglobin E (IgE), IL-5 recruits eosinophilia to the inflammation sites, and IL-13 promotes mucus production and goblet cell hyperplasia [<xref rid="B30-ijms-21-08011" ref-type="bibr">30</xref>]. These cytokines can also be produced by ILC2s (although IL-4 production by ILC2s is somewhat limited), and they work together to eliminate invading pathogens [<xref rid="B74-ijms-21-08011" ref-type="bibr">74</xref>]. Th2 cells and ILC2s also express chemokine receptors on the cell surface, including CCR3, CCR4, and CCR8, to receive migration signals from ligands (CCL11 for CCR3, CCL17 and CCL22 for CCR4, and CCL1 for CCR8) secreted by epithelial cells [<xref rid="B75-ijms-21-08011" ref-type="bibr">75</xref>,<xref rid="B76-ijms-21-08011" ref-type="bibr">76</xref>,<xref rid="B77-ijms-21-08011" ref-type="bibr">77</xref>]. In addition to recruiting Th2 cells and ILC2s, these chemokines can also recruit other cells, such as DCs, eosinophils, basophils, and mast cells to the damaged epithelial sites caused by helminth infection or protease allergens [<xref rid="B30-ijms-21-08011" ref-type="bibr">30</xref>,<xref rid="B78-ijms-21-08011" ref-type="bibr">78</xref>]. Human Th2 cells also express CRTh2, which serves as a reliable marker for identification of human Th2 cells [<xref rid="B79-ijms-21-08011" ref-type="bibr">79</xref>], although its expression in mouse Th2 cells has not been clearly demonstrated. Instead, T1/ST2 (an IL-33 receptor subunit) has been widely used to identify Th2 cells and ILC2s in mice [<xref rid="B80-ijms-21-08011" ref-type="bibr">80</xref>,<xref rid="B81-ijms-21-08011" ref-type="bibr">81</xref>].</p><p>Collaboration and interactions between the ILCs and Th cells of the same class during immune responses have been reported with the relationship between ILC2s and Th2 cells being the most certain one [<xref rid="B30-ijms-21-08011" ref-type="bibr">30</xref>]. During a type 2 immune response, ILC2s and Th2 cells may crosstalk to each other through direct and indirect mechanisms (<xref ref-type="fig" rid="ijms-21-08011-f002">Figure 2</xref>). After activation by inflammatory cytokines, such as IL-33, IL-25, and TSLP, ILC2s, by secreting IL-13, may promote the migration of DCs to draining lymph nodes to induce Th2 cell differentiation [<xref rid="B82-ijms-21-08011" ref-type="bibr">82</xref>]. Interestingly, some ILC2s also express MHCII, through which they may directly present antigens to Th2 cells [<xref rid="B83-ijms-21-08011" ref-type="bibr">83</xref>]. On the other hand, Th2 cells by secreting IL-2 may expand ILC2s. Furthermore, by secreting IL-4 and IL-13, Th2 cells can induce/enhance the production of ILC2-activating inflammatory cytokines by epithelial cells, forming a positive feedback loop at the cellular level [<xref rid="B84-ijms-21-08011" ref-type="bibr">84</xref>,<xref rid="B85-ijms-21-08011" ref-type="bibr">85</xref>]. Since ILC2s and Th2 cells have similar effector functions during type 2 immune responses and both can be activated by IL-33, the relative abundance of one population over the other at a particular stage may determine the relative importance of these cells at that moment [<xref rid="B86-ijms-21-08011" ref-type="bibr">86</xref>].</p><p>The heterogeneity of Th2 cells, particularly in vivo, has been documented [<xref rid="B87-ijms-21-08011" ref-type="bibr">87</xref>]. In fact, even GATA3<sup>+</sup>T-bet<sup>+</sup> and GATA3<sup>+</sup>ROR&#947;t<sup>+</sup> CD4 T cells have been found during type 2 immune responses [<xref rid="B88-ijms-21-08011" ref-type="bibr">88</xref>,<xref rid="B89-ijms-21-08011" ref-type="bibr">89</xref>,<xref rid="B90-ijms-21-08011" ref-type="bibr">90</xref>]. Such an appearance of mixed phenotype cells is possibly due to CD4 T cell plasticity [<xref rid="B91-ijms-21-08011" ref-type="bibr">91</xref>]. Whole genome analyses of Th2 cells have also identified a collection of Th2-specific genes, many of which are shared by their expression in ILC2s. The investigation of these molecules may help further understand the mechanisms of Th2 cell differentiation and ILC2 development as well as their unique and shared functions during helminth infection and allergic responses [<xref rid="B58-ijms-21-08011" ref-type="bibr">58</xref>,<xref rid="B70-ijms-21-08011" ref-type="bibr">70</xref>,<xref rid="B92-ijms-21-08011" ref-type="bibr">92</xref>,<xref rid="B93-ijms-21-08011" ref-type="bibr">93</xref>].</p></sec><sec id="sec3dot2-ijms-21-08011"><title>3.2. Th2 Related Diseases</title><p>Th2 cells play a central role in type 2 immune responses, and together with ILC2s, Th2 cells defend against large parasites such as helminths [<xref rid="B30-ijms-21-08011" ref-type="bibr">30</xref>]. On the other hand, the dysregulation of type 2 immune response often results in pathologic responses [<xref rid="B30-ijms-21-08011" ref-type="bibr">30</xref>,<xref rid="B94-ijms-21-08011" ref-type="bibr">94</xref>]. In addition to some well-known large parasites such as helminths, other stimulus derived from viruses, bacteria, and other nonmicrobial products including food allergens [<xref rid="B95-ijms-21-08011" ref-type="bibr">95</xref>], venoms [<xref rid="B96-ijms-21-08011" ref-type="bibr">96</xref>], interior allergens (such as house dust mites, HDM) [<xref rid="B97-ijms-21-08011" ref-type="bibr">97</xref>], pollen allergens [<xref rid="B98-ijms-21-08011" ref-type="bibr">98</xref>] and vaccine adjuvants (Alum, MF59) [<xref rid="B99-ijms-21-08011" ref-type="bibr">99</xref>], may also cause allergic inflammation including asthma, atopic dermatitis, rhinitis, food allergies, and eczema. GATA3, as the master transcription factor for Th2 cells, plays an essential role in Th2 cell differentiation and functions [<xref rid="B68-ijms-21-08011" ref-type="bibr">68</xref>]. In mice, <italic toggle="yes">Gata3</italic> germline deficiency results in embryonic lethality [<xref rid="B100-ijms-21-08011" ref-type="bibr">100</xref>]. It is probably true in humans as well. Therefore, only <italic toggle="yes">GATA3</italic> heterozygous mutations that cause a haploinsufficiency of GATA3 in the hypoparathyroidism, deafness, and renal dysplasia (HDR) patients have been reported [<xref rid="B101-ijms-21-08011" ref-type="bibr">101</xref>]. Th2 cell differentiation was reported to be partially defective in these patients&#8217; T cells; however, they do not show any major immunologic abnormalities [<xref rid="B102-ijms-21-08011" ref-type="bibr">102</xref>]. Consistently, another report showed that the differentiation of HDR patient T cells into Th2 cells is normal [<xref rid="B103-ijms-21-08011" ref-type="bibr">103</xref>]. However, since ILC2 development is sensitive to the dose of GATA3 expression [<xref rid="B104-ijms-21-08011" ref-type="bibr">104</xref>], whether the HDR patients have reduced ILC2 numbers and thus reduced ILC2-mediated immune responses remains to be tested.</p><p>RAG1 or RAG2 hypomorphic mutations are responsible for Omenn syndrome, which is an autosomal recessive disease of neonates characterized by erythroderma, chronic diarrhea, hepatosplenogaly, and lymphadenopathy [<xref rid="B105-ijms-21-08011" ref-type="bibr">105</xref>,<xref rid="B106-ijms-21-08011" ref-type="bibr">106</xref>]. Elevated numbers of Th2 cells, an overproduction of IL-4 and IL-5, and elevated serum IgE as well as eosinophilia were found in some of these patients. This is possibly because a partial RAG deficiency results in a limited T cell repertoire, which may lead to a Th2-biased disease. Consistent with this idea, transferring low numbers of mouse T cells (thus a reduced T cell repertoire) into a lymphopenic host also causes Th2-mediated diseases [<xref rid="B107-ijms-21-08011" ref-type="bibr">107</xref>].</p></sec></sec><sec id="sec4-ijms-21-08011"><title>4. Th17 Cells and Related Diseases</title><sec id="sec4dot1-ijms-21-08011"><title>4.1. Th17 Cells</title><p>Th17 cells are important for type 3 immune responses in defending extracellular bacteria and fungi invasion; they are also found to be involved in many autoimmune diseases, such as multiple sclerosis, because of their pathogenic effects [<xref rid="B108-ijms-21-08011" ref-type="bibr">108</xref>]. Several key reports on the role of IL-23 versus IL-12 in autoimmunity in 2003 [<xref rid="B109-ijms-21-08011" ref-type="bibr">109</xref>,<xref rid="B110-ijms-21-08011" ref-type="bibr">110</xref>,<xref rid="B111-ijms-21-08011" ref-type="bibr">111</xref>] lead to the discovery of Th17 cells in 2005 [<xref rid="B112-ijms-21-08011" ref-type="bibr">112</xref>,<xref rid="B113-ijms-21-08011" ref-type="bibr">113</xref>,<xref rid="B114-ijms-21-08011" ref-type="bibr">114</xref>]. Although the discovery of Th17 cells is much later than the identification of Th1 and Th2 cells, research on this unique CD4 subset progresses rapidly. Interestingly, more regulators have been identified for Th17 cell differentiation than for Th1/Th2 cell differentiation [<xref rid="B115-ijms-21-08011" ref-type="bibr">115</xref>,<xref rid="B116-ijms-21-08011" ref-type="bibr">116</xref>]. Products of extracellular bacteria and fungi can activate antigen-presenting cells to produce pro-inflammatory cytokines IL-1&#946;, IL-6, and IL-23, which in turn direct na&#239;ve CD4 T cells to differentiate into Th17 cells [<xref rid="B6-ijms-21-08011" ref-type="bibr">6</xref>]. IL-6 and IL-23 activate STAT3 to induce the expression of Th17 master transcription factor ROR&#947;t [<xref rid="B117-ijms-21-08011" ref-type="bibr">117</xref>,<xref rid="B118-ijms-21-08011" ref-type="bibr">118</xref>]. In addition, TCR signaling can induce ROR&#947;t expression through the NFAT/NF-&#954;B/AP-1 pathway [<xref rid="B5-ijms-21-08011" ref-type="bibr">5</xref>]. ROR&#947;t, by collaborating with other transcription factors such as IRF4, BATF, and Runx1, promotes the expression of Th17 lineage-specific genes [<xref rid="B5-ijms-21-08011" ref-type="bibr">5</xref>,<xref rid="B119-ijms-21-08011" ref-type="bibr">119</xref>]. IL-6 and IL-21 together with TGF-&#946; are involved in Th17 cell differentiation in vitro [<xref rid="B5-ijms-21-08011" ref-type="bibr">5</xref>], although the TGF-&#946;-independent pathway for Th17 cell differentiation has also been reported [<xref rid="B120-ijms-21-08011" ref-type="bibr">120</xref>]. Differentiated Th17 cells are capable of secreting effector cytokines, such as IL-17A, IL-17F, and IL-22, to activate nonimmune and immune cells to produce matrix metallopeptidases (MMPs), nitric oxide (NO), cytokines, and antimicrobial peptides to clear extracellular pathogens [<xref rid="B6-ijms-21-08011" ref-type="bibr">6</xref>,<xref rid="B112-ijms-21-08011" ref-type="bibr">112</xref>,<xref rid="B114-ijms-21-08011" ref-type="bibr">114</xref>,<xref rid="B121-ijms-21-08011" ref-type="bibr">121</xref>,<xref rid="B122-ijms-21-08011" ref-type="bibr">122</xref>]. In addition, CXCL8 and G-CSF produced by Th17 cells and other nonimmune cells recruit neutrophils to the inflammation sites to kill pathogens [<xref rid="B123-ijms-21-08011" ref-type="bibr">123</xref>]. Th17 cells express a signature chemokine receptor CCR6 (inflamed tissues homing receptor and essential for homeostasis) [<xref rid="B124-ijms-21-08011" ref-type="bibr">124</xref>], which is also considered as a unique marker in identifying human Th17 cells. In combination with CXCR3, CCR6 has been used to distinguish Th17 cells (CXCR3<sup>-</sup>CCR6<sup>+</sup>) from Th1 cells (CXCR3<sup>+</sup>CCR6<sup>-</sup>) and Th1* cells (CXCR3<sup>+</sup>CCR6<sup>+</sup>) [<xref rid="B125-ijms-21-08011" ref-type="bibr">125</xref>,<xref rid="B126-ijms-21-08011" ref-type="bibr">126</xref>].</p><p>ILC3s are also involved in type 3 immune responses [<xref rid="B37-ijms-21-08011" ref-type="bibr">37</xref>]. IL-22 production by ILC3s is important for host defense against extracellular bacteria [<xref rid="B127-ijms-21-08011" ref-type="bibr">127</xref>]. IL-22 induces the production of antimicrobial peptides by epithelial cells. In addition, ILC3-derived IL-22 may induce the expression of serum amyloid proteins, which promote IL-17 production by Th17 cells [<xref rid="B128-ijms-21-08011" ref-type="bibr">128</xref>]. On the other hand, Th17 cells may silence IL-22 production by ILC3s through controlling commensal bacteria; the sequential activation of ILC3s and Th17 cells has been noted during normal development, while steady-state commensalism is being established in the host, and in the absence of Th17 cell differentiation, ILC3s remain constitutively active, leading to an impaired lipid metabolism in the gut [<xref rid="B129-ijms-21-08011" ref-type="bibr">129</xref>]. Therefore, there is a crosstalk between ILC3s and Th17 cells in maintaining gut homeostasis.</p></sec><sec id="sec4dot2-ijms-21-08011"><title>4.2. CD4 T Cell Plasticity</title><p>Although cell plasticity has been found in almost all CD4 T cell subsets, Th17 cells are the most flexible in altering their phenotypes [<xref rid="B53-ijms-21-08011" ref-type="bibr">53</xref>,<xref rid="B130-ijms-21-08011" ref-type="bibr">130</xref>]. Now, many current studies focus on Th17 cells&#8217; dichotomous nature (protective and pathogenic effects), plasticity, and its application in therapy [<xref rid="B31-ijms-21-08011" ref-type="bibr">31</xref>]. Various important extracellular and intracellular regulators of Th17 cells have already been found [<xref rid="B119-ijms-21-08011" ref-type="bibr">119</xref>]. There are several regulators, such as IL-23 [<xref rid="B131-ijms-21-08011" ref-type="bibr">131</xref>], CD5L [<xref rid="B132-ijms-21-08011" ref-type="bibr">132</xref>], and REV-ERB&#945; [<xref rid="B133-ijms-21-08011" ref-type="bibr">133</xref>], that have been found recently to be involved in regulating Th17 dual functions. Although the detailed mechanism behind their dichotomous nature is still unclear, it may have something to do with Th17 cell plasticity being influenced by the environment. Indeed, several environmental factors, such as sodium chloride [<xref rid="B134-ijms-21-08011" ref-type="bibr">134</xref>], microbiota [<xref rid="B135-ijms-21-08011" ref-type="bibr">135</xref>,<xref rid="B136-ijms-21-08011" ref-type="bibr">136</xref>,<xref rid="B137-ijms-21-08011" ref-type="bibr">137</xref>], and angiogenesis [<xref rid="B138-ijms-21-08011" ref-type="bibr">138</xref>], may regulate the generation of pathogenic Th17 cells. In terms of cell plasticity, Th17 cells were reported to be unstable both in vitro and in vivo, and they may become Th1-like cells [<xref rid="B53-ijms-21-08011" ref-type="bibr">53</xref>,<xref rid="B139-ijms-21-08011" ref-type="bibr">139</xref>]. Glutamine metabolism was found to be important in regulating Th17 versus Th1 cell differentiation [<xref rid="B140-ijms-21-08011" ref-type="bibr">140</xref>,<xref rid="B141-ijms-21-08011" ref-type="bibr">141</xref>]. CK2 was reported to control Th17 and Treg cell differentiation through inhibiting FoxO1 [<xref rid="B142-ijms-21-08011" ref-type="bibr">142</xref>]. Recently, it has been found that metabolic heterogeneity may underlie reciprocal fates of Th17 cell stemness and plasticity [<xref rid="B143-ijms-21-08011" ref-type="bibr">143</xref>]. In a mouse model of autoimmune disease, it was found that Th17 cells are functionally and metabolically heterogeneous and contain two different subsets: one subset with stemness-associated features but lower anabolic metabolism, and another subset with higher metabolic activity that supports trans-differentiation into Th1-like cells. This study was also supported by another study, which reported a metabolism difference related with the degree of Th17 cell plasticity [<xref rid="B144-ijms-21-08011" ref-type="bibr">144</xref>]. Since IL-12 and IL-23 are responsible for converting Th17 cells to Th1-like cells [<xref rid="B52-ijms-21-08011" ref-type="bibr">52</xref>,<xref rid="B53-ijms-21-08011" ref-type="bibr">53</xref>,<xref rid="B145-ijms-21-08011" ref-type="bibr">145</xref>], the relationship between the production of IL-12/IL-23 and metabolic regulation requires further investigation.</p></sec><sec id="sec4dot3-ijms-21-08011"><title>4.3. Th17-Related Diseases</title><p>As discussed above, Th17 cells contribute to immunity against extracellular bacteria and fungi and the pathogenesis of multiple chronic inflammatory diseases [<xref rid="B5-ijms-21-08011" ref-type="bibr">5</xref>,<xref rid="B66-ijms-21-08011" ref-type="bibr">66</xref>]. Patients with mutations in the <italic toggle="yes">RORC</italic> (which encodes ROR&#947;t) gene suffer from chronic candidiasis consistent with a lack of Th17 cells in these patients [<xref rid="B146-ijms-21-08011" ref-type="bibr">146</xref>]. Interestingly, these patients are also susceptible to mycobacterium infection with reduced IFN&#947; response. Whether this is due to a defect in thymic development in these patients (ROR&#947;t also plays an important role in T cell development) or due to a blockage of the development of Th1 cells from a transient Th17 stage requires further investigation. <italic toggle="yes">STAT3</italic>, as the gene encoding a key transcription factor for Th17 cell differentiation, was found to be mutated in many patients with hyper-IgE syndrome, which is a primary immunodeficiency disorder [<xref rid="B147-ijms-21-08011" ref-type="bibr">147</xref>,<xref rid="B148-ijms-21-08011" ref-type="bibr">148</xref>,<xref rid="B149-ijms-21-08011" ref-type="bibr">149</xref>,<xref rid="B150-ijms-21-08011" ref-type="bibr">150</xref>]. These patients have heightened susceptibility to be infected by bacteria, such as <italic toggle="yes">Staphylococcus aureus</italic>, <italic toggle="yes">Streptococcus pneumoniae, Candida albicans</italic>, and other fungi due to impaired Th17 cells. It was also found that mutations in <italic toggle="yes">DOCK8</italic> may result in hyper-IgE syndrome [<xref rid="B151-ijms-21-08011" ref-type="bibr">151</xref>,<xref rid="B152-ijms-21-08011" ref-type="bibr">152</xref>], and patients with this form of mutation have a deficiency in Th17 cells. It was reported that mutations that take place in the Src homology 2 (SH2)-/tail segment (TS)-/transactivation (TA)-/DNA binding-domain of STAT1 result in loss-of-function in Th1, and patients with this form of mutation display increased susceptibility to mycobacteria and viruses [<xref rid="B153-ijms-21-08011" ref-type="bibr">153</xref>,<xref rid="B154-ijms-21-08011" ref-type="bibr">154</xref>]. However, mutations that take place in the coiled-coil domain of STAT1 cause enhanced Th1 but reduced Th17 cell-mediated responses; patients with this form of mutation suffered from chronic mucocutaneous candidiasis [<xref rid="B155-ijms-21-08011" ref-type="bibr">155</xref>,<xref rid="B156-ijms-21-08011" ref-type="bibr">156</xref>]. Mechanistically, this mutation within the coiled-coil domain of STAT1 reduces the dephosphorylation of activated STAT1 and thus increases the level of phosphorylated STAT1 in the nucleus [<xref rid="B155-ijms-21-08011" ref-type="bibr">155</xref>]. As a result, the dominance of activated STAT1 causes an overproduction of IFN-&#945;/&#946;, IFN-&#947;, and IL-27, which induce the STAT1-mediated inhibition of Th17 cell differentiation. It has also been reported that two different genetic etiologies of chronic mucocutaneous candidiasis diseases are associated with autosomal recessive deficiency in the cytokine receptor IL-17RA and autosomal dominant deficiency in IL-17F, respectively [<xref rid="B157-ijms-21-08011" ref-type="bibr">157</xref>]. In addition, due to the important role of IL-1&#946; during Th17 cell differentiation and/or stabilization [<xref rid="B117-ijms-21-08011" ref-type="bibr">117</xref>,<xref rid="B158-ijms-21-08011" ref-type="bibr">158</xref>], mutations in IL-1&#946; were found to cause several autoinflammatory disorders [<xref rid="B159-ijms-21-08011" ref-type="bibr">159</xref>].</p><p>Given that Th17 cells are closely associated with multiple inflammatory and autoimmune disorders, targeting these cells or their effector cytokines is considered to be an effective way for disease treatment. For example, antibodies against IL-12p40 (the common subunit of IL-12 and IL-23) have been successfully used in treating psoriasis [<xref rid="B160-ijms-21-08011" ref-type="bibr">160</xref>,<xref rid="B161-ijms-21-08011" ref-type="bibr">161</xref>]. Similarly, anti-IL-17A/F, anti-IL-17RA, and ROR&#947;t inhibitors have been used in treating different types of autoimmune diseases [<xref rid="B162-ijms-21-08011" ref-type="bibr">162</xref>,<xref rid="B163-ijms-21-08011" ref-type="bibr">163</xref>].</p></sec></sec><sec id="sec5-ijms-21-08011"><title>5. Treg Cells and Related Diseases</title><sec id="sec5dot1-ijms-21-08011"><title>5.1. Treg Cells</title><p>It has been long speculated that a specialized population of lymphocytes in mammals can perform an immune regulatory function. However, no one was able to provide strong evidence for the existence of these cells until a breakthrough report in 1995, in which Sakaguchi and his colleagues described that a subset of CD4 T cells marked by CD25 expression are essential for the maintenance of self-tolerance [<xref rid="B164-ijms-21-08011" ref-type="bibr">164</xref>]. Another groundbreaking discovery came in 2003, when three groups independently identified Foxp3 as the master transcription factor for Treg cells [<xref rid="B165-ijms-21-08011" ref-type="bibr">165</xref>,<xref rid="B166-ijms-21-08011" ref-type="bibr">166</xref>,<xref rid="B167-ijms-21-08011" ref-type="bibr">167</xref>].</p><p>Regulatory T cells can develop in the thymus during negative selection, and these Treg cells are called thymic-derived Treg (tTreg) cells [<xref rid="B168-ijms-21-08011" ref-type="bibr">168</xref>]. tTreg cells, by recognizing self-antigens, mainly control self-reactive effector T cells that escaped negative selection to maintain immune tolerance [<xref rid="B169-ijms-21-08011" ref-type="bibr">169</xref>]. Treg cells can also be induced in vitro from na&#239;ve CD4 T cells, and they are now called inducible Treg (iTreg) cells [<xref rid="B170-ijms-21-08011" ref-type="bibr">170</xref>,<xref rid="B171-ijms-21-08011" ref-type="bibr">171</xref>,<xref rid="B172-ijms-21-08011" ref-type="bibr">172</xref>,<xref rid="B173-ijms-21-08011" ref-type="bibr">173</xref>,<xref rid="B174-ijms-21-08011" ref-type="bibr">174</xref>]. In contrast, Treg cells differentiated from na&#239;ve CD4 T cells in vivo outside of the thymus are now named as peripherally induced Treg (pTreg) cells. The differentiation of pTreg cells, especially in the gut [<xref rid="B175-ijms-21-08011" ref-type="bibr">175</xref>], is promoted by retinoic acid in the environment and metabolites produced by microbiota [<xref rid="B176-ijms-21-08011" ref-type="bibr">176</xref>,<xref rid="B177-ijms-21-08011" ref-type="bibr">177</xref>]. Compared with tTreg cells, pTreg cells not only recognize self-antigens, but also recognize non-self-antigens including food antigens and innocuous commensal microbiota-derived antigens; therefore, they are important for the maintenance of mucosal tolerance [<xref rid="B178-ijms-21-08011" ref-type="bibr">178</xref>]. Several markers, including Helios and neuropilin (Nrp), have been proposed to distinguish pTreg cells from tTreg cells [<xref rid="B179-ijms-21-08011" ref-type="bibr">179</xref>,<xref rid="B180-ijms-21-08011" ref-type="bibr">180</xref>]; however, these molecules can also be expressed by some pTreg cells, indicating that they may simply mark more differentiated Treg cells. Similarly, it has been proposed that tTreg cells are more stable than pTreg and iTreg cells, but this could also be explained by the more differentiated status of tTreg cells compared to other Treg cells [<xref rid="B181-ijms-21-08011" ref-type="bibr">181</xref>,<xref rid="B182-ijms-21-08011" ref-type="bibr">182</xref>]. In the gut, ROR&#947;t-expressing Treg cells may represent pTreg cells, whereas GATA3-expressing Treg cells could be largely tTreg cells [<xref rid="B183-ijms-21-08011" ref-type="bibr">183</xref>,<xref rid="B184-ijms-21-08011" ref-type="bibr">184</xref>].</p><p>Cytokines, especially IL-2 and TGF-&#946;, play essential roles during the development and differentiation of Treg cells. IL-2 and TGF-&#946; promote Foxp3 expression by activating STAT5 and SMAD2/3, respectively [<xref rid="B185-ijms-21-08011" ref-type="bibr">185</xref>,<xref rid="B186-ijms-21-08011" ref-type="bibr">186</xref>,<xref rid="B187-ijms-21-08011" ref-type="bibr">187</xref>]. TCR signaling is also important and it induces Foxp3 expression through the activation of the NF-AT/NF-&#954;B/AP-1 pathways [<xref rid="B170-ijms-21-08011" ref-type="bibr">170</xref>].</p><p>In addition to Foxp3, many other transcription factors, such as Runx1 [<xref rid="B188-ijms-21-08011" ref-type="bibr">188</xref>], Nrfa2 [<xref rid="B189-ijms-21-08011" ref-type="bibr">189</xref>], Foxo family members [<xref rid="B190-ijms-21-08011" ref-type="bibr">190</xref>], SATB1 [<xref rid="B191-ijms-21-08011" ref-type="bibr">191</xref>], and Helios [<xref rid="B179-ijms-21-08011" ref-type="bibr">179</xref>,<xref rid="B192-ijms-21-08011" ref-type="bibr">192</xref>], can regulate the development and functions of Treg cells. Multiple mechanisms through which Treg cells exert their regulatory functions have been proposed: by secreting regulatory cytokines (such as IL-10, TGF&#946;, and IL-35) [<xref rid="B193-ijms-21-08011" ref-type="bibr">193</xref>]; by consuming IL-2, which is important for effective CD4 T cell survival and proliferation [<xref rid="B194-ijms-21-08011" ref-type="bibr">194</xref>,<xref rid="B195-ijms-21-08011" ref-type="bibr">195</xref>]; by expressing cell surface receptors that transmit negative signals (such as CTLA-4, CD39, CD73) [<xref rid="B34-ijms-21-08011" ref-type="bibr">34</xref>,<xref rid="B196-ijms-21-08011" ref-type="bibr">196</xref>]; by expressing perforin and granzyme B to directly kill APCs [<xref rid="B197-ijms-21-08011" ref-type="bibr">197</xref>]; and by inducing trogocytosis to strip off the antigen-MHCII complexes from APCs in an antigen-specific manner [<xref rid="B198-ijms-21-08011" ref-type="bibr">198</xref>].</p></sec><sec id="sec5dot2-ijms-21-08011"><title>5.2. Treg Related Diseases</title><p>Since Treg cells are essential for the maintenance of immunological tolerance and Foxp3 is the master transcription factor for Treg cells, mutations in the <italic toggle="yes">Foxp3</italic> gene in mice or in the <italic toggle="yes">FOXP3</italic> gene in humans lead to severe autoimmune diseases and death [<xref rid="B199-ijms-21-08011" ref-type="bibr">199</xref>,<xref rid="B200-ijms-21-08011" ref-type="bibr">200</xref>,<xref rid="B201-ijms-21-08011" ref-type="bibr">201</xref>]. Since the <italic toggle="yes">FOXP3</italic> is located in the X chromosome, boys carrying a deleterious <italic toggle="yes">FOXP3</italic> mutation will develop immunodysregulation polyendocrinopathy enteropathy X-linked (IPEX) syndrome. The syndrome of IPEX often includes insulin-dependent diabetes, elevated serum IgE with aspects of both eczema and psoriasis, and some other autoimmune symptoms include hypothyroidism, anemia, thrombocytopenia, and neutropenia. Hemizygous male mice with a mutant <italic toggle="yes">Foxp3</italic> (<italic toggle="yes">scurfy</italic> mice) develop lethal multi-organ autoimmunity and die 16&#8211;25 days after birth. Some <italic toggle="yes">FOXP3</italic> mutations cause less severe diseases. For example, patients with a point mutation in the domain swap interface of FOXP3 protein develop a Th2-related disease [<xref rid="B202-ijms-21-08011" ref-type="bibr">202</xref>]. In addition to Foxp3 mutations, deficiency in other regulators of Treg-suppressive functions, such as TRAF3 [<xref rid="B203-ijms-21-08011" ref-type="bibr">203</xref>], CD28 [<xref rid="B204-ijms-21-08011" ref-type="bibr">204</xref>], Id2/Id3 [<xref rid="B205-ijms-21-08011" ref-type="bibr">205</xref>], Ubc13 [<xref rid="B206-ijms-21-08011" ref-type="bibr">206</xref>], Ndfip1 [<xref rid="B207-ijms-21-08011" ref-type="bibr">207</xref>], NF-&#954;B p65 [<xref rid="B208-ijms-21-08011" ref-type="bibr">208</xref>], Helios [<xref rid="B209-ijms-21-08011" ref-type="bibr">209</xref>], Th-POK/LRF [<xref rid="B210-ijms-21-08011" ref-type="bibr">210</xref>], EZH2 [<xref rid="B211-ijms-21-08011" ref-type="bibr">211</xref>], BACH2 [<xref rid="B212-ijms-21-08011" ref-type="bibr">212</xref>,<xref rid="B213-ijms-21-08011" ref-type="bibr">213</xref>], SATB1 [<xref rid="B214-ijms-21-08011" ref-type="bibr">214</xref>], IRF-4 and Blimp-1 [<xref rid="B215-ijms-21-08011" ref-type="bibr">215</xref>], and LKB1 [<xref rid="B216-ijms-21-08011" ref-type="bibr">216</xref>], can also result in severe autoimmune diseases, although most of these studies were carried out in mice, and their relevance in human diseases remains to be tested.</p></sec></sec><sec id="sec6-ijms-21-08011"><title>6. Tfh Cells and Related Diseases</title><sec id="sec6dot1-ijms-21-08011"><title>6.1. Tfh Cells</title><p>Tfh cells were noticed about twenty years ago but only well accepted as a distinct lineage of CD4 T cells required for the formation of germinal centers (GCs) when its master transcription factor Bcl6 was identified [<xref rid="B217-ijms-21-08011" ref-type="bibr">217</xref>,<xref rid="B218-ijms-21-08011" ref-type="bibr">218</xref>,<xref rid="B219-ijms-21-08011" ref-type="bibr">219</xref>]. Tfh cells are mainly found in the B cell follicles in lymph nodes and spleen, so they may help B cells in antibody production and affinity maturation [<xref rid="B220-ijms-21-08011" ref-type="bibr">220</xref>]. How important Tfh cells are for antibody class switching remains to be tested, since antibody class switching happens largely outside of GCs [<xref rid="B221-ijms-21-08011" ref-type="bibr">221</xref>]. Similar to the differentiation of other CD4 T cell subsets, Tfh cell differentiation from na&#239;ve CD4 T cells is also tightly regulated by TCR signaling and cytokine milieu [<xref rid="B32-ijms-21-08011" ref-type="bibr">32</xref>]. Possibly because of an essential role of the interaction between antigen-specific B cells and pre-Tfh cells during Tfh cell development, it is difficult to generate Tfh cells in vitro [<xref rid="B222-ijms-21-08011" ref-type="bibr">222</xref>,<xref rid="B223-ijms-21-08011" ref-type="bibr">223</xref>]. Nevertheless, IL-6 and IL-21 by activating STAT3 were found to induce Tfh cell differentiation. IL-6 together with TCR signaling is involved in the initiation of Tfh cell differentiation by inducing an early wave of Bcl6 expression [<xref rid="B218-ijms-21-08011" ref-type="bibr">218</xref>,<xref rid="B224-ijms-21-08011" ref-type="bibr">224</xref>]. IL-21 was also reported to be involved in Tfh cell differentiation [<xref rid="B225-ijms-21-08011" ref-type="bibr">225</xref>]. Unlike IL-6 and IL-21, IL-2 [<xref rid="B219-ijms-21-08011" ref-type="bibr">219</xref>,<xref rid="B226-ijms-21-08011" ref-type="bibr">226</xref>] plays a negative role during Tfh cell differentiation by promoting the expression of Blimp-1, which inhibits Bcl6 expression. By producing cytokines or direct cell-cell contact, both DCs and B cells play an essential role in promoting Tfh differentiation and migration [<xref rid="B227-ijms-21-08011" ref-type="bibr">227</xref>]. After the activation of na&#239;ve CD4 T cells in the T cell zone by DCs, these activated T cells may migrate to the T-B border through upregulating CXCR5 and downregulating CCR7 expression; with further upregulation of CXCR5 expression after in contact with B cells, Tfh cells continue to migrate into GC to become GC Tfh cells [<xref rid="B228-ijms-21-08011" ref-type="bibr">228</xref>]. In addition to CXCR5, CCR7, PSGL1, and S1P receptors that are involved in cell migration, SLAM family receptors and integrins are also involved in regulating Tfh cell functions [<xref rid="B32-ijms-21-08011" ref-type="bibr">32</xref>]. In addition, other regulators, including ICOSL [<xref rid="B222-ijms-21-08011" ref-type="bibr">222</xref>], Ascl2 [<xref rid="B229-ijms-21-08011" ref-type="bibr">229</xref>], Itch [<xref rid="B230-ijms-21-08011" ref-type="bibr">230</xref>], VHL [<xref rid="B231-ijms-21-08011" ref-type="bibr">231</xref>], IL-37 [<xref rid="B232-ijms-21-08011" ref-type="bibr">232</xref>], HIF-1&#945; [<xref rid="B233-ijms-21-08011" ref-type="bibr">233</xref>], COX-1 [<xref rid="B234-ijms-21-08011" ref-type="bibr">234</xref>], Th-POK [<xref rid="B235-ijms-21-08011" ref-type="bibr">235</xref>], and Tox2 [<xref rid="B236-ijms-21-08011" ref-type="bibr">236</xref>] are also found to be important for Tfh cell differentiation and functions. Tfh cells provide help to GC B cells in two aspects: one is to promote GC B cell maturation, and the other is to promote antibody production. CD40L expressed on Tfh cells is required for inducing the formation of high-affinity plasma cells and memory B cells [<xref rid="B237-ijms-21-08011" ref-type="bibr">237</xref>,<xref rid="B238-ijms-21-08011" ref-type="bibr">238</xref>]. Signature cytokine IL-21 secreted by Tfh cells may control the maintenance and optimal affinity maturation of GC responses [<xref rid="B220-ijms-21-08011" ref-type="bibr">220</xref>,<xref rid="B239-ijms-21-08011" ref-type="bibr">239</xref>,<xref rid="B240-ijms-21-08011" ref-type="bibr">240</xref>].</p></sec><sec id="sec6dot2-ijms-21-08011"><title>6.2. Tfh Subsets</title><p>Although the main cytokine produced by Tfh cells is IL-21, it was found that Tfh cells can also secret cytokines that are produced by Th1, Th2, and Th17 cells; therefore, Tfh cells can be classified into Tfh1, Tfh2, and Tfh17 cell subsets [<xref rid="B241-ijms-21-08011" ref-type="bibr">241</xref>]. Recently, it has been reported that a new subset of Tfh, which is referred to as Tfh13 cells, have an unusual cytokine profile (IL-13<sup>hi</sup>/IL-4<sup>hi</sup>/IL-5<sup>hi</sup>/IL-21<sup>lo</sup>) and co-express Bcl6 and GATA3 [<xref rid="B242-ijms-21-08011" ref-type="bibr">242</xref>]. This subset is different from Tfh2, cells which are Bcl6/BATF co-expressing IL-4<sup>hi</sup>/IL-21<sup>hi</sup> Tfh cells. Interestingly, these Tfh13 cells are required for the production of high- but not low-affinity IgE and for subsequent allergen-induced anaphylaxis. Similarly, although class switching occurs infrequently in the germinal centers [<xref rid="B221-ijms-21-08011" ref-type="bibr">221</xref>], IFN&#947;-producing cells with a history of T-bet expression have been found in the germinal centers [<xref rid="B61-ijms-21-08011" ref-type="bibr">61</xref>]. Therefore, it is possible that germinal center IFN&#947;-producing Tfh cells may play an important role in the production of high-affinity IgGs.</p><p>It is likely that during activation, naive CD4 T cells may incorporate several layers of fate decisions over time and space at the stages of priming and reinforcement/terminal differentiation [<xref rid="B4-ijms-21-08011" ref-type="bibr">4</xref>]. During priming, there are two signals essential for na&#239;ve CD4 T cells fate determination: signals downstream of TCR/co-stimulation, which affect non-Tfh versus Tfh cell fate decision, and signals downstream of cytokine receptors, which influence T helper subset decision (e.g., Th1, Th2, or Th17). Therefore, high and low TCR stimulation, which cause a differential pattern of CD25/IRF4/Blimp-1/Bcl6/CXCR5 expression, will result in non-Tfh or Tfh cell fate, respectively. Meanwhile, specific cytokine signals triggered in a specific inflamed environment may lead to the expression of the transcriptional networks that control a specific effector program (e.g., Th1/Th2/Th17 or Tfh1/Tfh2/Tfh17). During reinforcement/terminal differentiation, non-Tfh Teff cells migrate to different tissues depending on the chemokine receptors they express and produce corresponding cytokines, whereas Tfh cells migrate to the T-B border and GC for further maturation and to give help to B cells. As a result, these bifurcated parallel axes allow CD4 T cells to rapidly and effectively augment their particular effector programs in host defense [<xref rid="B4-ijms-21-08011" ref-type="bibr">4</xref>]. Since the Tfh and non-Tfh Teff cell differentiation programs may antagonize each other, the fate determination of a particular Tfh cell subset may involve several sequential differentiation steps [<xref rid="B223-ijms-21-08011" ref-type="bibr">223</xref>]. Alternatively, the transient expression of non-Tfh Teff cell-associated transcription factors during early Tfh cell differentiation may epigenetically program the fate of a specific subset of Tfh cells [<xref rid="B61-ijms-21-08011" ref-type="bibr">61</xref>].</p></sec><sec id="sec6dot3-ijms-21-08011"><title>6.3. Tfh Related Diseases</title><p>Since Tfh cells are critical for the generation of effective long-lived protective antibody responses, the dysregulation of Tfh functions has been noted in various diseases such as inflammation, autoimmunity, allergy, and cancer [<xref rid="B32-ijms-21-08011" ref-type="bibr">32</xref>]. Diseases caused by Tfh cells can be divided into two distinct types: autoimmune diseases due to an overabundance of Tfh cells and immunodeficiencies due to a defect in the generation and functions of Tfh cells. One typical representative of autoimmune diseases is systemic lupus erythematosus (SLE), and these patients are found to have increased frequencies of Tfh-like cells in peripheral blood and an amplification of pathogenic autoantibodies [<xref rid="B243-ijms-21-08011" ref-type="bibr">243</xref>,<xref rid="B244-ijms-21-08011" ref-type="bibr">244</xref>]. Sjogren&#8217;s syndrome (SS) [<xref rid="B245-ijms-21-08011" ref-type="bibr">245</xref>], juvenile dermatomyositis [<xref rid="B246-ijms-21-08011" ref-type="bibr">246</xref>], and rheumatism [<xref rid="B247-ijms-21-08011" ref-type="bibr">247</xref>] are other common autoimmune diseases related to Tfh cells. For immunodeficient diseases, mutations of genes, such as <italic toggle="yes">STAT3</italic> [<xref rid="B248-ijms-21-08011" ref-type="bibr">248</xref>], <italic toggle="yes">CD40L</italic> [<xref rid="B249-ijms-21-08011" ref-type="bibr">249</xref>,<xref rid="B250-ijms-21-08011" ref-type="bibr">250</xref>], and <italic toggle="yes">ICOS</italic> [<xref rid="B251-ijms-21-08011" ref-type="bibr">251</xref>], which are important for Tfh cell differentiation and functions, were found in immunodeficient patients with reduced numbers of Tfh cells. Given the important role of Tfh cells in helping B cell antibody production, enhancing Tfh cell-associated biology is being considered for effective vaccination, whereas targeting Tfh cells aiming to reduce antibody production could be a base for therapeutic interventions in some human autoimmune diseases.</p></sec></sec><sec id="sec7-ijms-21-08011"><title>7. Concluding Remarks</title><p>In order to protect a host from the invasion of various pathogens, the immune system has evolved a series of mechanisms to respond rapidly and effectively. CD4 T helper subsets mediate effective adaptive immune responses particularly when innate immune responses fail to eliminate pathogens; CD4 T cell responses also generate memory, which can quickly respond to the second infection of the same or similar pathogens. Different types of adaptive immune responses are executed by Th1/Th2/Th17 cells, respectively, with each subset of T helper cells possessing their unique properties in producing their signature cytokines. Interestingly, before adaptive responses take place, innate lymphoid cells, which can also be divided into ILC1/ILC2/ILC3 subsets, may provide early protection and allow time for adaptive responses, whereas memory and/or memory-phenotype CD4 T cells, by possessing some similar features of ILCs (i.e., a completed differentiation process allowing a rapid response, capable of responding to inflammatory cytokines and tissue residency), may behave similarly as ILCs, to a certain extent, during a subsequent infection [<xref rid="B252-ijms-21-08011" ref-type="bibr">252</xref>,<xref rid="B253-ijms-21-08011" ref-type="bibr">253</xref>].</p><p>Th1, Th2, and Th17 cells can be categorized as non-Tfh Teff cells in parallel with Tfh and Treg cells, since both Tfh cells and Treg cells may be further divided into Th1-, Th2-, and Th17-like subpopulations [<xref rid="B7-ijms-21-08011" ref-type="bibr">7</xref>,<xref rid="B61-ijms-21-08011" ref-type="bibr">61</xref>,<xref rid="B183-ijms-21-08011" ref-type="bibr">183</xref>,<xref rid="B254-ijms-21-08011" ref-type="bibr">254</xref>]. Cell plasticity may exist between non-Tfh and Tfh cells, and between Teff cells and Treg cells [<xref rid="B130-ijms-21-08011" ref-type="bibr">130</xref>,<xref rid="B255-ijms-21-08011" ref-type="bibr">255</xref>,<xref rid="B256-ijms-21-08011" ref-type="bibr">256</xref>]. However, even within Teff cells, particularly for Th17 cells, cell plasticity has been well documented. Th1-like Th17 cells have been found during infections and in autoimmune settings. The heterogeneity and plasticity of CD4 T cell subsets are largely determined by the temporal and quantitative co-expression of multiple master transcription factors during the differentiation of these cell subsets [<xref rid="B7-ijms-21-08011" ref-type="bibr">7</xref>]. Between non-Tfh and Tfh cells, their balance may determine the magnitude of cellular versus humoral responses. In contrast, the balance between Teff and Treg cells reveals the yin and yang sides of the immune system. Understanding such balances is not only important for gaining our knowledge in basic immunology in infections and inflammations, but also for providing great opportunities in treating different types of immunological diseases. In fact, more and more attention is being paid to Treg-based therapies [<xref rid="B168-ijms-21-08011" ref-type="bibr">168</xref>], because Treg cells play critical roles in anti-inflammation, autoimmunity prevention, and cancer promotion.</p><p>With the rapid development of modern technologies, such as single-cell RNA sequencing [<xref rid="B257-ijms-21-08011" ref-type="bibr">257</xref>], CRISPR (clustered regularly interspaced short palindromic repeats)-mediated genome editing [<xref rid="B93-ijms-21-08011" ref-type="bibr">93</xref>,<xref rid="B258-ijms-21-08011" ref-type="bibr">258</xref>], Cryo-EM (cryogenic electron microscopy) structure analysis [<xref rid="B259-ijms-21-08011" ref-type="bibr">259</xref>], single-cell mass spectrometry [<xref rid="B260-ijms-21-08011" ref-type="bibr">260</xref>], and immunoimaging [<xref rid="B261-ijms-21-08011" ref-type="bibr">261</xref>,<xref rid="B262-ijms-21-08011" ref-type="bibr">262</xref>,<xref rid="B263-ijms-21-08011" ref-type="bibr">263</xref>], many important findings are being made in the identification, development, and regulation of new CD4 T cell and ILC subsets, as well as their relationship and crosstalks in diseases. In the future, it is also important to investigate how CD4 T cell memory for each subset is formed and maintained [<xref rid="B264-ijms-21-08011" ref-type="bibr">264</xref>] and whether the plasticity of antigen cross-reactive CD4 T cell memory cells may shape the primary response to a new infection [<xref rid="B265-ijms-21-08011" ref-type="bibr">265</xref>]. With exciting new findings in basic immunology, our better and deeper understanding of this powerful system will help us uncover innovative measures for diseases treatment, thereby improving human health.</p></sec></body><back><fn-group><fn><p><bold>Publisher&#8217;s Note:</bold> MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations.</p></fn></fn-group><notes><title>Author Contributions</title><p>X.Z. prepared the initial draft; X.Z. and J.Z. revised and finalized the manuscript. All authors have read and agreed to the published version of the manuscript.</p></notes><notes><title>Funding</title><p>This work is supported by the Division of Intramural Research of the NIAID (1ZIAAI001169, US National Institutes of Health).</p></notes><notes notes-type="COI-statement"><title>Conflicts of Interest</title><p>The authors declare no conflict of interest.</p></notes><ref-list><title>References</title><ref id="B1-ijms-21-08011"><label>1.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Pennington</surname><given-names>D.J.</given-names></name><name name-style="western"><surname>Vermijlen</surname><given-names>D.</given-names></name><name name-style="western"><surname>Wise</surname><given-names>E.L.</given-names></name><name name-style="western"><surname>Clarke</surname><given-names>S.L.</given-names></name><name name-style="western"><surname>Tigelaar</surname><given-names>R.E.</given-names></name><name name-style="western"><surname>Hayday</surname><given-names>A.C.</given-names></name></person-group><article-title>The integration of conventional and unconventional T cells that characterizes cell-mediated responses</article-title><source>Adv. Immunol.</source><year>2005</year><volume>87</volume><fpage>27</fpage><lpage>59</lpage><pub-id pub-id-type="doi">10.1016/S0065-2776(05)87002-6</pub-id><pub-id pub-id-type="pmid">16102571</pub-id></element-citation></ref><ref id="B2-ijms-21-08011"><label>2.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Girardi</surname><given-names>S.R.A.M.</given-names></name></person-group><article-title>Conventional and Unconventional T Cells</article-title><source>Clin. Basic Immunodermatol.</source><year>2008</year><volume>6</volume><fpage>85</fpage><lpage>104</lpage></element-citation></ref><ref id="B3-ijms-21-08011"><label>3.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kumar</surname><given-names>B.V.</given-names></name><name name-style="western"><surname>Connors</surname><given-names>T.J.</given-names></name><name name-style="western"><surname>Farber</surname><given-names>D.L.</given-names></name></person-group><article-title>Human T Cell Development, Localization, and Function throughout Life</article-title><source>Immunity</source><year>2018</year><volume>48</volume><fpage>202</fpage><lpage>213</lpage><pub-id pub-id-type="doi">10.1016/j.immuni.2018.01.007</pub-id><pub-id pub-id-type="pmid">29466753</pub-id><pub-id pub-id-type="pmcid">PMC5826622</pub-id></element-citation></ref><ref id="B4-ijms-21-08011"><label>4.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ruterbusch</surname><given-names>M.</given-names></name><name name-style="western"><surname>Pruner</surname><given-names>K.B.</given-names></name><name name-style="western"><surname>Shehata</surname><given-names>L.</given-names></name><name name-style="western"><surname>Pepper</surname><given-names>M.</given-names></name></person-group><article-title>In Vivo CD4(+) T Cell Differentiation and Function: Revisiting the Th1/Th2 Paradigm</article-title><source>Annu. Rev. Immunol.</source><year>2020</year><volume>38</volume><fpage>705</fpage><lpage>725</lpage><pub-id pub-id-type="doi">10.1146/annurev-immunol-103019-085803</pub-id><pub-id pub-id-type="pmid">32340571</pub-id></element-citation></ref><ref id="B5-ijms-21-08011"><label>5.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Zhu</surname><given-names>J.</given-names></name><name name-style="western"><surname>Yamane</surname><given-names>H.</given-names></name><name name-style="western"><surname>Paul</surname><given-names>W.E.</given-names></name></person-group><article-title>Differentiation of effector CD4 T cell populations (*)</article-title><source>Annu. Rev. Immunol.</source><year>2010</year><volume>28</volume><fpage>445</fpage><lpage>489</lpage><pub-id pub-id-type="doi">10.1146/annurev-immunol-030409-101212</pub-id><pub-id pub-id-type="pmid">20192806</pub-id><pub-id pub-id-type="pmcid">PMC3502616</pub-id></element-citation></ref><ref id="B6-ijms-21-08011"><label>6.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Annunziato</surname><given-names>F.</given-names></name><name name-style="western"><surname>Romagnani</surname><given-names>C.</given-names></name><name name-style="western"><surname>Romagnani</surname><given-names>S.</given-names></name></person-group><article-title>The 3 major types of innate and adaptive cell-mediated effector immunity</article-title><source>J. Allergy Clin. Immunol.</source><year>2015</year><volume>135</volume><fpage>626</fpage><lpage>635</lpage><pub-id pub-id-type="doi">10.1016/j.jaci.2014.11.001</pub-id><pub-id pub-id-type="pmid">25528359</pub-id></element-citation></ref><ref id="B7-ijms-21-08011"><label>7.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Fang</surname><given-names>D.</given-names></name><name name-style="western"><surname>Zhu</surname><given-names>J.</given-names></name></person-group><article-title>Dynamic balance between master transcription factors determines the fates and functions of CD4 T cell and innate lymphoid cell subsets</article-title><source>J. Exp. Med.</source><year>2017</year><volume>214</volume><fpage>1861</fpage><lpage>1876</lpage><pub-id pub-id-type="doi">10.1084/jem.20170494</pub-id><pub-id pub-id-type="pmid">28630089</pub-id><pub-id pub-id-type="pmcid">PMC5502437</pub-id></element-citation></ref><ref id="B8-ijms-21-08011"><label>8.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Chen</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Kuchroo</surname><given-names>V.K.</given-names></name><name name-style="western"><surname>Inobe</surname><given-names>J.</given-names></name><name name-style="western"><surname>Hafler</surname><given-names>D.A.</given-names></name><name name-style="western"><surname>Weiner</surname><given-names>H.L.</given-names></name></person-group><article-title>Regulatory T cell clones induced by oral tolerance: Suppression of autoimmune encephalomyelitis</article-title><source>Science</source><year>1994</year><volume>265</volume><fpage>1237</fpage><lpage>1240</lpage><pub-id pub-id-type="doi">10.1126/science.7520605</pub-id><pub-id pub-id-type="pmid">7520605</pub-id></element-citation></ref><ref id="B9-ijms-21-08011"><label>9.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Groux</surname><given-names>H.</given-names></name><name name-style="western"><surname>O&#8217;Garra</surname><given-names>A.</given-names></name><name name-style="western"><surname>Bigler</surname><given-names>M.</given-names></name><name name-style="western"><surname>Rouleau</surname><given-names>M.</given-names></name><name name-style="western"><surname>Antonenko</surname><given-names>S.</given-names></name><name name-style="western"><surname>de Vries</surname><given-names>J.E.</given-names></name><name name-style="western"><surname>Roncarolo</surname><given-names>M.G.</given-names></name></person-group><article-title>A CD4+ T-cell subset inhibits antigen-specific T-cell responses and prevents colitis</article-title><source>Nature</source><year>1997</year><volume>389</volume><fpage>737</fpage><lpage>742</lpage><pub-id pub-id-type="doi">10.1038/39614</pub-id><pub-id pub-id-type="pmid">9338786</pub-id></element-citation></ref><ref id="B10-ijms-21-08011"><label>10.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Dardalhon</surname><given-names>V.</given-names></name><name name-style="western"><surname>Awasthi</surname><given-names>A.</given-names></name><name name-style="western"><surname>Kwon</surname><given-names>H.</given-names></name><name name-style="western"><surname>Galileos</surname><given-names>G.</given-names></name><name name-style="western"><surname>Gao</surname><given-names>W.</given-names></name><name name-style="western"><surname>Sobel</surname><given-names>R.A.</given-names></name><name name-style="western"><surname>Mitsdoerffer</surname><given-names>M.</given-names></name><name name-style="western"><surname>Strom</surname><given-names>T.B.</given-names></name><name name-style="western"><surname>Elyaman</surname><given-names>W.</given-names></name><name name-style="western"><surname>Ho</surname><given-names>I.C.</given-names></name><etal/></person-group><article-title>IL-4 inhibits TGF-beta-induced Foxp3+ T cells and, together with TGF-beta, generates IL-9+ IL-10+ Foxp3(-) effector T cells</article-title><source>Nat. Immunol.</source><year>2008</year><volume>9</volume><fpage>1347</fpage><lpage>1355</lpage><pub-id pub-id-type="doi">10.1038/ni.1677</pub-id><pub-id pub-id-type="pmid">18997793</pub-id><pub-id pub-id-type="pmcid">PMC2999006</pub-id></element-citation></ref><ref id="B11-ijms-21-08011"><label>11.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Veldhoen</surname><given-names>M.</given-names></name><name name-style="western"><surname>Uyttenhove</surname><given-names>C.</given-names></name><name name-style="western"><surname>van Snick</surname><given-names>J.</given-names></name><name name-style="western"><surname>Helmby</surname><given-names>H.</given-names></name><name name-style="western"><surname>Westendorf</surname><given-names>A.</given-names></name><name name-style="western"><surname>Buer</surname><given-names>J.</given-names></name><name name-style="western"><surname>Martin</surname><given-names>B.</given-names></name><name name-style="western"><surname>Wilhelm</surname><given-names>C.</given-names></name><name name-style="western"><surname>Stockinger</surname><given-names>B.</given-names></name></person-group><article-title>Transforming growth factor-beta &#8216;reprograms&#8217; the differentiation of T helper 2 cells and promotes an interleukin 9-producing subset</article-title><source>Nat. Immunol.</source><year>2008</year><volume>9</volume><fpage>1341</fpage><lpage>1346</lpage><pub-id pub-id-type="doi">10.1038/ni.1659</pub-id><pub-id pub-id-type="pmid">18931678</pub-id></element-citation></ref><ref id="B12-ijms-21-08011"><label>12.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Eyerich</surname><given-names>S.</given-names></name><name name-style="western"><surname>Eyerich</surname><given-names>K.</given-names></name><name name-style="western"><surname>Pennino</surname><given-names>D.</given-names></name><name name-style="western"><surname>Carbone</surname><given-names>T.</given-names></name><name name-style="western"><surname>Nasorri</surname><given-names>F.</given-names></name><name name-style="western"><surname>Pallotta</surname><given-names>S.</given-names></name><name name-style="western"><surname>Cianfarani</surname><given-names>F.</given-names></name><name name-style="western"><surname>Odorisio</surname><given-names>T.</given-names></name><name name-style="western"><surname>Traidl-Hoffmann</surname><given-names>C.</given-names></name><name name-style="western"><surname>Behrendt</surname><given-names>H.</given-names></name><etal/></person-group><article-title>Th22 cells represent a distinct human T cell subset involved in epidermal immunity and remodeling</article-title><source>J. Clin. Investig.</source><year>2009</year><volume>119</volume><fpage>3573</fpage><lpage>3585</lpage><pub-id pub-id-type="doi">10.1172/JCI40202</pub-id><pub-id pub-id-type="pmid">19920355</pub-id><pub-id pub-id-type="pmcid">PMC2786807</pub-id></element-citation></ref><ref id="B13-ijms-21-08011"><label>13.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Devarajan</surname><given-names>P.</given-names></name><name name-style="western"><surname>Jones</surname><given-names>M.C.</given-names></name><name name-style="western"><surname>Kugler-Umana</surname><given-names>O.</given-names></name><name name-style="western"><surname>Vong</surname><given-names>A.M.</given-names></name><name name-style="western"><surname>Xia</surname><given-names>J.</given-names></name><name name-style="western"><surname>Swain</surname><given-names>S.L.</given-names></name></person-group><article-title>Pathogen Recognition by CD4 Effectors Drives Key Effector and Most Memory Cell Generation against Respiratory Virus</article-title><source>Front. Immunol.</source><year>2018</year><volume>9</volume><fpage>596</fpage><pub-id pub-id-type="doi">10.3389/fimmu.2018.00596</pub-id><pub-id pub-id-type="pmid">29632538</pub-id><pub-id pub-id-type="pmcid">PMC5879149</pub-id></element-citation></ref><ref id="B14-ijms-21-08011"><label>14.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Juno</surname><given-names>J.A.</given-names></name><name name-style="western"><surname>van Bockel</surname><given-names>D.</given-names></name><name name-style="western"><surname>Kent</surname><given-names>S.J.</given-names></name><name name-style="western"><surname>Kelleher</surname><given-names>A.D.</given-names></name><name name-style="western"><surname>Zaunders</surname><given-names>J.J.</given-names></name><name name-style="western"><surname>Munier</surname><given-names>C.M.</given-names></name></person-group><article-title>Cytotoxic CD4 T Cells-Friend or Foe during Viral Infection?</article-title><source>Front. Immunol.</source><year>2017</year><volume>8</volume><fpage>19</fpage><pub-id pub-id-type="doi">10.3389/fimmu.2017.00019</pub-id><pub-id pub-id-type="pmid">28167943</pub-id><pub-id pub-id-type="pmcid">PMC5253382</pub-id></element-citation></ref><ref id="B15-ijms-21-08011"><label>15.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Takeuchi</surname><given-names>A.</given-names></name><name name-style="western"><surname>Saito</surname><given-names>T.</given-names></name></person-group><article-title>CD4 CTL, a Cytotoxic Subset of CD4(+) T Cells, Their Differentiation and Function</article-title><source>Front. Immunol.</source><year>2017</year><volume>8</volume><fpage>194</fpage><pub-id pub-id-type="doi">10.3389/fimmu.2017.00194</pub-id><pub-id pub-id-type="pmid">28280496</pub-id><pub-id pub-id-type="pmcid">PMC5321676</pub-id></element-citation></ref><ref id="B16-ijms-21-08011"><label>16.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Eshima</surname><given-names>K.</given-names></name><name name-style="western"><surname>Chiba</surname><given-names>S.</given-names></name><name name-style="western"><surname>Suzuki</surname><given-names>H.</given-names></name><name name-style="western"><surname>Kokubo</surname><given-names>K.</given-names></name><name name-style="western"><surname>Kobayashi</surname><given-names>H.</given-names></name><name name-style="western"><surname>Iizuka</surname><given-names>M.</given-names></name><name name-style="western"><surname>Iwabuchi</surname><given-names>K.</given-names></name><name name-style="western"><surname>Shinohara</surname><given-names>N.</given-names></name></person-group><article-title>Ectopic expression of a T-box transcription factor, eomesodermin, renders CD4(+) Th cells cytotoxic by activating both perforin- and FasL-pathways</article-title><source>Immunol. Lett.</source><year>2012</year><volume>144</volume><fpage>7</fpage><lpage>15</lpage><pub-id pub-id-type="doi">10.1016/j.imlet.2012.02.013</pub-id><pub-id pub-id-type="pmid">22425747</pub-id></element-citation></ref><ref id="B17-ijms-21-08011"><label>17.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Reis</surname><given-names>B.S.</given-names></name><name name-style="western"><surname>Hoytema van Konijnenburg</surname><given-names>D.P.</given-names></name><name name-style="western"><surname>Grivennikov</surname><given-names>S.I.</given-names></name><name name-style="western"><surname>Mucida</surname><given-names>D.</given-names></name></person-group><article-title>Transcription factor T-bet regulates intraepithelial lymphocyte functional maturation</article-title><source>Immunity</source><year>2014</year><volume>41</volume><fpage>244</fpage><lpage>256</lpage><pub-id pub-id-type="doi">10.1016/j.immuni.2014.06.017</pub-id><pub-id pub-id-type="pmid">25148025</pub-id><pub-id pub-id-type="pmcid">PMC4287410</pub-id></element-citation></ref><ref id="B18-ijms-21-08011"><label>18.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Sledzinska</surname><given-names>A.</given-names></name><name name-style="western"><surname>Vila de Mucha</surname><given-names>M.</given-names></name><name name-style="western"><surname>Bergerhoff</surname><given-names>K.</given-names></name><name name-style="western"><surname>Hotblack</surname><given-names>A.</given-names></name><name name-style="western"><surname>Demane</surname><given-names>D.F.</given-names></name><name name-style="western"><surname>Ghorani</surname><given-names>E.</given-names></name><name name-style="western"><surname>Akarca</surname><given-names>A.U.</given-names></name><name name-style="western"><surname>Marzolini</surname><given-names>M.A.V.</given-names></name><name name-style="western"><surname>Solomon</surname><given-names>I.</given-names></name><name name-style="western"><surname>Vargas</surname><given-names>F.A.</given-names></name><etal/></person-group><article-title>Regulatory T Cells Restrain Interleukin-2- and Blimp-1-Dependent Acquisition of Cytotoxic Function by CD4(+) T Cells</article-title><source>Immunity</source><year>2020</year><volume>52</volume><fpage>151</fpage><lpage>166.e156</lpage><pub-id pub-id-type="doi">10.1016/j.immuni.2019.12.007</pub-id><pub-id pub-id-type="pmid">31924474</pub-id><pub-id pub-id-type="pmcid">PMC7369640</pub-id></element-citation></ref><ref id="B19-ijms-21-08011"><label>19.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Cheroutre</surname><given-names>H.</given-names></name><name name-style="western"><surname>Husain</surname><given-names>M.M.</given-names></name></person-group><article-title>CD4 CTL: Living up to the challenge</article-title><source>Semin. Immunol.</source><year>2013</year><volume>25</volume><fpage>273</fpage><lpage>281</lpage><pub-id pub-id-type="doi">10.1016/j.smim.2013.10.022</pub-id><pub-id pub-id-type="pmid">24246226</pub-id><pub-id pub-id-type="pmcid">PMC3886800</pub-id></element-citation></ref><ref id="B20-ijms-21-08011"><label>20.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Mucida</surname><given-names>D.</given-names></name><name name-style="western"><surname>Husain</surname><given-names>M.M.</given-names></name><name name-style="western"><surname>Muroi</surname><given-names>S.</given-names></name><name name-style="western"><surname>van Wijk</surname><given-names>F.</given-names></name><name name-style="western"><surname>Shinnakasu</surname><given-names>R.</given-names></name><name name-style="western"><surname>Naoe</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Reis</surname><given-names>B.S.</given-names></name><name name-style="western"><surname>Huang</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Lambolez</surname><given-names>F.</given-names></name><name name-style="western"><surname>Docherty</surname><given-names>M.</given-names></name><etal/></person-group><article-title>Transcriptional reprogramming of mature CD4(+) helper T cells generates distinct MHC class II-restricted cytotoxic T lymphocytes</article-title><source>Nat. Immunol.</source><year>2013</year><volume>14</volume><fpage>281</fpage><lpage>289</lpage><pub-id pub-id-type="doi">10.1038/ni.2523</pub-id><pub-id pub-id-type="pmid">23334788</pub-id><pub-id pub-id-type="pmcid">PMC3581083</pub-id></element-citation></ref><ref id="B21-ijms-21-08011"><label>21.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Reis</surname><given-names>B.S.</given-names></name><name name-style="western"><surname>Rogoz</surname><given-names>A.</given-names></name><name name-style="western"><surname>Costa-Pinto</surname><given-names>F.A.</given-names></name><name name-style="western"><surname>Taniuchi</surname><given-names>I.</given-names></name><name name-style="western"><surname>Mucida</surname><given-names>D.</given-names></name></person-group><article-title>Mutual expression of the transcription factors Runx3 and ThPOK regulates intestinal CD4(+) T cell immunity</article-title><source>Nat. Immunol.</source><year>2013</year><volume>14</volume><fpage>271</fpage><lpage>280</lpage><pub-id pub-id-type="doi">10.1038/ni.2518</pub-id><pub-id pub-id-type="pmid">23334789</pub-id><pub-id pub-id-type="pmcid">PMC3804366</pub-id></element-citation></ref><ref id="B22-ijms-21-08011"><label>22.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Serroukh</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Gu-Trantien</surname><given-names>C.</given-names></name><name name-style="western"><surname>Hooshiar Kashani</surname><given-names>B.</given-names></name><name name-style="western"><surname>Defrance</surname><given-names>M.</given-names></name><name name-style="western"><surname>Vu Manh</surname><given-names>T.P.</given-names></name><name name-style="western"><surname>Azouz</surname><given-names>A.</given-names></name><name name-style="western"><surname>Detavernier</surname><given-names>A.</given-names></name><name name-style="western"><surname>Hoyois</surname><given-names>A.</given-names></name><name name-style="western"><surname>Das</surname><given-names>J.</given-names></name><name name-style="western"><surname>Bizet</surname><given-names>M.</given-names></name><etal/></person-group><article-title>The transcription factors Runx3 and ThPOK cross-regulate acquisition of cytotoxic function by human Th1 lymphocytes</article-title><source>eLife</source><year>2018</year><volume>7</volume><fpage>e30496</fpage><pub-id pub-id-type="doi">10.7554/eLife.30496</pub-id><pub-id pub-id-type="pmid">29488879</pub-id><pub-id pub-id-type="pmcid">PMC5844691</pub-id></element-citation></ref><ref id="B23-ijms-21-08011"><label>23.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Donnarumma</surname><given-names>T.</given-names></name><name name-style="western"><surname>Young</surname><given-names>G.R.</given-names></name><name name-style="western"><surname>Merkenschlager</surname><given-names>J.</given-names></name><name name-style="western"><surname>Eksmond</surname><given-names>U.</given-names></name><name name-style="western"><surname>Bongard</surname><given-names>N.</given-names></name><name name-style="western"><surname>Nutt</surname><given-names>S.L.</given-names></name><name name-style="western"><surname>Boyer</surname><given-names>C.</given-names></name><name name-style="western"><surname>Dittmer</surname><given-names>U.</given-names></name><name name-style="western"><surname>Le-Trilling</surname><given-names>V.T.</given-names></name><name name-style="western"><surname>Trilling</surname><given-names>M.</given-names></name><etal/></person-group><article-title>Opposing Development of Cytotoxic and Follicular Helper CD4 T Cells Controlled by the TCF-1-Bcl6 Nexus</article-title><source>Cell Rep.</source><year>2016</year><volume>17</volume><fpage>1571</fpage><lpage>1583</lpage><pub-id pub-id-type="doi">10.1016/j.celrep.2016.10.013</pub-id><pub-id pub-id-type="pmid">27806296</pub-id><pub-id pub-id-type="pmcid">PMC5149578</pub-id></element-citation></ref><ref id="B24-ijms-21-08011"><label>24.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Takeuchi</surname><given-names>A.</given-names></name><name name-style="western"><surname>Badr Mel</surname><given-names>S.</given-names></name><name name-style="western"><surname>Miyauchi</surname><given-names>K.</given-names></name><name name-style="western"><surname>Ishihara</surname><given-names>C.</given-names></name><name name-style="western"><surname>Onishi</surname><given-names>R.</given-names></name><name name-style="western"><surname>Guo</surname><given-names>Z.</given-names></name><name name-style="western"><surname>Sasaki</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Ike</surname><given-names>H.</given-names></name><name name-style="western"><surname>Takumi</surname><given-names>A.</given-names></name><name name-style="western"><surname>Tsuji</surname><given-names>N.M.</given-names></name><etal/></person-group><article-title>CRTAM determines the CD4+ cytotoxic T lymphocyte lineage</article-title><source>J. Exp. Med.</source><year>2016</year><volume>213</volume><fpage>123</fpage><lpage>138</lpage><pub-id pub-id-type="doi">10.1084/jem.20150519</pub-id><pub-id pub-id-type="pmid">26694968</pub-id><pub-id pub-id-type="pmcid">PMC4710199</pub-id></element-citation></ref><ref id="B25-ijms-21-08011"><label>25.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Marshall</surname><given-names>N.B.</given-names></name><name name-style="western"><surname>Vong</surname><given-names>A.M.</given-names></name><name name-style="western"><surname>Devarajan</surname><given-names>P.</given-names></name><name name-style="western"><surname>Brauner</surname><given-names>M.D.</given-names></name><name name-style="western"><surname>Kuang</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Nayar</surname><given-names>R.</given-names></name><name name-style="western"><surname>Schutten</surname><given-names>E.A.</given-names></name><name name-style="western"><surname>Castonguay</surname><given-names>C.H.</given-names></name><name name-style="western"><surname>Berg</surname><given-names>L.J.</given-names></name><name name-style="western"><surname>Nutt</surname><given-names>S.L.</given-names></name><etal/></person-group><article-title>NKG2C/E Marks the Unique Cytotoxic CD4 T Cell Subset, ThCTL, Generated by Influenza Infection</article-title><source>J. Immunol.</source><year>2017</year><volume>198</volume><fpage>1142</fpage><lpage>1155</lpage><pub-id pub-id-type="doi">10.4049/jimmunol.1601297</pub-id><pub-id pub-id-type="pmid">28031335</pub-id><pub-id pub-id-type="pmcid">PMC5263106</pub-id></element-citation></ref><ref id="B26-ijms-21-08011"><label>26.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Meckiff</surname><given-names>B.J.</given-names></name><name name-style="western"><surname>Ram&#237;rez-Su&#225;stegui</surname><given-names>C.</given-names></name><name name-style="western"><surname>Fajardo</surname><given-names>V.</given-names></name><name name-style="western"><surname>Chee</surname><given-names>S.J.</given-names></name><name name-style="western"><surname>Kusnadi</surname><given-names>A.</given-names></name><name name-style="western"><surname>Simon</surname><given-names>H.</given-names></name><name name-style="western"><surname>Eschweiler</surname><given-names>S.</given-names></name><name name-style="western"><surname>Grifoni</surname><given-names>A.</given-names></name><name name-style="western"><surname>Pelosi</surname><given-names>E.</given-names></name><name name-style="western"><surname>Weiskopf</surname><given-names>D.</given-names></name><etal/></person-group><article-title>Imbalance of regulatory and cytotoxic SARS-CoV-2-reactive CD4+ T cells in COVID-19</article-title><source>Cell</source><year>2020</year><pub-id pub-id-type="doi">10.1016/j.cell.2020.10.001</pub-id><pub-id pub-id-type="pmid">33096020</pub-id><pub-id pub-id-type="pmcid">PMC7534589</pub-id></element-citation></ref><ref id="B27-ijms-21-08011"><label>27.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Oh</surname><given-names>D.Y.</given-names></name><name name-style="western"><surname>Kwek</surname><given-names>S.S.</given-names></name><name name-style="western"><surname>Raju</surname><given-names>S.S.</given-names></name><name name-style="western"><surname>Li</surname><given-names>T.</given-names></name><name name-style="western"><surname>McCarthy</surname><given-names>E.</given-names></name><name name-style="western"><surname>Chow</surname><given-names>E.</given-names></name><name name-style="western"><surname>Aran</surname><given-names>D.</given-names></name><name name-style="western"><surname>Ilano</surname><given-names>A.</given-names></name><name name-style="western"><surname>Pai</surname><given-names>C.S.</given-names></name><name name-style="western"><surname>Rancan</surname><given-names>C.</given-names></name><etal/></person-group><article-title>Intratumoral CD4(+) T Cells Mediate Anti-tumor Cytotoxicity in Human Bladder Cancer</article-title><source>Cell</source><year>2020</year><volume>181</volume><fpage>1612</fpage><lpage>1625</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2020.05.017</pub-id><pub-id pub-id-type="pmid">32497499</pub-id><pub-id pub-id-type="pmcid">PMC7321885</pub-id></element-citation></ref><ref id="B28-ijms-21-08011"><label>28.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Mattoo</surname><given-names>H.</given-names></name><name name-style="western"><surname>Stone</surname><given-names>J.H.</given-names></name><name name-style="western"><surname>Pillai</surname><given-names>S.</given-names></name></person-group><article-title>Clonally expanded cytotoxic CD4(+) T cells and the pathogenesis of IgG4-related disease</article-title><source>Autoimmunity</source><year>2017</year><volume>50</volume><fpage>19</fpage><lpage>24</lpage><pub-id pub-id-type="doi">10.1080/08916934.2017.1280029</pub-id><pub-id pub-id-type="pmid">28166682</pub-id><pub-id pub-id-type="pmcid">PMC5880292</pub-id></element-citation></ref><ref id="B29-ijms-21-08011"><label>29.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Hashimoto</surname><given-names>K.</given-names></name><name name-style="western"><surname>Kouno</surname><given-names>T.</given-names></name><name name-style="western"><surname>Ikawa</surname><given-names>T.</given-names></name><name name-style="western"><surname>Hayatsu</surname><given-names>N.</given-names></name><name name-style="western"><surname>Miyajima</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Yabukami</surname><given-names>H.</given-names></name><name name-style="western"><surname>Terooatea</surname><given-names>T.</given-names></name><name name-style="western"><surname>Sasaki</surname><given-names>T.</given-names></name><name name-style="western"><surname>Suzuki</surname><given-names>T.</given-names></name><name name-style="western"><surname>Valentine</surname><given-names>M.</given-names></name><etal/></person-group><article-title>Single-cell transcriptomics reveals expansion of cytotoxic CD4 T cells in supercentenarians</article-title><source>Proc. Natl. Acad. Sci. USA</source><year>2019</year><volume>116</volume><fpage>24242</fpage><lpage>24251</lpage><pub-id pub-id-type="doi">10.1073/pnas.1907883116</pub-id><pub-id pub-id-type="pmid">31719197</pub-id><pub-id pub-id-type="pmcid">PMC6883788</pub-id></element-citation></ref><ref id="B30-ijms-21-08011"><label>30.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Gurram</surname><given-names>R.K.</given-names></name><name name-style="western"><surname>Zhu</surname><given-names>J.</given-names></name></person-group><article-title>Orchestration between ILC2s and Th2 cells in shaping type 2 immune responses</article-title><source>Cell. Mol. Immunol.</source><year>2019</year><volume>16</volume><fpage>225</fpage><lpage>235</lpage><pub-id pub-id-type="doi">10.1038/s41423-019-0210-8</pub-id><pub-id pub-id-type="pmid">30792500</pub-id><pub-id pub-id-type="pmcid">PMC6460501</pub-id></element-citation></ref><ref id="B31-ijms-21-08011"><label>31.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Stockinger</surname><given-names>B.</given-names></name><name name-style="western"><surname>Omenetti</surname><given-names>S.</given-names></name></person-group><article-title>The dichotomous nature of T helper 17 cells</article-title><source>Nat. Rev. Immunol.</source><year>2017</year><volume>17</volume><fpage>535</fpage><lpage>544</lpage><pub-id pub-id-type="doi">10.1038/nri.2017.50</pub-id><pub-id pub-id-type="pmid">28555673</pub-id></element-citation></ref><ref id="B32-ijms-21-08011"><label>32.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Crotty</surname><given-names>S.</given-names></name></person-group><article-title>T Follicular Helper Cell Biology: A Decade of Discovery and Diseases</article-title><source>Immunity</source><year>2019</year><volume>50</volume><fpage>1132</fpage><lpage>1148</lpage><pub-id pub-id-type="doi">10.1016/j.immuni.2019.04.011</pub-id><pub-id pub-id-type="pmid">31117010</pub-id><pub-id pub-id-type="pmcid">PMC6532429</pub-id></element-citation></ref><ref id="B33-ijms-21-08011"><label>33.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Miyauchi</surname><given-names>K.</given-names></name><name name-style="western"><surname>Sugimoto-Ishige</surname><given-names>A.</given-names></name><name name-style="western"><surname>Harada</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Adachi</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Usami</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Kaji</surname><given-names>T.</given-names></name><name name-style="western"><surname>Inoue</surname><given-names>K.</given-names></name><name name-style="western"><surname>Hasegawa</surname><given-names>H.</given-names></name><name name-style="western"><surname>Watanabe</surname><given-names>T.</given-names></name><name name-style="western"><surname>Hijikata</surname><given-names>A.</given-names></name><etal/></person-group><article-title>Protective neutralizing influenza antibody response in the absence of T follicular helper cells</article-title><source>Nat. Immunol.</source><year>2016</year><volume>17</volume><fpage>1447</fpage><lpage>1458</lpage><pub-id pub-id-type="doi">10.1038/ni.3563</pub-id><pub-id pub-id-type="pmid">27798619</pub-id></element-citation></ref><ref id="B34-ijms-21-08011"><label>34.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Dominguez-Villar</surname><given-names>M.</given-names></name><name name-style="western"><surname>Hafler</surname><given-names>D.A.</given-names></name></person-group><article-title>Regulatory T cells in autoimmune disease</article-title><source>Nat. Immunol.</source><year>2018</year><volume>19</volume><fpage>665</fpage><lpage>673</lpage><pub-id pub-id-type="doi">10.1038/s41590-018-0120-4</pub-id><pub-id pub-id-type="pmid">29925983</pub-id><pub-id pub-id-type="pmcid">PMC7882196</pub-id></element-citation></ref><ref id="B35-ijms-21-08011"><label>35.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Shevach</surname><given-names>E.M.</given-names></name></person-group><article-title>CD4+ CD25+ suppressor T cells: More questions than answers</article-title><source>Nat. Rev. Immunol.</source><year>2002</year><volume>2</volume><fpage>389</fpage><lpage>400</lpage><pub-id pub-id-type="doi">10.1038/nri821</pub-id><pub-id pub-id-type="pmid">12093005</pub-id></element-citation></ref><ref id="B36-ijms-21-08011"><label>36.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Vivier</surname><given-names>E.</given-names></name><name name-style="western"><surname>Artis</surname><given-names>D.</given-names></name><name name-style="western"><surname>Colonna</surname><given-names>M.</given-names></name><name name-style="western"><surname>Diefenbach</surname><given-names>A.</given-names></name><name name-style="western"><surname>Di Santo</surname><given-names>J.P.</given-names></name><name name-style="western"><surname>Eberl</surname><given-names>G.</given-names></name><name name-style="western"><surname>Koyasu</surname><given-names>S.</given-names></name><name name-style="western"><surname>Locksley</surname><given-names>R.M.</given-names></name><name name-style="western"><surname>McKenzie</surname><given-names>A.N.J.</given-names></name><name name-style="western"><surname>Mebius</surname><given-names>R.E.</given-names></name><etal/></person-group><article-title>Innate Lymphoid Cells: 10 Years On</article-title><source>Cell</source><year>2018</year><volume>174</volume><fpage>1054</fpage><lpage>1066</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2018.07.017</pub-id><pub-id pub-id-type="pmid">30142344</pub-id></element-citation></ref><ref id="B37-ijms-21-08011"><label>37.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Artis</surname><given-names>D.</given-names></name><name name-style="western"><surname>Spits</surname><given-names>H.</given-names></name></person-group><article-title>The biology of innate lymphoid cells</article-title><source>Nature</source><year>2015</year><volume>517</volume><fpage>293</fpage><lpage>301</lpage><pub-id pub-id-type="doi">10.1038/nature14189</pub-id><pub-id pub-id-type="pmid">25592534</pub-id></element-citation></ref><ref id="B38-ijms-21-08011"><label>38.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Cherrier</surname><given-names>D.E.</given-names></name><name name-style="western"><surname>Serafini</surname><given-names>N.</given-names></name><name name-style="western"><surname>Di Santo</surname><given-names>J.P.</given-names></name></person-group><article-title>Innate Lymphoid Cell Development: A T Cell Perspective</article-title><source>Immunity</source><year>2018</year><volume>48</volume><fpage>1091</fpage><lpage>1103</lpage><pub-id pub-id-type="doi">10.1016/j.immuni.2018.05.010</pub-id><pub-id pub-id-type="pmid">29924975</pub-id></element-citation></ref><ref id="B39-ijms-21-08011"><label>39.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ebbo</surname><given-names>M.</given-names></name><name name-style="western"><surname>Crinier</surname><given-names>A.</given-names></name><name name-style="western"><surname>Vely</surname><given-names>F.</given-names></name><name name-style="western"><surname>Vivier</surname><given-names>E.</given-names></name></person-group><article-title>Innate lymphoid cells: Major players in inflammatory diseases</article-title><source>Nat. Rev. Immunol.</source><year>2017</year><volume>17</volume><fpage>665</fpage><lpage>678</lpage><pub-id pub-id-type="doi">10.1038/nri.2017.86</pub-id><pub-id pub-id-type="pmid">28804130</pub-id></element-citation></ref><ref id="B40-ijms-21-08011"><label>40.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Zhong</surname><given-names>C.</given-names></name><name name-style="western"><surname>Zheng</surname><given-names>M.</given-names></name><name name-style="western"><surname>Zhu</surname><given-names>J.</given-names></name></person-group><article-title>Lymphoid tissue inducer-A divergent member of the ILC family</article-title><source>Cytokine Growth Factor Rev.</source><year>2018</year><volume>42</volume><fpage>5</fpage><lpage>12</lpage><pub-id pub-id-type="doi">10.1016/j.cytogfr.2018.02.004</pub-id><pub-id pub-id-type="pmid">29454785</pub-id><pub-id pub-id-type="pmcid">PMC6089680</pub-id></element-citation></ref><ref id="B41-ijms-21-08011"><label>41.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Sallusto</surname><given-names>F.</given-names></name></person-group><article-title>Heterogeneity of Human CD4(+) T Cells Against Microbes</article-title><source>Annu. Rev. Immunol.</source><year>2016</year><volume>34</volume><fpage>317</fpage><lpage>334</lpage><pub-id pub-id-type="doi">10.1146/annurev-immunol-032414-112056</pub-id><pub-id pub-id-type="pmid">27168241</pub-id></element-citation></ref><ref id="B42-ijms-21-08011"><label>42.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Hirahara</surname><given-names>K.</given-names></name><name name-style="western"><surname>Poholek</surname><given-names>A.</given-names></name><name name-style="western"><surname>Vahedi</surname><given-names>G.</given-names></name><name name-style="western"><surname>Laurence</surname><given-names>A.</given-names></name><name name-style="western"><surname>Kanno</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Milner</surname><given-names>J.D.</given-names></name><name name-style="western"><surname>O&#8217;Shea</surname><given-names>J.J.</given-names></name></person-group><article-title>Mechanisms underlying helper T-cell plasticity: Implications for immune-mediated disease</article-title><source>J. Allergy Clin. Immunol.</source><year>2013</year><volume>131</volume><fpage>1276</fpage><lpage>1287</lpage><pub-id pub-id-type="doi">10.1016/j.jaci.2013.03.015</pub-id><pub-id pub-id-type="pmid">23622118</pub-id><pub-id pub-id-type="pmcid">PMC3677748</pub-id></element-citation></ref><ref id="B43-ijms-21-08011"><label>43.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Leonard</surname><given-names>W.J.</given-names></name><name name-style="western"><surname>Lin</surname><given-names>J.X.</given-names></name><name name-style="western"><surname>O&#8217;Shea</surname><given-names>J.J.</given-names></name></person-group><article-title>The gammac Family of Cytokines: Basic Biology to Therapeutic Ramifications</article-title><source>Immunity</source><year>2019</year><volume>50</volume><fpage>832</fpage><lpage>850</lpage><pub-id pub-id-type="doi">10.1016/j.immuni.2019.03.028</pub-id><pub-id pub-id-type="pmid">30995502</pub-id></element-citation></ref><ref id="B44-ijms-21-08011"><label>44.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Mosmann</surname><given-names>T.R.</given-names></name><name name-style="western"><surname>Cherwinski</surname><given-names>H.</given-names></name><name name-style="western"><surname>Bond</surname><given-names>M.W.</given-names></name><name name-style="western"><surname>Giedlin</surname><given-names>M.A.</given-names></name><name name-style="western"><surname>Coffman</surname><given-names>R.L.</given-names></name></person-group><article-title>Two types of murine helper T cell clone. I. Definition according to profiles of lymphokine activities and secreted proteins</article-title><source>J. Immunol.</source><year>1986</year><volume>136</volume><fpage>2348</fpage><lpage>2357</lpage><pub-id pub-id-type="pmid">2419430</pub-id></element-citation></ref><ref id="B45-ijms-21-08011"><label>45.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Zhu</surname><given-names>J.</given-names></name><name name-style="western"><surname>Jankovic</surname><given-names>D.</given-names></name><name name-style="western"><surname>Oler</surname><given-names>A.J.</given-names></name><name name-style="western"><surname>Wei</surname><given-names>G.</given-names></name><name name-style="western"><surname>Sharma</surname><given-names>S.</given-names></name><name name-style="western"><surname>Hu</surname><given-names>G.</given-names></name><name name-style="western"><surname>Guo</surname><given-names>L.</given-names></name><name name-style="western"><surname>Yagi</surname><given-names>R.</given-names></name><name name-style="western"><surname>Yamane</surname><given-names>H.</given-names></name><name name-style="western"><surname>Punkosdy</surname><given-names>G.</given-names></name><etal/></person-group><article-title>The transcription factor T-bet is induced by multiple pathways and prevents an endogenous Th2 cell program during Th1 cell responses</article-title><source>Immunity</source><year>2012</year><volume>37</volume><fpage>660</fpage><lpage>673</lpage><pub-id pub-id-type="doi">10.1016/j.immuni.2012.09.007</pub-id><pub-id pub-id-type="pmid">23041064</pub-id><pub-id pub-id-type="pmcid">PMC3717271</pub-id></element-citation></ref><ref id="B46-ijms-21-08011"><label>46.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kanno</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Vahedi</surname><given-names>G.</given-names></name><name name-style="western"><surname>Hirahara</surname><given-names>K.</given-names></name><name name-style="western"><surname>Singleton</surname><given-names>K.</given-names></name><name name-style="western"><surname>O&#8217;Shea</surname><given-names>J.J.</given-names></name></person-group><article-title>Transcriptional and epigenetic control of T helper cell specification: Molecular mechanisms underlying commitment and plasticity</article-title><source>Annu. Rev. Immunol.</source><year>2012</year><volume>30</volume><fpage>707</fpage><lpage>731</lpage><pub-id pub-id-type="doi">10.1146/annurev-immunol-020711-075058</pub-id><pub-id pub-id-type="pmid">22224760</pub-id><pub-id pub-id-type="pmcid">PMC3314163</pub-id></element-citation></ref><ref id="B47-ijms-21-08011"><label>47.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Mullen</surname><given-names>A.C.</given-names></name><name name-style="western"><surname>Hutchins</surname><given-names>A.S.</given-names></name><name name-style="western"><surname>High</surname><given-names>F.A.</given-names></name><name name-style="western"><surname>Lee</surname><given-names>H.W.</given-names></name><name name-style="western"><surname>Sykes</surname><given-names>K.J.</given-names></name><name name-style="western"><surname>Chodosh</surname><given-names>L.A.</given-names></name><name name-style="western"><surname>Reiner</surname><given-names>S.L.</given-names></name></person-group><article-title>Hlx is induced by and genetically interacts with T-bet to promote heritable T(H)1 gene induction</article-title><source>Nat. Immunol.</source><year>2002</year><volume>3</volume><fpage>652</fpage><lpage>658</lpage><pub-id pub-id-type="doi">10.1038/ni807</pub-id><pub-id pub-id-type="pmid">12055627</pub-id></element-citation></ref><ref id="B48-ijms-21-08011"><label>48.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Djuretic</surname><given-names>I.M.</given-names></name><name name-style="western"><surname>Levanon</surname><given-names>D.</given-names></name><name name-style="western"><surname>Negreanu</surname><given-names>V.</given-names></name><name name-style="western"><surname>Groner</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Rao</surname><given-names>A.</given-names></name><name name-style="western"><surname>Ansel</surname><given-names>K.M.</given-names></name></person-group><article-title>Transcription factors T-bet and Runx3 cooperate to activate Ifng and silence Il4 in T helper type 1 cells</article-title><source>Nat. Immunol.</source><year>2007</year><volume>8</volume><fpage>145</fpage><lpage>153</lpage><pub-id pub-id-type="doi">10.1038/ni1424</pub-id><pub-id pub-id-type="pmid">17195845</pub-id></element-citation></ref><ref id="B49-ijms-21-08011"><label>49.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Yagi</surname><given-names>R.</given-names></name><name name-style="western"><surname>Junttila</surname><given-names>I.S.</given-names></name><name name-style="western"><surname>Wei</surname><given-names>G.</given-names></name><name name-style="western"><surname>Urban</surname><given-names>J.F.</given-names><suffix>Jr.</suffix></name><name name-style="western"><surname>Zhao</surname><given-names>K.</given-names></name><name name-style="western"><surname>Paul</surname><given-names>W.E.</given-names></name><name name-style="western"><surname>Zhu</surname><given-names>J.</given-names></name></person-group><article-title>The transcription factor GATA3 actively represses RUNX3 protein-regulated production of interferon-gamma</article-title><source>Immunity</source><year>2010</year><volume>32</volume><fpage>507</fpage><lpage>517</lpage><pub-id pub-id-type="doi">10.1016/j.immuni.2010.04.004</pub-id><pub-id pub-id-type="pmid">20399120</pub-id><pub-id pub-id-type="pmcid">PMC2867662</pub-id></element-citation></ref><ref id="B50-ijms-21-08011"><label>50.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Grenningloh</surname><given-names>R.</given-names></name><name name-style="western"><surname>Kang</surname><given-names>B.Y.</given-names></name><name name-style="western"><surname>Ho</surname><given-names>I.C.</given-names></name></person-group><article-title>Ets-1, a functional cofactor of T-bet, is essential for Th1 inflammatory responses</article-title><source>J. Exp. Med.</source><year>2005</year><volume>201</volume><fpage>615</fpage><lpage>626</lpage><pub-id pub-id-type="doi">10.1084/jem.20041330</pub-id><pub-id pub-id-type="pmid">15728239</pub-id><pub-id pub-id-type="pmcid">PMC2213045</pub-id></element-citation></ref><ref id="B51-ijms-21-08011"><label>51.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Yu</surname><given-names>F.</given-names></name><name name-style="western"><surname>Sharma</surname><given-names>S.</given-names></name><name name-style="western"><surname>Jankovic</surname><given-names>D.</given-names></name><name name-style="western"><surname>Gurram</surname><given-names>R.K.</given-names></name><name name-style="western"><surname>Su</surname><given-names>P.</given-names></name><name name-style="western"><surname>Hu</surname><given-names>G.</given-names></name><name name-style="western"><surname>Li</surname><given-names>R.</given-names></name><name name-style="western"><surname>Rieder</surname><given-names>S.</given-names></name><name name-style="western"><surname>Zhao</surname><given-names>K.</given-names></name><name name-style="western"><surname>Sun</surname><given-names>B.</given-names></name><etal/></person-group><article-title>The transcription factor Bhlhe40 is a switch of inflammatory versus antiinflammatory Th1 cell fate determination</article-title><source>J. Exp. Med.</source><year>2018</year><volume>215</volume><fpage>1813</fpage><lpage>1821</lpage><pub-id pub-id-type="doi">10.1084/jem.20170155</pub-id><pub-id pub-id-type="pmid">29773643</pub-id><pub-id pub-id-type="pmcid">PMC6028509</pub-id></element-citation></ref><ref id="B52-ijms-21-08011"><label>52.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Lazarevic</surname><given-names>V.</given-names></name><name name-style="western"><surname>Chen</surname><given-names>X.</given-names></name><name name-style="western"><surname>Shim</surname><given-names>J.H.</given-names></name><name name-style="western"><surname>Hwang</surname><given-names>E.S.</given-names></name><name name-style="western"><surname>Jang</surname><given-names>E.</given-names></name><name name-style="western"><surname>Bolm</surname><given-names>A.N.</given-names></name><name name-style="western"><surname>Oukka</surname><given-names>M.</given-names></name><name name-style="western"><surname>Kuchroo</surname><given-names>V.K.</given-names></name><name name-style="western"><surname>Glimcher</surname><given-names>L.H.</given-names></name></person-group><article-title>T-bet represses T(H)17 differentiation by preventing Runx1-mediated activation of the gene encoding RORgammat</article-title><source>Nat. Immunol.</source><year>2011</year><volume>12</volume><fpage>96</fpage><lpage>104</lpage><pub-id pub-id-type="doi">10.1038/ni.1969</pub-id><pub-id pub-id-type="pmid">21151104</pub-id><pub-id pub-id-type="pmcid">PMC3077962</pub-id></element-citation></ref><ref id="B53-ijms-21-08011"><label>53.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Lee</surname><given-names>Y.K.</given-names></name><name name-style="western"><surname>Turner</surname><given-names>H.</given-names></name><name name-style="western"><surname>Maynard</surname><given-names>C.L.</given-names></name><name name-style="western"><surname>Oliver</surname><given-names>J.R.</given-names></name><name name-style="western"><surname>Chen</surname><given-names>D.</given-names></name><name name-style="western"><surname>Elson</surname><given-names>C.O.</given-names></name><name name-style="western"><surname>Weaver</surname><given-names>C.T.</given-names></name></person-group><article-title>Late developmental plasticity in the T helper 17 lineage</article-title><source>Immunity</source><year>2009</year><volume>30</volume><fpage>92</fpage><lpage>107</lpage><pub-id pub-id-type="doi">10.1016/j.immuni.2008.11.005</pub-id><pub-id pub-id-type="pmid">19119024</pub-id><pub-id pub-id-type="pmcid">PMC3607320</pub-id></element-citation></ref><ref id="B54-ijms-21-08011"><label>54.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Wei</surname><given-names>G.</given-names></name><name name-style="western"><surname>Wei</surname><given-names>L.</given-names></name><name name-style="western"><surname>Zhu</surname><given-names>J.</given-names></name><name name-style="western"><surname>Zang</surname><given-names>C.</given-names></name><name name-style="western"><surname>Hu-Li</surname><given-names>J.</given-names></name><name name-style="western"><surname>Yao</surname><given-names>Z.</given-names></name><name name-style="western"><surname>Cui</surname><given-names>K.</given-names></name><name name-style="western"><surname>Kanno</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Roh</surname><given-names>T.Y.</given-names></name><name name-style="western"><surname>Watford</surname><given-names>W.T.</given-names></name><etal/></person-group><article-title>Global mapping of H3K4me3 and H3K27me3 reveals specificity and plasticity in lineage fate determination of differentiating CD4+ T cells</article-title><source>Immunity</source><year>2009</year><volume>30</volume><fpage>155</fpage><lpage>167</lpage><pub-id pub-id-type="doi">10.1016/j.immuni.2008.12.009</pub-id><pub-id pub-id-type="pmid">19144320</pub-id><pub-id pub-id-type="pmcid">PMC2722509</pub-id></element-citation></ref><ref id="B55-ijms-21-08011"><label>55.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Bonecchi</surname><given-names>R.</given-names></name><name name-style="western"><surname>Bianchi</surname><given-names>G.</given-names></name><name name-style="western"><surname>Bordignon</surname><given-names>P.P.</given-names></name><name name-style="western"><surname>D&#8217;Ambrosio</surname><given-names>D.</given-names></name><name name-style="western"><surname>Lang</surname><given-names>R.</given-names></name><name name-style="western"><surname>Borsatti</surname><given-names>A.</given-names></name><name name-style="western"><surname>Sozzani</surname><given-names>S.</given-names></name><name name-style="western"><surname>Allavena</surname><given-names>P.</given-names></name><name name-style="western"><surname>Gray</surname><given-names>P.A.</given-names></name><name name-style="western"><surname>Mantovani</surname><given-names>A.</given-names></name><etal/></person-group><article-title>Differential expression of chemokine receptors and chemotactic responsiveness of type 1 T helper cells (Th1s) and Th2s</article-title><source>J. Exp. Med.</source><year>1998</year><volume>187</volume><fpage>129</fpage><lpage>134</lpage><pub-id pub-id-type="doi">10.1084/jem.187.1.129</pub-id><pub-id pub-id-type="pmid">9419219</pub-id><pub-id pub-id-type="pmcid">PMC2199181</pub-id></element-citation></ref><ref id="B56-ijms-21-08011"><label>56.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Klose</surname><given-names>C.S.</given-names></name><name name-style="western"><surname>Flach</surname><given-names>M.</given-names></name><name name-style="western"><surname>Mohle</surname><given-names>L.</given-names></name><name name-style="western"><surname>Rogell</surname><given-names>L.</given-names></name><name name-style="western"><surname>Hoyler</surname><given-names>T.</given-names></name><name name-style="western"><surname>Ebert</surname><given-names>K.</given-names></name><name name-style="western"><surname>Fabiunke</surname><given-names>C.</given-names></name><name name-style="western"><surname>Pfeifer</surname><given-names>D.</given-names></name><name name-style="western"><surname>Sexl</surname><given-names>V.</given-names></name><name name-style="western"><surname>Fonseca-Pereira</surname><given-names>D.</given-names></name><etal/></person-group><article-title>Differentiation of type 1 ILCs from a common progenitor to all helper-like innate lymphoid cell lineages</article-title><source>Cell</source><year>2014</year><volume>157</volume><fpage>340</fpage><lpage>356</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2014.03.030</pub-id><pub-id pub-id-type="pmid">24725403</pub-id></element-citation></ref><ref id="B57-ijms-21-08011"><label>57.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Weizman</surname><given-names>O.E.</given-names></name><name name-style="western"><surname>Adams</surname><given-names>N.M.</given-names></name><name name-style="western"><surname>Schuster</surname><given-names>I.S.</given-names></name><name name-style="western"><surname>Krishna</surname><given-names>C.</given-names></name><name name-style="western"><surname>Pritykin</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Lau</surname><given-names>C.</given-names></name><name name-style="western"><surname>Degli-Esposti</surname><given-names>M.A.</given-names></name><name name-style="western"><surname>Leslie</surname><given-names>C.S.</given-names></name><name name-style="western"><surname>Sun</surname><given-names>J.C.</given-names></name><name name-style="western"><surname>O&#8217;Sullivan</surname><given-names>T.E.</given-names></name></person-group><article-title>ILC1 Confer Early Host Protection at Initial Sites of Viral Infection</article-title><source>Cell</source><year>2017</year><volume>171</volume><fpage>795</fpage><lpage>808</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2017.09.052</pub-id><pub-id pub-id-type="pmid">29056343</pub-id><pub-id pub-id-type="pmcid">PMC5687850</pub-id></element-citation></ref><ref id="B58-ijms-21-08011"><label>58.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Wei</surname><given-names>G.</given-names></name><name name-style="western"><surname>Abraham</surname><given-names>B.J.</given-names></name><name name-style="western"><surname>Yagi</surname><given-names>R.</given-names></name><name name-style="western"><surname>Jothi</surname><given-names>R.</given-names></name><name name-style="western"><surname>Cui</surname><given-names>K.</given-names></name><name name-style="western"><surname>Sharma</surname><given-names>S.</given-names></name><name name-style="western"><surname>Narlikar</surname><given-names>L.</given-names></name><name name-style="western"><surname>Northrup</surname><given-names>D.L.</given-names></name><name name-style="western"><surname>Tang</surname><given-names>Q.</given-names></name><name name-style="western"><surname>Paul</surname><given-names>W.E.</given-names></name><etal/></person-group><article-title>Genome-wide analyses of transcription factor GATA3-mediated gene regulation in distinct T cell types</article-title><source>Immunity</source><year>2011</year><volume>35</volume><fpage>299</fpage><lpage>311</lpage><pub-id pub-id-type="doi">10.1016/j.immuni.2011.08.007</pub-id><pub-id pub-id-type="pmid">21867929</pub-id><pub-id pub-id-type="pmcid">PMC3169184</pub-id></element-citation></ref><ref id="B59-ijms-21-08011"><label>59.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Hu</surname><given-names>G.</given-names></name><name name-style="western"><surname>Tang</surname><given-names>Q.</given-names></name><name name-style="western"><surname>Sharma</surname><given-names>S.</given-names></name><name name-style="western"><surname>Yu</surname><given-names>F.</given-names></name><name name-style="western"><surname>Escobar</surname><given-names>T.M.</given-names></name><name name-style="western"><surname>Muljo</surname><given-names>S.A.</given-names></name><name name-style="western"><surname>Zhu</surname><given-names>J.</given-names></name><name name-style="western"><surname>Zhao</surname><given-names>K.</given-names></name></person-group><article-title>Expression and regulation of intergenic long noncoding RNAs during T cell development and differentiation</article-title><source>Nat. Immunol.</source><year>2013</year><volume>14</volume><fpage>1190</fpage><lpage>1198</lpage><pub-id pub-id-type="doi">10.1038/ni.2712</pub-id><pub-id pub-id-type="pmid">24056746</pub-id><pub-id pub-id-type="pmcid">PMC3805781</pub-id></element-citation></ref><ref id="B60-ijms-21-08011"><label>60.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Lund</surname><given-names>R.J.</given-names></name><name name-style="western"><surname>Loytomaki</surname><given-names>M.</given-names></name><name name-style="western"><surname>Naumanen</surname><given-names>T.</given-names></name><name name-style="western"><surname>Dixon</surname><given-names>C.</given-names></name><name name-style="western"><surname>Chen</surname><given-names>Z.</given-names></name><name name-style="western"><surname>Ahlfors</surname><given-names>H.</given-names></name><name name-style="western"><surname>Tuomela</surname><given-names>S.</given-names></name><name name-style="western"><surname>Tahvanainen</surname><given-names>J.</given-names></name><name name-style="western"><surname>Scheinin</surname><given-names>J.</given-names></name><name name-style="western"><surname>Henttinen</surname><given-names>T.</given-names></name><etal/></person-group><article-title>Genome-wide identification of novel genes involved in early Th1 and Th2 cell differentiation</article-title><source>J. Immunol.</source><year>2007</year><volume>178</volume><fpage>3648</fpage><lpage>3660</lpage><pub-id pub-id-type="doi">10.4049/jimmunol.178.6.3648</pub-id><pub-id pub-id-type="pmid">17339462</pub-id></element-citation></ref><ref id="B61-ijms-21-08011"><label>61.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Fang</surname><given-names>D.</given-names></name><name name-style="western"><surname>Cui</surname><given-names>K.</given-names></name><name name-style="western"><surname>Mao</surname><given-names>K.</given-names></name><name name-style="western"><surname>Hu</surname><given-names>G.</given-names></name><name name-style="western"><surname>Li</surname><given-names>R.</given-names></name><name name-style="western"><surname>Zheng</surname><given-names>M.</given-names></name><name name-style="western"><surname>Riteau</surname><given-names>N.</given-names></name><name name-style="western"><surname>Reiner</surname><given-names>S.L.</given-names></name><name name-style="western"><surname>Sher</surname><given-names>A.</given-names></name><name name-style="western"><surname>Zhao</surname><given-names>K.</given-names></name><etal/></person-group><article-title>Transient T-bet expression functionally specifies a distinct T follicular helper subset</article-title><source>J. Exp. Med.</source><year>2018</year><volume>215</volume><fpage>2705</fpage><lpage>2714</lpage><pub-id pub-id-type="doi">10.1084/jem.20180927</pub-id><pub-id pub-id-type="pmid">30232200</pub-id><pub-id pub-id-type="pmcid">PMC6219743</pub-id></element-citation></ref><ref id="B62-ijms-21-08011"><label>62.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Romagnani</surname><given-names>S.</given-names></name></person-group><article-title>The Th1/Th2 paradigm</article-title><source>Immunol. Today</source><year>1997</year><volume>18</volume><fpage>263</fpage><lpage>266</lpage><pub-id pub-id-type="doi">10.1016/S0167-5699(97)80019-9</pub-id><pub-id pub-id-type="pmid">9190109</pub-id></element-citation></ref><ref id="B63-ijms-21-08011"><label>63.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Yang</surname><given-names>R.</given-names></name><name name-style="western"><surname>Mele</surname><given-names>F.</given-names></name><name name-style="western"><surname>Worley</surname><given-names>L.</given-names></name><name name-style="western"><surname>Langlais</surname><given-names>D.</given-names></name><name name-style="western"><surname>Rosain</surname><given-names>J.</given-names></name><name name-style="western"><surname>Benhsaien</surname><given-names>I.</given-names></name><name name-style="western"><surname>Elarabi</surname><given-names>H.</given-names></name><name name-style="western"><surname>Croft</surname><given-names>C.A.</given-names></name><name name-style="western"><surname>Doisne</surname><given-names>J.M.</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>P.</given-names></name><etal/></person-group><article-title>Human T-bet governs innate and innate-like adaptive IFN-g immunity against mycobacteria</article-title><source>BioRxiv Prep.</source><year>2020</year><pub-id pub-id-type="doi">10.1101/2020.08.31.274589</pub-id><pub-id pub-id-type="pmcid">PMC7770098</pub-id><pub-id pub-id-type="pmid">33296702</pub-id></element-citation></ref><ref id="B64-ijms-21-08011"><label>64.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Filipe-Santos</surname><given-names>O.</given-names></name><name name-style="western"><surname>Bustamante</surname><given-names>J.</given-names></name><name name-style="western"><surname>Chapgier</surname><given-names>A.</given-names></name><name name-style="western"><surname>Vogt</surname><given-names>G.</given-names></name><name name-style="western"><surname>de Beaucoudrey</surname><given-names>L.</given-names></name><name name-style="western"><surname>Feinberg</surname><given-names>J.</given-names></name><name name-style="western"><surname>Jouanguy</surname><given-names>E.</given-names></name><name name-style="western"><surname>Boisson-Dupuis</surname><given-names>S.</given-names></name><name name-style="western"><surname>Fieschi</surname><given-names>C.</given-names></name><name name-style="western"><surname>Picard</surname><given-names>C.</given-names></name><etal/></person-group><article-title>Inborn errors of IL-12/23- and IFN-gamma-mediated immunity: Molecular, cellular, and clinical features</article-title><source>Semin. Immunol.</source><year>2006</year><volume>18</volume><fpage>347</fpage><lpage>361</lpage><pub-id pub-id-type="doi">10.1016/j.smim.2006.07.010</pub-id><pub-id pub-id-type="pmid">16997570</pub-id></element-citation></ref><ref id="B65-ijms-21-08011"><label>65.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Peng</surname><given-names>D.</given-names></name><name name-style="western"><surname>Kryczek</surname><given-names>I.</given-names></name><name name-style="western"><surname>Nagarsheth</surname><given-names>N.</given-names></name><name name-style="western"><surname>Zhao</surname><given-names>L.</given-names></name><name name-style="western"><surname>Wei</surname><given-names>S.</given-names></name><name name-style="western"><surname>Wang</surname><given-names>W.</given-names></name><name name-style="western"><surname>Sun</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Zhao</surname><given-names>E.</given-names></name><name name-style="western"><surname>Vatan</surname><given-names>L.</given-names></name><name name-style="western"><surname>Szeliga</surname><given-names>W.</given-names></name><etal/></person-group><article-title>Epigenetic silencing of TH1-type chemokines shapes tumour immunity and immunotherapy</article-title><source>Nature</source><year>2015</year><volume>527</volume><fpage>249</fpage><lpage>253</lpage><pub-id pub-id-type="doi">10.1038/nature15520</pub-id><pub-id pub-id-type="pmid">26503055</pub-id><pub-id pub-id-type="pmcid">PMC4779053</pub-id></element-citation></ref><ref id="B66-ijms-21-08011"><label>66.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Paul</surname><given-names>W.E.</given-names></name><name name-style="western"><surname>Zhu</surname><given-names>J.</given-names></name></person-group><article-title>How are T(H)2-type immune responses initiated and amplified?</article-title><source>Nat. Rev. Immunol.</source><year>2010</year><volume>10</volume><fpage>225</fpage><lpage>235</lpage><pub-id pub-id-type="doi">10.1038/nri2735</pub-id><pub-id pub-id-type="pmid">20336151</pub-id><pub-id pub-id-type="pmcid">PMC3496776</pub-id></element-citation></ref><ref id="B67-ijms-21-08011"><label>67.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Zhu</surname><given-names>J.</given-names></name><name name-style="western"><surname>Min</surname><given-names>B.</given-names></name><name name-style="western"><surname>Hu-Li</surname><given-names>J.</given-names></name><name name-style="western"><surname>Watson</surname><given-names>C.J.</given-names></name><name name-style="western"><surname>Grinberg</surname><given-names>A.</given-names></name><name name-style="western"><surname>Wang</surname><given-names>Q.</given-names></name><name name-style="western"><surname>Killeen</surname><given-names>N.</given-names></name><name name-style="western"><surname>Urban</surname><given-names>J.F.</given-names><suffix>Jr.</suffix></name><name name-style="western"><surname>Guo</surname><given-names>L.</given-names></name><name name-style="western"><surname>Paul</surname><given-names>W.E.</given-names></name></person-group><article-title>Conditional deletion of Gata3 shows its essential function in T(H)1-T(H)2 responses</article-title><source>Nat. Immunol.</source><year>2004</year><volume>5</volume><fpage>1157</fpage><lpage>1165</lpage><pub-id pub-id-type="doi">10.1038/ni1128</pub-id><pub-id pub-id-type="pmid">15475959</pub-id></element-citation></ref><ref id="B68-ijms-21-08011"><label>68.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Zhu</surname><given-names>J.</given-names></name></person-group><article-title>Seventeen-Year Journey Working with a Master</article-title><source>Front. Immunol.</source><year>2018</year><volume>9</volume><fpage>960</fpage><pub-id pub-id-type="doi">10.3389/fimmu.2018.00960</pub-id><pub-id pub-id-type="pmid">29770140</pub-id><pub-id pub-id-type="pmcid">PMC5940735</pub-id></element-citation></ref><ref id="B69-ijms-21-08011"><label>69.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Wohlfert</surname><given-names>E.A.</given-names></name><name name-style="western"><surname>Grainger</surname><given-names>J.R.</given-names></name><name name-style="western"><surname>Bouladoux</surname><given-names>N.</given-names></name><name name-style="western"><surname>Konkel</surname><given-names>J.E.</given-names></name><name name-style="western"><surname>Oldenhove</surname><given-names>G.</given-names></name><name name-style="western"><surname>Ribeiro</surname><given-names>C.H.</given-names></name><name name-style="western"><surname>Hall</surname><given-names>J.A.</given-names></name><name name-style="western"><surname>Yagi</surname><given-names>R.</given-names></name><name name-style="western"><surname>Naik</surname><given-names>S.</given-names></name><name name-style="western"><surname>Bhairavabhotla</surname><given-names>R.</given-names></name><etal/></person-group><article-title>GATA3 controls Foxp3(+) regulatory T cell fate during inflammation in mice</article-title><source>J. Clin. Investig.</source><year>2011</year><volume>121</volume><fpage>4503</fpage><lpage>4515</lpage><pub-id pub-id-type="doi">10.1172/JCI57456</pub-id><pub-id pub-id-type="pmid">21965331</pub-id><pub-id pub-id-type="pmcid">PMC3204837</pub-id></element-citation></ref><ref id="B70-ijms-21-08011"><label>70.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Fang</surname><given-names>D.</given-names></name><name name-style="western"><surname>Cui</surname><given-names>K.</given-names></name><name name-style="western"><surname>Hu</surname><given-names>G.</given-names></name><name name-style="western"><surname>Gurram</surname><given-names>R.K.</given-names></name><name name-style="western"><surname>Zhong</surname><given-names>C.</given-names></name><name name-style="western"><surname>Oler</surname><given-names>A.J.</given-names></name><name name-style="western"><surname>Yagi</surname><given-names>R.</given-names></name><name name-style="western"><surname>Zhao</surname><given-names>M.</given-names></name><name name-style="western"><surname>Sharma</surname><given-names>S.</given-names></name><name name-style="western"><surname>Liu</surname><given-names>P.</given-names></name><etal/></person-group><article-title>Bcl11b, a novel GATA3-interacting protein, suppresses Th1 while limiting Th2 cell differentiation</article-title><source>J. Exp. Med.</source><year>2018</year><volume>215</volume><fpage>1449</fpage><lpage>1462</lpage><pub-id pub-id-type="doi">10.1084/jem.20171127</pub-id><pub-id pub-id-type="pmid">29514917</pub-id><pub-id pub-id-type="pmcid">PMC5940260</pub-id></element-citation></ref><ref id="B71-ijms-21-08011"><label>71.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kim</surname><given-names>J.I.</given-names></name><name name-style="western"><surname>Ho</surname><given-names>I.C.</given-names></name><name name-style="western"><surname>Grusby</surname><given-names>M.J.</given-names></name><name name-style="western"><surname>Glimcher</surname><given-names>L.H.</given-names></name></person-group><article-title>The transcription factor c-Maf controls the production of interleukin-4 but not other Th2 cytokines</article-title><source>Immunity</source><year>1999</year><volume>10</volume><fpage>745</fpage><lpage>751</lpage><pub-id pub-id-type="doi">10.1016/S1074-7613(00)80073-4</pub-id><pub-id pub-id-type="pmid">10403649</pub-id></element-citation></ref><ref id="B72-ijms-21-08011"><label>72.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Stritesky</surname><given-names>G.L.</given-names></name><name name-style="western"><surname>Muthukrishnan</surname><given-names>R.</given-names></name><name name-style="western"><surname>Sehra</surname><given-names>S.</given-names></name><name name-style="western"><surname>Goswami</surname><given-names>R.</given-names></name><name name-style="western"><surname>Pham</surname><given-names>D.</given-names></name><name name-style="western"><surname>Travers</surname><given-names>J.</given-names></name><name name-style="western"><surname>Nguyen</surname><given-names>E.T.</given-names></name><name name-style="western"><surname>Levy</surname><given-names>D.E.</given-names></name><name name-style="western"><surname>Kaplan</surname><given-names>M.H.</given-names></name></person-group><article-title>The transcription factor STAT3 is required for T helper 2 cell development</article-title><source>Immunity</source><year>2011</year><volume>34</volume><fpage>39</fpage><lpage>49</lpage><pub-id pub-id-type="doi">10.1016/j.immuni.2010.12.013</pub-id><pub-id pub-id-type="pmid">21215659</pub-id><pub-id pub-id-type="pmcid">PMC3040244</pub-id></element-citation></ref><ref id="B73-ijms-21-08011"><label>73.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Amsen</surname><given-names>D.</given-names></name><name name-style="western"><surname>Blander</surname><given-names>J.M.</given-names></name><name name-style="western"><surname>Lee</surname><given-names>G.R.</given-names></name><name name-style="western"><surname>Tanigaki</surname><given-names>K.</given-names></name><name name-style="western"><surname>Honjo</surname><given-names>T.</given-names></name><name name-style="western"><surname>Flavell</surname><given-names>R.A.</given-names></name></person-group><article-title>Instruction of distinct CD4 T helper cell fates by different notch ligands on antigen-presenting cells</article-title><source>Cell</source><year>2004</year><volume>117</volume><fpage>515</fpage><lpage>526</lpage><pub-id pub-id-type="doi">10.1016/S0092-8674(04)00451-9</pub-id><pub-id pub-id-type="pmid">15137944</pub-id></element-citation></ref><ref id="B74-ijms-21-08011"><label>74.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Zhu</surname><given-names>J.</given-names></name></person-group><article-title>T helper 2 (Th2) cell differentiation, type 2 innate lymphoid cell (ILC2) development and regulation of interleukin-4 (IL-4) and IL-13 production</article-title><source>Cytokine</source><year>2015</year><volume>75</volume><fpage>14</fpage><lpage>24</lpage><pub-id pub-id-type="doi">10.1016/j.cyto.2015.05.010</pub-id><pub-id pub-id-type="pmid">26044597</pub-id><pub-id pub-id-type="pmcid">PMC4532589</pub-id></element-citation></ref><ref id="B75-ijms-21-08011"><label>75.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Sekiya</surname><given-names>T.</given-names></name><name name-style="western"><surname>Miyamasu</surname><given-names>M.</given-names></name><name name-style="western"><surname>Imanishi</surname><given-names>M.</given-names></name><name name-style="western"><surname>Yamada</surname><given-names>H.</given-names></name><name name-style="western"><surname>Nakajima</surname><given-names>T.</given-names></name><name name-style="western"><surname>Yamaguchi</surname><given-names>M.</given-names></name><name name-style="western"><surname>Fujisawa</surname><given-names>T.</given-names></name><name name-style="western"><surname>Pawankar</surname><given-names>R.</given-names></name><name name-style="western"><surname>Sano</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Ohta</surname><given-names>K.</given-names></name><etal/></person-group><article-title>Inducible expression of a Th2-type CC chemokine thymus- and activation-regulated chemokine by human bronchial epithelial cells</article-title><source>J. Immunol.</source><year>2000</year><volume>165</volume><fpage>2205</fpage><lpage>2213</lpage><pub-id pub-id-type="doi">10.4049/jimmunol.165.4.2205</pub-id><pub-id pub-id-type="pmid">10925308</pub-id></element-citation></ref><ref id="B76-ijms-21-08011"><label>76.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Panina-Bordignon</surname><given-names>P.</given-names></name><name name-style="western"><surname>Papi</surname><given-names>A.</given-names></name><name name-style="western"><surname>Mariani</surname><given-names>M.</given-names></name><name name-style="western"><surname>Di Lucia</surname><given-names>P.</given-names></name><name name-style="western"><surname>Casoni</surname><given-names>G.</given-names></name><name name-style="western"><surname>Bellettato</surname><given-names>C.</given-names></name><name name-style="western"><surname>Buonsanti</surname><given-names>C.</given-names></name><name name-style="western"><surname>Miotto</surname><given-names>D.</given-names></name><name name-style="western"><surname>Mapp</surname><given-names>C.</given-names></name><name name-style="western"><surname>Villa</surname><given-names>A.</given-names></name><etal/></person-group><article-title>The C-C chemokine receptors CCR4 and CCR8 identify airway T cells of allergen-challenged atopic asthmatics</article-title><source>J. Clin. Investig.</source><year>2001</year><volume>107</volume><fpage>1357</fpage><lpage>1364</lpage><pub-id pub-id-type="doi">10.1172/JCI12655</pub-id><pub-id pub-id-type="pmid">11390417</pub-id><pub-id pub-id-type="pmcid">PMC209325</pub-id></element-citation></ref><ref id="B77-ijms-21-08011"><label>77.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Knipfer</surname><given-names>L.</given-names></name><name name-style="western"><surname>Schulz-Kuhnt</surname><given-names>A.</given-names></name><name name-style="western"><surname>Kindermann</surname><given-names>M.</given-names></name><name name-style="western"><surname>Greif</surname><given-names>V.</given-names></name><name name-style="western"><surname>Symowski</surname><given-names>C.</given-names></name><name name-style="western"><surname>Voehringer</surname><given-names>D.</given-names></name><name name-style="western"><surname>Neurath</surname><given-names>M.F.</given-names></name><name name-style="western"><surname>Atreya</surname><given-names>I.</given-names></name><name name-style="western"><surname>Wirtz</surname><given-names>S.</given-names></name></person-group><article-title>A CCL1/CCR8-dependent feed-forward mechanism drives ILC2 functions in type 2-mediated inflammation</article-title><source>J. Exp. Med.</source><year>2019</year><volume>216</volume><fpage>2763</fpage><lpage>2777</lpage><pub-id pub-id-type="doi">10.1084/jem.20182111</pub-id><pub-id pub-id-type="pmid">31537642</pub-id><pub-id pub-id-type="pmcid">PMC6888976</pub-id></element-citation></ref><ref id="B78-ijms-21-08011"><label>78.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Liu</surname><given-names>Y.J.</given-names></name></person-group><article-title>TSLP in epithelial cell and dendritic cell cross talk</article-title><source>Adv. Immunol.</source><year>2009</year><volume>101</volume><fpage>1</fpage><lpage>25</lpage><pub-id pub-id-type="doi">10.1016/S0065-2776(08)01001-8</pub-id><pub-id pub-id-type="pmid">19231591</pub-id><pub-id pub-id-type="pmcid">PMC3645262</pub-id></element-citation></ref><ref id="B79-ijms-21-08011"><label>79.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Cosmi</surname><given-names>L.</given-names></name><name name-style="western"><surname>Annunziato</surname><given-names>F.</given-names></name><name name-style="western"><surname>Iwasaki</surname><given-names>M.</given-names></name><name name-style="western"><surname>Galli</surname><given-names>G.</given-names></name><name name-style="western"><surname>Manetti</surname><given-names>R.</given-names></name><name name-style="western"><surname>Maggi</surname><given-names>E.</given-names></name><name name-style="western"><surname>Nagata</surname><given-names>K.</given-names></name><name name-style="western"><surname>Romagnani</surname><given-names>S.</given-names></name></person-group><article-title>CRTH2 is the most reliable marker for the detection of circulating human type 2 Th and type 2 T cytotoxic cells in health and disease</article-title><source>Eur. J. Immunol.</source><year>2000</year><volume>30</volume><fpage>2972</fpage><lpage>2979</lpage><pub-id pub-id-type="doi" assigning-authority="pmc">10.1002/1521-4141(200010)30:10&amp;#x0003c;2972::AID-IMMU2972&amp;#x0003e;3.0.CO;2-#</pub-id><pub-id pub-id-type="pmid">11069080</pub-id></element-citation></ref><ref id="B80-ijms-21-08011"><label>80.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Xu</surname><given-names>D.</given-names></name><name name-style="western"><surname>Chan</surname><given-names>W.L.</given-names></name><name name-style="western"><surname>Leung</surname><given-names>B.P.</given-names></name><name name-style="western"><surname>Huang</surname><given-names>F.</given-names></name><name name-style="western"><surname>Wheeler</surname><given-names>R.</given-names></name><name name-style="western"><surname>Piedrafita</surname><given-names>D.</given-names></name><name name-style="western"><surname>Robinson</surname><given-names>J.H.</given-names></name><name name-style="western"><surname>Liew</surname><given-names>F.Y.</given-names></name></person-group><article-title>Selective expression of a stable cell surface molecule on type 2 but not type 1 helper T cells</article-title><source>J. Exp. Med.</source><year>1998</year><volume>187</volume><fpage>787</fpage><lpage>794</lpage><pub-id pub-id-type="doi">10.1084/jem.187.5.787</pub-id><pub-id pub-id-type="pmid">9480988</pub-id><pub-id pub-id-type="pmcid">PMC2212173</pub-id></element-citation></ref><ref id="B81-ijms-21-08011"><label>81.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Zhong</surname><given-names>C.</given-names></name><name name-style="western"><surname>Zheng</surname><given-names>M.</given-names></name><name name-style="western"><surname>Cui</surname><given-names>K.</given-names></name><name name-style="western"><surname>Martins</surname><given-names>A.J.</given-names></name><name name-style="western"><surname>Hu</surname><given-names>G.</given-names></name><name name-style="western"><surname>Li</surname><given-names>D.</given-names></name><name name-style="western"><surname>Tessarollo</surname><given-names>L.</given-names></name><name name-style="western"><surname>Kozlov</surname><given-names>S.</given-names></name><name name-style="western"><surname>Keller</surname><given-names>J.R.</given-names></name><name name-style="western"><surname>Tsang</surname><given-names>J.S.</given-names></name><etal/></person-group><article-title>Differential Expression of the Transcription Factor GATA3 Specifies Lineage and Functions of Innate Lymphoid Cells</article-title><source>Immunity</source><year>2020</year><volume>52</volume><fpage>83</fpage><lpage>95.e84</lpage><pub-id pub-id-type="doi">10.1016/j.immuni.2019.12.001</pub-id><pub-id pub-id-type="pmid">31882362</pub-id><pub-id pub-id-type="pmcid">PMC6962539</pub-id></element-citation></ref><ref id="B82-ijms-21-08011"><label>82.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Halim</surname><given-names>T.Y.</given-names></name><name name-style="western"><surname>Steer</surname><given-names>C.A.</given-names></name><name name-style="western"><surname>Matha</surname><given-names>L.</given-names></name><name name-style="western"><surname>Gold</surname><given-names>M.J.</given-names></name><name name-style="western"><surname>Martinez-Gonzalez</surname><given-names>I.</given-names></name><name name-style="western"><surname>McNagny</surname><given-names>K.M.</given-names></name><name name-style="western"><surname>McKenzie</surname><given-names>A.N.</given-names></name><name name-style="western"><surname>Takei</surname><given-names>F.</given-names></name></person-group><article-title>Group 2 innate lymphoid cells are critical for the initiation of adaptive T helper 2 cell-mediated allergic lung inflammation</article-title><source>Immunity</source><year>2014</year><volume>40</volume><fpage>425</fpage><lpage>435</lpage><pub-id pub-id-type="doi">10.1016/j.immuni.2014.01.011</pub-id><pub-id pub-id-type="pmid">24613091</pub-id><pub-id pub-id-type="pmcid">PMC4210641</pub-id></element-citation></ref><ref id="B83-ijms-21-08011"><label>83.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Oliphant</surname><given-names>C.J.</given-names></name><name name-style="western"><surname>Hwang</surname><given-names>Y.Y.</given-names></name><name name-style="western"><surname>Walker</surname><given-names>J.A.</given-names></name><name name-style="western"><surname>Salimi</surname><given-names>M.</given-names></name><name name-style="western"><surname>Wong</surname><given-names>S.H.</given-names></name><name name-style="western"><surname>Brewer</surname><given-names>J.M.</given-names></name><name name-style="western"><surname>Englezakis</surname><given-names>A.</given-names></name><name name-style="western"><surname>Barlow</surname><given-names>J.L.</given-names></name><name name-style="western"><surname>Hams</surname><given-names>E.</given-names></name><name name-style="western"><surname>Scanlon</surname><given-names>S.T.</given-names></name><etal/></person-group><article-title>MHCII-mediated dialog between group 2 innate lymphoid cells and CD4(+) T cells potentiates type 2 immunity and promotes parasitic helminth expulsion</article-title><source>Immunity</source><year>2014</year><volume>41</volume><fpage>283</fpage><lpage>295</lpage><pub-id pub-id-type="doi">10.1016/j.immuni.2014.06.016</pub-id><pub-id pub-id-type="pmid">25088770</pub-id><pub-id pub-id-type="pmcid">PMC4148706</pub-id></element-citation></ref><ref id="B84-ijms-21-08011"><label>84.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Von Moltke</surname><given-names>J.</given-names></name><name name-style="western"><surname>Ji</surname><given-names>M.</given-names></name><name name-style="western"><surname>Liang</surname><given-names>H.E.</given-names></name><name name-style="western"><surname>Locksley</surname><given-names>R.M.</given-names></name></person-group><article-title>Tuft-cell-derived IL-25 regulates an intestinal ILC2-epithelial response circuit</article-title><source>Nature</source><year>2016</year><volume>529</volume><fpage>221</fpage><lpage>225</lpage><pub-id pub-id-type="doi">10.1038/nature16161</pub-id><pub-id pub-id-type="pmid">26675736</pub-id><pub-id pub-id-type="pmcid">PMC4830391</pub-id></element-citation></ref><ref id="B85-ijms-21-08011"><label>85.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Dewas</surname><given-names>C.</given-names></name><name name-style="western"><surname>Chen</surname><given-names>X.</given-names></name><name name-style="western"><surname>Honda</surname><given-names>T.</given-names></name><name name-style="western"><surname>Junttila</surname><given-names>I.</given-names></name><name name-style="western"><surname>Linton</surname><given-names>J.</given-names></name><name name-style="western"><surname>Udey</surname><given-names>M.C.</given-names></name><name name-style="western"><surname>Porcella</surname><given-names>S.F.</given-names></name><name name-style="western"><surname>Sturdevant</surname><given-names>D.E.</given-names></name><name name-style="western"><surname>Feigenbaum</surname><given-names>L.</given-names></name><name name-style="western"><surname>Koo</surname><given-names>L.</given-names></name><etal/></person-group><article-title>TSLP expression: Analysis with a ZsGreen TSLP reporter mouse</article-title><source>J. Immunol.</source><year>2015</year><volume>194</volume><fpage>1372</fpage><lpage>1380</lpage><pub-id pub-id-type="doi">10.4049/jimmunol.1400519</pub-id><pub-id pub-id-type="pmid">25539812</pub-id><pub-id pub-id-type="pmcid">PMC4297686</pub-id></element-citation></ref><ref id="B86-ijms-21-08011"><label>86.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Guo</surname><given-names>L.</given-names></name><name name-style="western"><surname>Huang</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Chen</surname><given-names>X.</given-names></name><name name-style="western"><surname>Hu-Li</surname><given-names>J.</given-names></name><name name-style="western"><surname>Urban</surname><given-names>J.F.</given-names><suffix>Jr.</suffix></name><name name-style="western"><surname>Paul</surname><given-names>W.E.</given-names></name></person-group><article-title>Innate immunological function of TH2 cells in vivo</article-title><source>Nat. Immunol.</source><year>2015</year><volume>16</volume><fpage>1051</fpage><lpage>1059</lpage><pub-id pub-id-type="doi">10.1038/ni.3244</pub-id><pub-id pub-id-type="pmid">26322482</pub-id><pub-id pub-id-type="pmcid">PMC4575627</pub-id></element-citation></ref><ref id="B87-ijms-21-08011"><label>87.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Liang</surname><given-names>H.E.</given-names></name><name name-style="western"><surname>Reinhardt</surname><given-names>R.L.</given-names></name><name name-style="western"><surname>Bando</surname><given-names>J.K.</given-names></name><name name-style="western"><surname>Sullivan</surname><given-names>B.M.</given-names></name><name name-style="western"><surname>Ho</surname><given-names>I.C.</given-names></name><name name-style="western"><surname>Locksley</surname><given-names>R.M.</given-names></name></person-group><article-title>Divergent expression patterns of IL-4 and IL-13 define unique functions in allergic immunity</article-title><source>Nat. Immunol.</source><year>2012</year><volume>13</volume><fpage>58</fpage><lpage>66</lpage><pub-id pub-id-type="doi">10.1038/ni.2182</pub-id><pub-id pub-id-type="pmid">22138715</pub-id><pub-id pub-id-type="pmcid">PMC3242938</pub-id></element-citation></ref><ref id="B88-ijms-21-08011"><label>88.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Peine</surname><given-names>M.</given-names></name><name name-style="western"><surname>Rausch</surname><given-names>S.</given-names></name><name name-style="western"><surname>Helmstetter</surname><given-names>C.</given-names></name><name name-style="western"><surname>Frohlich</surname><given-names>A.</given-names></name><name name-style="western"><surname>Hegazy</surname><given-names>A.N.</given-names></name><name name-style="western"><surname>Kuhl</surname><given-names>A.A.</given-names></name><name name-style="western"><surname>Grevelding</surname><given-names>C.G.</given-names></name><name name-style="western"><surname>Hofer</surname><given-names>T.</given-names></name><name name-style="western"><surname>Hartmann</surname><given-names>S.</given-names></name><name name-style="western"><surname>Lohning</surname><given-names>M.</given-names></name></person-group><article-title>Stable T-bet(+)GATA-3(+) Th1/Th2 hybrid cells arise in vivo, can develop directly from naive precursors, and limit immunopathologic inflammation</article-title><source>PLoS Biol.</source><year>2013</year><volume>11</volume><elocation-id>e1001633</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pbio.1001633</pub-id><pub-id pub-id-type="pmid">23976880</pub-id><pub-id pub-id-type="pmcid">PMC3747991</pub-id></element-citation></ref><ref id="B89-ijms-21-08011"><label>89.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Wang</surname><given-names>Y.H.</given-names></name><name name-style="western"><surname>Voo</surname><given-names>K.S.</given-names></name><name name-style="western"><surname>Liu</surname><given-names>B.</given-names></name><name name-style="western"><surname>Chen</surname><given-names>C.Y.</given-names></name><name name-style="western"><surname>Uygungil</surname><given-names>B.</given-names></name><name name-style="western"><surname>Spoede</surname><given-names>W.</given-names></name><name name-style="western"><surname>Bernstein</surname><given-names>J.A.</given-names></name><name name-style="western"><surname>Huston</surname><given-names>D.P.</given-names></name><name name-style="western"><surname>Liu</surname><given-names>Y.J.</given-names></name></person-group><article-title>A novel subset of CD4(+) T(H)2 memory/effector cells that produce inflammatory IL-17 cytokine and promote the exacerbation of chronic allergic asthma</article-title><source>J. Exp. Med.</source><year>2010</year><volume>207</volume><fpage>2479</fpage><lpage>2491</lpage><pub-id pub-id-type="doi">10.1084/jem.20101376</pub-id><pub-id pub-id-type="pmid">20921287</pub-id><pub-id pub-id-type="pmcid">PMC2964570</pub-id></element-citation></ref><ref id="B90-ijms-21-08011"><label>90.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Irvin</surname><given-names>C.</given-names></name><name name-style="western"><surname>Zafar</surname><given-names>I.</given-names></name><name name-style="western"><surname>Good</surname><given-names>J.</given-names></name><name name-style="western"><surname>Rollins</surname><given-names>D.</given-names></name><name name-style="western"><surname>Christianson</surname><given-names>C.</given-names></name><name name-style="western"><surname>Gorska</surname><given-names>M.M.</given-names></name><name name-style="western"><surname>Martin</surname><given-names>R.J.</given-names></name><name name-style="western"><surname>Alam</surname><given-names>R.</given-names></name></person-group><article-title>Increased frequency of dual-positive TH2/TH17 cells in bronchoalveolar lavage fluid characterizes a population of patients with severe asthma</article-title><source>J. Allergy Clin. Immunol.</source><year>2014</year><volume>134</volume><fpage>1175</fpage><lpage>1186.e1177</lpage><pub-id pub-id-type="doi">10.1016/j.jaci.2014.05.038</pub-id><pub-id pub-id-type="pmid">25042748</pub-id><pub-id pub-id-type="pmcid">PMC4254017</pub-id></element-citation></ref><ref id="B91-ijms-21-08011"><label>91.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Hegazy</surname><given-names>A.N.</given-names></name><name name-style="western"><surname>Peine</surname><given-names>M.</given-names></name><name name-style="western"><surname>Helmstetter</surname><given-names>C.</given-names></name><name name-style="western"><surname>Panse</surname><given-names>I.</given-names></name><name name-style="western"><surname>Frohlich</surname><given-names>A.</given-names></name><name name-style="western"><surname>Bergthaler</surname><given-names>A.</given-names></name><name name-style="western"><surname>Flatz</surname><given-names>L.</given-names></name><name name-style="western"><surname>Pinschewer</surname><given-names>D.D.</given-names></name><name name-style="western"><surname>Radbruch</surname><given-names>A.</given-names></name><name name-style="western"><surname>Lohning</surname><given-names>M.</given-names></name></person-group><article-title>Interferons direct Th2 cell reprogramming to generate a stable GATA-3(+)T-bet(+) cell subset with combined Th2 and Th1 cell functions</article-title><source>Immunity</source><year>2010</year><volume>32</volume><fpage>116</fpage><lpage>128</lpage><pub-id pub-id-type="doi">10.1016/j.immuni.2009.12.004</pub-id><pub-id pub-id-type="pmid">20079668</pub-id></element-citation></ref><ref id="B92-ijms-21-08011"><label>92.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Yagi</surname><given-names>R.</given-names></name><name name-style="western"><surname>Zhong</surname><given-names>C.</given-names></name><name name-style="western"><surname>Northrup</surname><given-names>D.L.</given-names></name><name name-style="western"><surname>Yu</surname><given-names>F.</given-names></name><name name-style="western"><surname>Bouladoux</surname><given-names>N.</given-names></name><name name-style="western"><surname>Spencer</surname><given-names>S.</given-names></name><name name-style="western"><surname>Hu</surname><given-names>G.</given-names></name><name name-style="western"><surname>Barron</surname><given-names>L.</given-names></name><name name-style="western"><surname>Sharma</surname><given-names>S.</given-names></name><name name-style="western"><surname>Nakayama</surname><given-names>T.</given-names></name><etal/></person-group><article-title>The transcription factor GATA3 is critical for the development of all IL-7Ralpha-expressing innate lymphoid cells</article-title><source>Immunity</source><year>2014</year><volume>40</volume><fpage>378</fpage><lpage>388</lpage><pub-id pub-id-type="doi">10.1016/j.immuni.2014.01.012</pub-id><pub-id pub-id-type="pmid">24631153</pub-id><pub-id pub-id-type="pmcid">PMC4026797</pub-id></element-citation></ref><ref id="B93-ijms-21-08011"><label>93.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Henriksson</surname><given-names>J.</given-names></name><name name-style="western"><surname>Chen</surname><given-names>X.</given-names></name><name name-style="western"><surname>Gomes</surname><given-names>T.</given-names></name><name name-style="western"><surname>Ullah</surname><given-names>U.</given-names></name><name name-style="western"><surname>Meyer</surname><given-names>K.B.</given-names></name><name name-style="western"><surname>Miragaia</surname><given-names>R.</given-names></name><name name-style="western"><surname>Duddy</surname><given-names>G.</given-names></name><name name-style="western"><surname>Pramanik</surname><given-names>J.</given-names></name><name name-style="western"><surname>Yusa</surname><given-names>K.</given-names></name><name name-style="western"><surname>Lahesmaa</surname><given-names>R.</given-names></name><etal/></person-group><article-title>Genome-wide CRISPR Screens in T Helper Cells Reveal Pervasive Crosstalk between Activation and Differentiation</article-title><source>Cell</source><year>2019</year><volume>176</volume><fpage>882</fpage><lpage>896.e818</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2018.11.044</pub-id><pub-id pub-id-type="pmid">30639098</pub-id><pub-id pub-id-type="pmcid">PMC6370901</pub-id></element-citation></ref><ref id="B94-ijms-21-08011"><label>94.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Pulendran</surname><given-names>B.</given-names></name><name name-style="western"><surname>Artis</surname><given-names>D.</given-names></name></person-group><article-title>New paradigms in type 2 immunity</article-title><source>Science</source><year>2012</year><volume>337</volume><fpage>431</fpage><lpage>435</lpage><pub-id pub-id-type="doi">10.1126/science.1221064</pub-id><pub-id pub-id-type="pmid">22837519</pub-id><pub-id pub-id-type="pmcid">PMC4078898</pub-id></element-citation></ref><ref id="B95-ijms-21-08011"><label>95.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Helm</surname><given-names>R.M.</given-names></name><name name-style="western"><surname>Burks</surname><given-names>A.W.</given-names></name></person-group><article-title>Mechanisms of food allergy</article-title><source>Curr. Opin. Immunol.</source><year>2000</year><volume>12</volume><fpage>647</fpage><lpage>653</lpage><pub-id pub-id-type="doi">10.1016/S0952-7915(00)00157-6</pub-id><pub-id pub-id-type="pmid">11102767</pub-id></element-citation></ref><ref id="B96-ijms-21-08011"><label>96.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Palm</surname><given-names>N.W.</given-names></name><name name-style="western"><surname>Rosenstein</surname><given-names>R.K.</given-names></name><name name-style="western"><surname>Medzhitov</surname><given-names>R.</given-names></name></person-group><article-title>Allergic host defences</article-title><source>Nature</source><year>2012</year><volume>484</volume><fpage>465</fpage><lpage>472</lpage><pub-id pub-id-type="doi">10.1038/nature11047</pub-id><pub-id pub-id-type="pmid">22538607</pub-id><pub-id pub-id-type="pmcid">PMC3596087</pub-id></element-citation></ref><ref id="B97-ijms-21-08011"><label>97.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Thomas</surname><given-names>W.R.</given-names></name><name name-style="western"><surname>Hales</surname><given-names>B.J.</given-names></name></person-group><article-title>T and B cell responses to HDM allergens and antigens</article-title><source>Immunol. Res.</source><year>2007</year><volume>37</volume><fpage>187</fpage><lpage>199</lpage><pub-id pub-id-type="doi">10.1007/BF02697369</pub-id><pub-id pub-id-type="pmid">17873403</pub-id></element-citation></ref><ref id="B98-ijms-21-08011"><label>98.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Mariani</surname><given-names>V.</given-names></name><name name-style="western"><surname>Gilles</surname><given-names>S.</given-names></name><name name-style="western"><surname>Jakob</surname><given-names>T.</given-names></name><name name-style="western"><surname>Thiel</surname><given-names>M.</given-names></name><name name-style="western"><surname>Mueller</surname><given-names>M.J.</given-names></name><name name-style="western"><surname>Ring</surname><given-names>J.</given-names></name><name name-style="western"><surname>Behrendt</surname><given-names>H.</given-names></name><name name-style="western"><surname>Traidl-Hoffmann</surname><given-names>C.</given-names></name></person-group><article-title>Immunomodulatory mediators from pollen enhance the migratory capacity of dendritic cells and license them for Th2 attraction</article-title><source>J. Immunol.</source><year>2007</year><volume>178</volume><fpage>7623</fpage><lpage>7631</lpage><pub-id pub-id-type="doi">10.4049/jimmunol.178.12.7623</pub-id><pub-id pub-id-type="pmid">17548598</pub-id></element-citation></ref><ref id="B99-ijms-21-08011"><label>99.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Coffman</surname><given-names>R.L.</given-names></name><name name-style="western"><surname>Sher</surname><given-names>A.</given-names></name><name name-style="western"><surname>Seder</surname><given-names>R.A.</given-names></name></person-group><article-title>Vaccine adjuvants: Putting innate immunity to work</article-title><source>Immunity</source><year>2010</year><volume>33</volume><fpage>492</fpage><lpage>503</lpage><pub-id pub-id-type="doi">10.1016/j.immuni.2010.10.002</pub-id><pub-id pub-id-type="pmid">21029960</pub-id><pub-id pub-id-type="pmcid">PMC3420356</pub-id></element-citation></ref><ref id="B100-ijms-21-08011"><label>100.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ting</surname><given-names>C.N.</given-names></name><name name-style="western"><surname>Olson</surname><given-names>M.C.</given-names></name><name name-style="western"><surname>Barton</surname><given-names>K.P.</given-names></name><name name-style="western"><surname>Leiden</surname><given-names>J.M.</given-names></name></person-group><article-title>Transcription factor GATA-3 is required for development of the T-cell lineage</article-title><source>Nature</source><year>1996</year><volume>384</volume><fpage>474</fpage><lpage>478</lpage><pub-id pub-id-type="doi">10.1038/384474a0</pub-id><pub-id pub-id-type="pmid">8945476</pub-id></element-citation></ref><ref id="B101-ijms-21-08011"><label>101.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Van Esch</surname><given-names>H.</given-names></name><name name-style="western"><surname>Groenen</surname><given-names>P.</given-names></name><name name-style="western"><surname>Nesbit</surname><given-names>M.A.</given-names></name><name name-style="western"><surname>Schuffenhauer</surname><given-names>S.</given-names></name><name name-style="western"><surname>Lichtner</surname><given-names>P.</given-names></name><name name-style="western"><surname>Vanderlinden</surname><given-names>G.</given-names></name><name name-style="western"><surname>Harding</surname><given-names>B.</given-names></name><name name-style="western"><surname>Beetz</surname><given-names>R.</given-names></name><name name-style="western"><surname>Bilous</surname><given-names>R.W.</given-names></name><name name-style="western"><surname>Holdaway</surname><given-names>I.</given-names></name><etal/></person-group><article-title>GATA3 haplo-insufficiency causes human HDR syndrome</article-title><source>Nature</source><year>2000</year><volume>406</volume><fpage>419</fpage><lpage>422</lpage><pub-id pub-id-type="doi">10.1038/35019088</pub-id><pub-id pub-id-type="pmid">10935639</pub-id></element-citation></ref><ref id="B102-ijms-21-08011"><label>102.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Skapenko</surname><given-names>A.</given-names></name><name name-style="western"><surname>Leipe</surname><given-names>J.</given-names></name><name name-style="western"><surname>Niesner</surname><given-names>U.</given-names></name><name name-style="western"><surname>Devriendt</surname><given-names>K.</given-names></name><name name-style="western"><surname>Beetz</surname><given-names>R.</given-names></name><name name-style="western"><surname>Radbruch</surname><given-names>A.</given-names></name><name name-style="western"><surname>Kalden</surname><given-names>J.R.</given-names></name><name name-style="western"><surname>Lipsky</surname><given-names>P.E.</given-names></name><name name-style="western"><surname>Schulze-Koops</surname><given-names>H.</given-names></name></person-group><article-title>GATA-3 in human T cell helper type 2 development</article-title><source>J. Exp. Med.</source><year>2004</year><volume>199</volume><fpage>423</fpage><lpage>428</lpage><pub-id pub-id-type="doi">10.1084/jem.20031323</pub-id><pub-id pub-id-type="pmid">14757746</pub-id><pub-id pub-id-type="pmcid">PMC2211796</pub-id></element-citation></ref><ref id="B103-ijms-21-08011"><label>103.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Lawrence</surname><given-names>M.G.</given-names></name><name name-style="western"><surname>Leiding</surname><given-names>J.W.</given-names></name><name name-style="western"><surname>Lyons</surname><given-names>J.J.</given-names></name><name name-style="western"><surname>Hsu</surname><given-names>A.P.</given-names></name><name name-style="western"><surname>Nelson</surname><given-names>C.C.</given-names></name><name name-style="western"><surname>Jones</surname><given-names>N.</given-names></name><name name-style="western"><surname>Fitzgerald</surname><given-names>A.</given-names></name><name name-style="western"><surname>Chien</surname><given-names>W.W.</given-names></name><name name-style="western"><surname>Workman</surname><given-names>L.</given-names></name><name name-style="western"><surname>Platts-Mills</surname><given-names>T.A.</given-names></name><etal/></person-group><article-title>GATA3 haploinsufficiency does not block allergic sensitization or atopic disease</article-title><source>J. Allergy Clin. Immunol.</source><year>2016</year><volume>137</volume><fpage>627</fpage><lpage>629.e622</lpage><pub-id pub-id-type="doi">10.1016/j.jaci.2015.06.041</pub-id><pub-id pub-id-type="pmid">26282285</pub-id><pub-id pub-id-type="pmcid">PMC4747849</pub-id></element-citation></ref><ref id="B104-ijms-21-08011"><label>104.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Klein Wolterink</surname><given-names>R.G.</given-names></name><name name-style="western"><surname>Serafini</surname><given-names>N.</given-names></name><name name-style="western"><surname>van Nimwegen</surname><given-names>M.</given-names></name><name name-style="western"><surname>Vosshenrich</surname><given-names>C.A.</given-names></name><name name-style="western"><surname>de Bruijn</surname><given-names>M.J.</given-names></name><name name-style="western"><surname>Fonseca Pereira</surname><given-names>D.</given-names></name><name name-style="western"><surname>Veiga Fernandes</surname><given-names>H.</given-names></name><name name-style="western"><surname>Hendriks</surname><given-names>R.W.</given-names></name><name name-style="western"><surname>Di Santo</surname><given-names>J.P.</given-names></name></person-group><article-title>Essential, dose-dependent role for the transcription factor Gata3 in the development of IL-5+ and IL-13+ type 2 innate lymphoid cells</article-title><source>Proc. Natl. Acad. Sci. USA</source><year>2013</year><volume>110</volume><fpage>10240</fpage><lpage>10245</lpage><pub-id pub-id-type="doi">10.1073/pnas.1217158110</pub-id><pub-id pub-id-type="pmid">23733962</pub-id><pub-id pub-id-type="pmcid">PMC3690884</pub-id></element-citation></ref><ref id="B105-ijms-21-08011"><label>105.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Marrella</surname><given-names>V.</given-names></name><name name-style="western"><surname>Poliani</surname><given-names>P.L.</given-names></name><name name-style="western"><surname>Sobacchi</surname><given-names>C.</given-names></name><name name-style="western"><surname>Grassi</surname><given-names>F.</given-names></name><name name-style="western"><surname>Villa</surname><given-names>A.</given-names></name></person-group><article-title>Of Omenn and mice</article-title><source>Trends Immunol.</source><year>2008</year><volume>29</volume><fpage>133</fpage><lpage>140</lpage><pub-id pub-id-type="doi">10.1016/j.it.2007.12.001</pub-id><pub-id pub-id-type="pmid">18255337</pub-id></element-citation></ref><ref id="B106-ijms-21-08011"><label>106.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Villa</surname><given-names>A.</given-names></name><name name-style="western"><surname>Notarangelo</surname><given-names>L.D.</given-names></name></person-group><article-title>RAG gene defects at the verge of immunodeficiency and immune dysregulation</article-title><source>Immunol. Rev.</source><year>2019</year><volume>287</volume><fpage>73</fpage><lpage>90</lpage><pub-id pub-id-type="doi">10.1111/imr.12713</pub-id><pub-id pub-id-type="pmid">30565244</pub-id><pub-id pub-id-type="pmcid">PMC6309314</pub-id></element-citation></ref><ref id="B107-ijms-21-08011"><label>107.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Milner</surname><given-names>J.D.</given-names></name><name name-style="western"><surname>Ward</surname><given-names>J.M.</given-names></name><name name-style="western"><surname>Keane-Myers</surname><given-names>A.</given-names></name><name name-style="western"><surname>Paul</surname><given-names>W.E.</given-names></name></person-group><article-title>Lymphopenic mice reconstituted with limited repertoire T cells develop severe, multiorgan, Th2-associated inflammatory disease</article-title><source>Proc. Natl. Acad. Sci. USA</source><year>2007</year><volume>104</volume><fpage>576</fpage><lpage>581</lpage><pub-id pub-id-type="doi">10.1073/pnas.0610289104</pub-id><pub-id pub-id-type="pmid">17202252</pub-id><pub-id pub-id-type="pmcid">PMC1761908</pub-id></element-citation></ref><ref id="B108-ijms-21-08011"><label>108.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Dolff</surname><given-names>S.</given-names></name><name name-style="western"><surname>Witzke</surname><given-names>O.</given-names></name><name name-style="western"><surname>Wilde</surname><given-names>B.</given-names></name></person-group><article-title>Th17 cells in renal inflammation and autoimmunity</article-title><source>Autoimmun. Rev.</source><year>2019</year><volume>18</volume><fpage>129</fpage><lpage>136</lpage><pub-id pub-id-type="doi">10.1016/j.autrev.2018.08.006</pub-id><pub-id pub-id-type="pmid">30572135</pub-id></element-citation></ref><ref id="B109-ijms-21-08011"><label>109.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Aggarwal</surname><given-names>S.</given-names></name><name name-style="western"><surname>Ghilardi</surname><given-names>N.</given-names></name><name name-style="western"><surname>Xie</surname><given-names>M.H.</given-names></name><name name-style="western"><surname>de Sauvage</surname><given-names>F.J.</given-names></name><name name-style="western"><surname>Gurney</surname><given-names>A.L.</given-names></name></person-group><article-title>Interleukin-23 promotes a distinct CD4 T cell activation state characterized by the production of interleukin-17</article-title><source>J. Biol. Chem.</source><year>2003</year><volume>278</volume><fpage>1910</fpage><lpage>1914</lpage><pub-id pub-id-type="doi">10.1074/jbc.M207577200</pub-id><pub-id pub-id-type="pmid">12417590</pub-id></element-citation></ref><ref id="B110-ijms-21-08011"><label>110.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Cua</surname><given-names>D.J.</given-names></name><name name-style="western"><surname>Sherlock</surname><given-names>J.</given-names></name><name name-style="western"><surname>Chen</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Murphy</surname><given-names>C.A.</given-names></name><name name-style="western"><surname>Joyce</surname><given-names>B.</given-names></name><name name-style="western"><surname>Seymour</surname><given-names>B.</given-names></name><name name-style="western"><surname>Lucian</surname><given-names>L.</given-names></name><name name-style="western"><surname>To</surname><given-names>W.</given-names></name><name name-style="western"><surname>Kwan</surname><given-names>S.</given-names></name><name name-style="western"><surname>Churakova</surname><given-names>T.</given-names></name><etal/></person-group><article-title>Interleukin-23 rather than interleukin-12 is the critical cytokine for autoimmune inflammation of the brain</article-title><source>Nature</source><year>2003</year><volume>421</volume><fpage>744</fpage><lpage>748</lpage><pub-id pub-id-type="doi">10.1038/nature01355</pub-id><pub-id pub-id-type="pmid">12610626</pub-id></element-citation></ref><ref id="B111-ijms-21-08011"><label>111.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Murphy</surname><given-names>C.A.</given-names></name><name name-style="western"><surname>Langrish</surname><given-names>C.L.</given-names></name><name name-style="western"><surname>Chen</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Blumenschein</surname><given-names>W.</given-names></name><name name-style="western"><surname>McClanahan</surname><given-names>T.</given-names></name><name name-style="western"><surname>Kastelein</surname><given-names>R.A.</given-names></name><name name-style="western"><surname>Sedgwick</surname><given-names>J.D.</given-names></name><name name-style="western"><surname>Cua</surname><given-names>D.J.</given-names></name></person-group><article-title>Divergent pro- and antiinflammatory roles for IL-23 and IL-12 in joint autoimmune inflammation</article-title><source>J. Exp. Med.</source><year>2003</year><volume>198</volume><fpage>1951</fpage><lpage>1957</lpage><pub-id pub-id-type="doi">10.1084/jem.20030896</pub-id><pub-id pub-id-type="pmid">14662908</pub-id><pub-id pub-id-type="pmcid">PMC2194162</pub-id></element-citation></ref><ref id="B112-ijms-21-08011"><label>112.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Park</surname><given-names>H.</given-names></name><name name-style="western"><surname>Li</surname><given-names>Z.X.</given-names></name><name name-style="western"><surname>Yang</surname><given-names>X.O.</given-names></name><name name-style="western"><surname>Chang</surname><given-names>S.H.</given-names></name><name name-style="western"><surname>Nurieva</surname><given-names>R.</given-names></name><name name-style="western"><surname>Wang</surname><given-names>Y.H.</given-names></name><name name-style="western"><surname>Wang</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Hood</surname><given-names>L.</given-names></name><name name-style="western"><surname>Zhu</surname><given-names>Z.</given-names></name><name name-style="western"><surname>Tian</surname><given-names>Q.</given-names></name><etal/></person-group><article-title>A distinct lineage of CD4 T cells regulates tissue inflammation by producing interleukin 17</article-title><source>Nat. Immunol.</source><year>2005</year><volume>6</volume><fpage>1133</fpage><lpage>1141</lpage><pub-id pub-id-type="doi">10.1038/ni1261</pub-id><pub-id pub-id-type="pmid">16200068</pub-id><pub-id pub-id-type="pmcid">PMC1618871</pub-id></element-citation></ref><ref id="B113-ijms-21-08011"><label>113.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Bettelli</surname><given-names>E.</given-names></name><name name-style="western"><surname>Carrier</surname><given-names>Y.J.</given-names></name><name name-style="western"><surname>Gao</surname><given-names>W.D.</given-names></name><name name-style="western"><surname>Korn</surname><given-names>T.</given-names></name><name name-style="western"><surname>Strom</surname><given-names>T.B.</given-names></name><name name-style="western"><surname>Oukka</surname><given-names>M.</given-names></name><name name-style="western"><surname>Weiner</surname><given-names>H.L.</given-names></name><name name-style="western"><surname>Kuchroo</surname><given-names>V.K.</given-names></name></person-group><article-title>Reciprocal developmental pathways for the generation of pathogenic effector T(H)17 and regulatory T cells</article-title><source>Nature</source><year>2006</year><volume>441</volume><fpage>235</fpage><lpage>238</lpage><pub-id pub-id-type="doi">10.1038/nature04753</pub-id><pub-id pub-id-type="pmid">16648838</pub-id></element-citation></ref><ref id="B114-ijms-21-08011"><label>114.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Harrington</surname><given-names>L.E.</given-names></name><name name-style="western"><surname>Hatton</surname><given-names>R.D.</given-names></name><name name-style="western"><surname>Mangan</surname><given-names>P.R.</given-names></name><name name-style="western"><surname>Turner</surname><given-names>H.</given-names></name><name name-style="western"><surname>Murphy</surname><given-names>T.L.</given-names></name><name name-style="western"><surname>Murphy</surname><given-names>K.M.</given-names></name><name name-style="western"><surname>Weaver</surname><given-names>C.T.</given-names></name></person-group><article-title>Interleukin 17-producing CD4+ effector T cells develop via a lineage distinct from the T helper type 1 and 2 lineages</article-title><source>Nat. Immunol.</source><year>2005</year><volume>6</volume><fpage>1123</fpage><lpage>1132</lpage><pub-id pub-id-type="doi">10.1038/ni1254</pub-id><pub-id pub-id-type="pmid">16200070</pub-id></element-citation></ref><ref id="B115-ijms-21-08011"><label>115.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Gaublomme</surname><given-names>J.T.</given-names></name><name name-style="western"><surname>Yosef</surname><given-names>N.</given-names></name><name name-style="western"><surname>Lee</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Gertner</surname><given-names>R.S.</given-names></name><name name-style="western"><surname>Yang</surname><given-names>L.V.</given-names></name><name name-style="western"><surname>Wu</surname><given-names>C.</given-names></name><name name-style="western"><surname>Pandolfi</surname><given-names>P.P.</given-names></name><name name-style="western"><surname>Mak</surname><given-names>T.</given-names></name><name name-style="western"><surname>Satija</surname><given-names>R.</given-names></name><name name-style="western"><surname>Shalek</surname><given-names>A.K.</given-names></name><etal/></person-group><article-title>Single-Cell Genomics Unveils Critical Regulators of Th17 Cell Pathogenicity</article-title><source>Cell</source><year>2015</year><volume>163</volume><fpage>1400</fpage><lpage>1412</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2015.11.009</pub-id><pub-id pub-id-type="pmid">26607794</pub-id><pub-id pub-id-type="pmcid">PMC4671824</pub-id></element-citation></ref><ref id="B116-ijms-21-08011"><label>116.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ciofani</surname><given-names>M.</given-names></name><name name-style="western"><surname>Madar</surname><given-names>A.</given-names></name><name name-style="western"><surname>Galan</surname><given-names>C.</given-names></name><name name-style="western"><surname>Sellars</surname><given-names>M.</given-names></name><name name-style="western"><surname>Mace</surname><given-names>K.</given-names></name><name name-style="western"><surname>Pauli</surname><given-names>F.</given-names></name><name name-style="western"><surname>Agarwal</surname><given-names>A.</given-names></name><name name-style="western"><surname>Huang</surname><given-names>W.</given-names></name><name name-style="western"><surname>Parkurst</surname><given-names>C.N.</given-names></name><name name-style="western"><surname>Muratet</surname><given-names>M.</given-names></name><etal/></person-group><article-title>A Validated Regulatory Network for Th17 Cell Specification</article-title><source>Cell</source><year>2012</year><volume>151</volume><fpage>289</fpage><lpage>303</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2012.09.016</pub-id><pub-id pub-id-type="pmid">23021777</pub-id><pub-id pub-id-type="pmcid">PMC3503487</pub-id></element-citation></ref><ref id="B117-ijms-21-08011"><label>117.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Chung</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Chang</surname><given-names>S.H.</given-names></name><name name-style="western"><surname>Martinez</surname><given-names>G.J.</given-names></name><name name-style="western"><surname>Yang</surname><given-names>X.O.</given-names></name><name name-style="western"><surname>Nurieva</surname><given-names>R.</given-names></name><name name-style="western"><surname>Kang</surname><given-names>H.S.</given-names></name><name name-style="western"><surname>Ma</surname><given-names>L.</given-names></name><name name-style="western"><surname>Watowich</surname><given-names>S.S.</given-names></name><name name-style="western"><surname>Jetten</surname><given-names>A.M.</given-names></name><name name-style="western"><surname>Tian</surname><given-names>Q.</given-names></name><etal/></person-group><article-title>Critical regulation of early Th17 cell differentiation by interleukin-1 signaling</article-title><source>Immunity</source><year>2009</year><volume>30</volume><fpage>576</fpage><lpage>587</lpage><pub-id pub-id-type="doi">10.1016/j.immuni.2009.02.007</pub-id><pub-id pub-id-type="pmid">19362022</pub-id><pub-id pub-id-type="pmcid">PMC2705871</pub-id></element-citation></ref><ref id="B118-ijms-21-08011"><label>118.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Guo</surname><given-names>L.</given-names></name><name name-style="western"><surname>Wei</surname><given-names>G.</given-names></name><name name-style="western"><surname>Zhu</surname><given-names>J.</given-names></name><name name-style="western"><surname>Liao</surname><given-names>W.</given-names></name><name name-style="western"><surname>Leonard</surname><given-names>W.J.</given-names></name><name name-style="western"><surname>Zhao</surname><given-names>K.</given-names></name><name name-style="western"><surname>Paul</surname><given-names>W.</given-names></name></person-group><article-title>IL-1 family members and STAT activators induce cytokine production by Th2, Th17, and Th1 cells</article-title><source>Proc. Natl. Acad. Sci. USA</source><year>2009</year><volume>106</volume><fpage>13463</fpage><lpage>13468</lpage><pub-id pub-id-type="doi">10.1073/pnas.0906988106</pub-id><pub-id pub-id-type="pmid">19666510</pub-id><pub-id pub-id-type="pmcid">PMC2726336</pub-id></element-citation></ref><ref id="B119-ijms-21-08011"><label>119.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Dong</surname><given-names>C.</given-names></name></person-group><article-title>TH17 cells in development: An updated view of their molecular identity and genetic programming</article-title><source>Nat. Rev. Immunol.</source><year>2008</year><volume>8</volume><fpage>337</fpage><lpage>348</lpage><pub-id pub-id-type="doi">10.1038/nri2295</pub-id><pub-id pub-id-type="pmid">18408735</pub-id></element-citation></ref><ref id="B120-ijms-21-08011"><label>120.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ghoreschi</surname><given-names>K.</given-names></name><name name-style="western"><surname>Laurence</surname><given-names>A.</given-names></name><name name-style="western"><surname>Yang</surname><given-names>X.P.</given-names></name><name name-style="western"><surname>Tato</surname><given-names>C.M.</given-names></name><name name-style="western"><surname>McGeachy</surname><given-names>M.J.</given-names></name><name name-style="western"><surname>Konkel</surname><given-names>J.E.</given-names></name><name name-style="western"><surname>Ramos</surname><given-names>H.L.</given-names></name><name name-style="western"><surname>Wei</surname><given-names>L.</given-names></name><name name-style="western"><surname>Davidson</surname><given-names>T.S.</given-names></name><name name-style="western"><surname>Bouladoux</surname><given-names>N.</given-names></name><etal/></person-group><article-title>Generation of pathogenic T(H)17 cells in the absence of TGF-beta signalling</article-title><source>Nature</source><year>2010</year><volume>467</volume><fpage>967</fpage><lpage>971</lpage><pub-id pub-id-type="doi">10.1038/nature09447</pub-id><pub-id pub-id-type="pmid">20962846</pub-id><pub-id pub-id-type="pmcid">PMC3108066</pub-id></element-citation></ref><ref id="B121-ijms-21-08011"><label>121.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Pawlak</surname><given-names>M.</given-names></name><name name-style="western"><surname>Ho</surname><given-names>A.W.</given-names></name><name name-style="western"><surname>Kuchroo</surname><given-names>V.K.</given-names></name></person-group><article-title>Cytokines and transcription factors in the differentiation of CD4<sup>+</sup> T helper cell subsets and induction of tissue inflammation and autoimmunity</article-title><source>Curr. Opin. Immunol.</source><year>2020</year><volume>67</volume><fpage>57</fpage><lpage>67</lpage><pub-id pub-id-type="doi">10.1016/j.coi.2020.09.001</pub-id><pub-id pub-id-type="pmid">33039897</pub-id><pub-id pub-id-type="pmcid">PMC7747296</pub-id></element-citation></ref><ref id="B122-ijms-21-08011"><label>122.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Veldhoen</surname><given-names>M.</given-names></name><name name-style="western"><surname>Hocking</surname><given-names>R.J.</given-names></name><name name-style="western"><surname>Atkins</surname><given-names>C.J.</given-names></name><name name-style="western"><surname>Locksley</surname><given-names>R.M.</given-names></name><name name-style="western"><surname>Stockinger</surname><given-names>B.</given-names></name></person-group><article-title>TGFbeta in the context of an inflammatory cytokine milieu supports de novo differentiation of IL-17-producing T cells</article-title><source>Immunity</source><year>2006</year><volume>24</volume><fpage>179</fpage><lpage>189</lpage><pub-id pub-id-type="doi">10.1016/j.immuni.2006.01.001</pub-id><pub-id pub-id-type="pmid">16473830</pub-id></element-citation></ref><ref id="B123-ijms-21-08011"><label>123.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Matsuzaki</surname><given-names>G.</given-names></name><name name-style="western"><surname>Umemura</surname><given-names>M.</given-names></name></person-group><article-title>Interleukin-17 as an effector molecule of innate and acquired immunity against infections</article-title><source>Microbiol. Immunol.</source><year>2007</year><volume>51</volume><fpage>1139</fpage><lpage>1147</lpage><pub-id pub-id-type="doi">10.1111/j.1348-0421.2007.tb04008.x</pub-id><pub-id pub-id-type="pmid">18094532</pub-id></element-citation></ref><ref id="B124-ijms-21-08011"><label>124.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kim</surname><given-names>C.H.</given-names></name></person-group><article-title>Migration and function of Th17 cells</article-title><source>Inflamm. Allergy Drug Targets</source><year>2009</year><volume>8</volume><fpage>221</fpage><lpage>228</lpage><pub-id pub-id-type="doi">10.2174/187152809788681001</pub-id><pub-id pub-id-type="pmid">19601882</pub-id></element-citation></ref><ref id="B125-ijms-21-08011"><label>125.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Acosta-Rodriguez</surname><given-names>E.V.</given-names></name><name name-style="western"><surname>Rivino</surname><given-names>L.</given-names></name><name name-style="western"><surname>Geginat</surname><given-names>J.</given-names></name><name name-style="western"><surname>Jarrossay</surname><given-names>D.</given-names></name><name name-style="western"><surname>Gattorno</surname><given-names>M.</given-names></name><name name-style="western"><surname>Lanzavecchia</surname><given-names>A.</given-names></name><name name-style="western"><surname>Sallusto</surname><given-names>F.</given-names></name><name name-style="western"><surname>Napolitani</surname><given-names>G.</given-names></name></person-group><article-title>Surface phenotype and antigenic specificity of human interleukin 17-producing T helper memory cells</article-title><source>Nat. Immunol.</source><year>2007</year><volume>8</volume><fpage>639</fpage><lpage>646</lpage><pub-id pub-id-type="doi">10.1038/ni1467</pub-id><pub-id pub-id-type="pmid">17486092</pub-id></element-citation></ref><ref id="B126-ijms-21-08011"><label>126.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Annunziato</surname><given-names>F.</given-names></name><name name-style="western"><surname>Cosmi</surname><given-names>L.</given-names></name><name name-style="western"><surname>Santarlasci</surname><given-names>V.</given-names></name><name name-style="western"><surname>Maggi</surname><given-names>L.</given-names></name><name name-style="western"><surname>Liotta</surname><given-names>F.</given-names></name><name name-style="western"><surname>Mazzinghi</surname><given-names>B.</given-names></name><name name-style="western"><surname>Parente</surname><given-names>E.</given-names></name><name name-style="western"><surname>Fili</surname><given-names>L.</given-names></name><name name-style="western"><surname>Ferri</surname><given-names>S.</given-names></name><name name-style="western"><surname>Frosali</surname><given-names>F.</given-names></name><etal/></person-group><article-title>Phenotypic and functional features of human Th17 cells</article-title><source>J. Exp. Med.</source><year>2007</year><volume>204</volume><fpage>1849</fpage><lpage>1861</lpage><pub-id pub-id-type="doi">10.1084/jem.20070663</pub-id><pub-id pub-id-type="pmid">17635957</pub-id><pub-id pub-id-type="pmcid">PMC2118657</pub-id></element-citation></ref><ref id="B127-ijms-21-08011"><label>127.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Rankin</surname><given-names>L.C.</given-names></name><name name-style="western"><surname>Girard-Madoux</surname><given-names>M.J.</given-names></name><name name-style="western"><surname>Seillet</surname><given-names>C.</given-names></name><name name-style="western"><surname>Mielke</surname><given-names>L.A.</given-names></name><name name-style="western"><surname>Kerdiles</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Fenis</surname><given-names>A.</given-names></name><name name-style="western"><surname>Wieduwild</surname><given-names>E.</given-names></name><name name-style="western"><surname>Putoczki</surname><given-names>T.</given-names></name><name name-style="western"><surname>Mondot</surname><given-names>S.</given-names></name><name name-style="western"><surname>Lantz</surname><given-names>O.</given-names></name><etal/></person-group><article-title>Complementarity and redundancy of IL-22-producing innate lymphoid cells</article-title><source>Nat. Immunol.</source><year>2016</year><volume>17</volume><fpage>179</fpage><lpage>186</lpage><pub-id pub-id-type="doi">10.1038/ni.3332</pub-id><pub-id pub-id-type="pmid">26595889</pub-id><pub-id pub-id-type="pmcid">PMC4720992</pub-id></element-citation></ref><ref id="B128-ijms-21-08011"><label>128.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Sano</surname><given-names>T.</given-names></name><name name-style="western"><surname>Huang</surname><given-names>W.</given-names></name><name name-style="western"><surname>Hall</surname><given-names>J.A.</given-names></name><name name-style="western"><surname>Yang</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Chen</surname><given-names>A.</given-names></name><name name-style="western"><surname>Gavzy</surname><given-names>S.J.</given-names></name><name name-style="western"><surname>Lee</surname><given-names>J.Y.</given-names></name><name name-style="western"><surname>Ziel</surname><given-names>J.W.</given-names></name><name name-style="western"><surname>Miraldi</surname><given-names>E.R.</given-names></name><name name-style="western"><surname>Domingos</surname><given-names>A.I.</given-names></name><etal/></person-group><article-title>An IL-23R/IL-22 Circuit Regulates Epithelial Serum Amyloid A to Promote Local Effector Th17 Responses</article-title><source>Cell</source><year>2015</year><volume>163</volume><fpage>381</fpage><lpage>393</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2015.08.061</pub-id><pub-id pub-id-type="pmid">26411290</pub-id><pub-id pub-id-type="pmcid">PMC4621768</pub-id></element-citation></ref><ref id="B129-ijms-21-08011"><label>129.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Mao</surname><given-names>K.</given-names></name><name name-style="western"><surname>Baptista</surname><given-names>A.P.</given-names></name><name name-style="western"><surname>Tamoutounour</surname><given-names>S.</given-names></name><name name-style="western"><surname>Zhuang</surname><given-names>L.</given-names></name><name name-style="western"><surname>Bouladoux</surname><given-names>N.</given-names></name><name name-style="western"><surname>Martins</surname><given-names>A.J.</given-names></name><name name-style="western"><surname>Huang</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Gerner</surname><given-names>M.Y.</given-names></name><name name-style="western"><surname>Belkaid</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Germain</surname><given-names>R.N.</given-names></name></person-group><article-title>Innate and adaptive lymphocytes sequentially shape the gut microbiota and lipid metabolism</article-title><source>Nature</source><year>2018</year><volume>554</volume><fpage>255</fpage><lpage>259</lpage><pub-id pub-id-type="doi">10.1038/nature25437</pub-id><pub-id pub-id-type="pmid">29364878</pub-id></element-citation></ref><ref id="B130-ijms-21-08011"><label>130.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Zhu</surname><given-names>J.</given-names></name><name name-style="western"><surname>Paul</surname><given-names>W.E.</given-names></name></person-group><article-title>Heterogeneity and plasticity of T helper cells</article-title><source>Cell Res.</source><year>2010</year><volume>20</volume><fpage>4</fpage><lpage>12</lpage><pub-id pub-id-type="doi">10.1038/cr.2009.138</pub-id><pub-id pub-id-type="pmid">20010916</pub-id><pub-id pub-id-type="pmcid">PMC3494736</pub-id></element-citation></ref><ref id="B131-ijms-21-08011"><label>131.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Lee</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Awasthi</surname><given-names>A.</given-names></name><name name-style="western"><surname>Yosef</surname><given-names>N.</given-names></name><name name-style="western"><surname>Quintana</surname><given-names>F.J.</given-names></name><name name-style="western"><surname>Xiao</surname><given-names>S.</given-names></name><name name-style="western"><surname>Peters</surname><given-names>A.</given-names></name><name name-style="western"><surname>Wu</surname><given-names>C.</given-names></name><name name-style="western"><surname>Kleinewietfeld</surname><given-names>M.</given-names></name><name name-style="western"><surname>Kunder</surname><given-names>S.</given-names></name><name name-style="western"><surname>Hafler</surname><given-names>D.A.</given-names></name><etal/></person-group><article-title>Induction and molecular signature of pathogenic TH17 cells</article-title><source>Nat. Immunol.</source><year>2012</year><volume>13</volume><fpage>991</fpage><lpage>999</lpage><pub-id pub-id-type="doi">10.1038/ni.2416</pub-id><pub-id pub-id-type="pmid">22961052</pub-id><pub-id pub-id-type="pmcid">PMC3459594</pub-id></element-citation></ref><ref id="B132-ijms-21-08011"><label>132.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Wang</surname><given-names>C.</given-names></name><name name-style="western"><surname>Yosef</surname><given-names>N.</given-names></name><name name-style="western"><surname>Gaublomme</surname><given-names>J.</given-names></name><name name-style="western"><surname>Wu</surname><given-names>C.</given-names></name><name name-style="western"><surname>Lee</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Clish</surname><given-names>C.B.</given-names></name><name name-style="western"><surname>Kaminski</surname><given-names>J.</given-names></name><name name-style="western"><surname>Xiao</surname><given-names>S.</given-names></name><name name-style="western"><surname>Meyer Zu Horste</surname><given-names>G.</given-names></name><name name-style="western"><surname>Pawlak</surname><given-names>M.</given-names></name><etal/></person-group><article-title>CD5L/AIM Regulates Lipid Biosynthesis and Restrains Th17 Cell Pathogenicity</article-title><source>Cell</source><year>2015</year><volume>163</volume><fpage>1413</fpage><lpage>1427</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2015.10.068</pub-id><pub-id pub-id-type="pmid">26607793</pub-id><pub-id pub-id-type="pmcid">PMC4671820</pub-id></element-citation></ref><ref id="B133-ijms-21-08011"><label>133.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Amir</surname><given-names>M.</given-names></name><name name-style="western"><surname>Chaudhari</surname><given-names>S.</given-names></name><name name-style="western"><surname>Wang</surname><given-names>R.</given-names></name><name name-style="western"><surname>Campbell</surname><given-names>S.</given-names></name><name name-style="western"><surname>Mosure</surname><given-names>S.A.</given-names></name><name name-style="western"><surname>Chopp</surname><given-names>L.B.</given-names></name><name name-style="western"><surname>Lu</surname><given-names>Q.</given-names></name><name name-style="western"><surname>Shang</surname><given-names>J.</given-names></name><name name-style="western"><surname>Pelletier</surname><given-names>O.B.</given-names></name><name name-style="western"><surname>He</surname><given-names>Y.</given-names></name><etal/></person-group><article-title>REV-ERBalpha Regulates TH17 Cell Development and Autoimmunity</article-title><source>Cell Rep.</source><year>2018</year><volume>25</volume><fpage>3733</fpage><lpage>3749.e3738</lpage><pub-id pub-id-type="doi">10.1016/j.celrep.2018.11.101</pub-id><pub-id pub-id-type="pmid">30590045</pub-id><pub-id pub-id-type="pmcid">PMC6400287</pub-id></element-citation></ref><ref id="B134-ijms-21-08011"><label>134.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kleinewietfeld</surname><given-names>M.</given-names></name><name name-style="western"><surname>Manzel</surname><given-names>A.</given-names></name><name name-style="western"><surname>Titze</surname><given-names>J.</given-names></name><name name-style="western"><surname>Kvakan</surname><given-names>H.</given-names></name><name name-style="western"><surname>Yosef</surname><given-names>N.</given-names></name><name name-style="western"><surname>Linker</surname><given-names>R.A.</given-names></name><name name-style="western"><surname>Muller</surname><given-names>D.N.</given-names></name><name name-style="western"><surname>Hafler</surname><given-names>D.A.</given-names></name></person-group><article-title>Sodium chloride drives autoimmune disease by the induction of pathogenic TH17 cells</article-title><source>Nature</source><year>2013</year><volume>496</volume><fpage>518</fpage><lpage>522</lpage><pub-id pub-id-type="doi">10.1038/nature11868</pub-id><pub-id pub-id-type="pmid">23467095</pub-id><pub-id pub-id-type="pmcid">PMC3746493</pub-id></element-citation></ref><ref id="B135-ijms-21-08011"><label>135.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Wilck</surname><given-names>N.</given-names></name><name name-style="western"><surname>Matus</surname><given-names>M.G.</given-names></name><name name-style="western"><surname>Kearney</surname><given-names>S.M.</given-names></name><name name-style="western"><surname>Olesen</surname><given-names>S.W.</given-names></name><name name-style="western"><surname>Forslund</surname><given-names>K.</given-names></name><name name-style="western"><surname>Bartolomaeus</surname><given-names>H.</given-names></name><name name-style="western"><surname>Haase</surname><given-names>S.</given-names></name><name name-style="western"><surname>Mahler</surname><given-names>A.</given-names></name><name name-style="western"><surname>Balogh</surname><given-names>A.</given-names></name><name name-style="western"><surname>Marko</surname><given-names>L.</given-names></name><etal/></person-group><article-title>Salt-responsive gut commensal modulates TH17 axis and disease</article-title><source>Nature</source><year>2017</year><volume>551</volume><fpage>585</fpage><lpage>589</lpage><pub-id pub-id-type="doi">10.1038/nature24628</pub-id><pub-id pub-id-type="pmid">29143823</pub-id><pub-id pub-id-type="pmcid">PMC6070150</pub-id></element-citation></ref><ref id="B136-ijms-21-08011"><label>136.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Bacher</surname><given-names>P.</given-names></name><name name-style="western"><surname>Hohnstein</surname><given-names>T.</given-names></name><name name-style="western"><surname>Beerbaum</surname><given-names>E.</given-names></name><name name-style="western"><surname>Rocker</surname><given-names>M.</given-names></name><name name-style="western"><surname>Blango</surname><given-names>M.G.</given-names></name><name name-style="western"><surname>Kaufmann</surname><given-names>S.</given-names></name><name name-style="western"><surname>Rohmel</surname><given-names>J.</given-names></name><name name-style="western"><surname>Eschenhagen</surname><given-names>P.</given-names></name><name name-style="western"><surname>Grehn</surname><given-names>C.</given-names></name><name name-style="western"><surname>Seidel</surname><given-names>K.</given-names></name><etal/></person-group><article-title>Human Anti-fungal Th17 Immunity and Pathology Rely on Cross-Reactivity against Candida albicans</article-title><source>Cell</source><year>2019</year><volume>176</volume><fpage>1340</fpage><lpage>1355.e1315</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2019.01.041</pub-id><pub-id pub-id-type="pmid">30799037</pub-id></element-citation></ref><ref id="B137-ijms-21-08011"><label>137.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Britton</surname><given-names>G.J.</given-names></name><name name-style="western"><surname>Contijoch</surname><given-names>E.J.</given-names></name><name name-style="western"><surname>Mogno</surname><given-names>I.</given-names></name><name name-style="western"><surname>Vennaro</surname><given-names>O.H.</given-names></name><name name-style="western"><surname>Llewellyn</surname><given-names>S.R.</given-names></name><name name-style="western"><surname>Ng</surname><given-names>R.</given-names></name><name name-style="western"><surname>Li</surname><given-names>Z.</given-names></name><name name-style="western"><surname>Mortha</surname><given-names>A.</given-names></name><name name-style="western"><surname>Merad</surname><given-names>M.</given-names></name><name name-style="western"><surname>Das</surname><given-names>A.</given-names></name><etal/></person-group><article-title>Microbiotas from Humans with Inflammatory Bowel Disease Alter the Balance of Gut Th17 and RORgammat(+) Regulatory T Cells and Exacerbate Colitis in Mice</article-title><source>Immunity</source><year>2019</year><volume>50</volume><fpage>212</fpage><lpage>224.e214</lpage><pub-id pub-id-type="doi">10.1016/j.immuni.2018.12.015</pub-id><pub-id pub-id-type="pmid">30650377</pub-id><pub-id pub-id-type="pmcid">PMC6512335</pub-id></element-citation></ref><ref id="B138-ijms-21-08011"><label>138.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Yoo</surname><given-names>S.A.</given-names></name><name name-style="western"><surname>Kim</surname><given-names>M.</given-names></name><name name-style="western"><surname>Kang</surname><given-names>M.C.</given-names></name><name name-style="western"><surname>Kong</surname><given-names>J.S.</given-names></name><name name-style="western"><surname>Kim</surname><given-names>K.M.</given-names></name><name name-style="western"><surname>Lee</surname><given-names>S.</given-names></name><name name-style="western"><surname>Hong</surname><given-names>B.K.</given-names></name><name name-style="western"><surname>Jeong</surname><given-names>G.H.</given-names></name><name name-style="western"><surname>Lee</surname><given-names>J.</given-names></name><name name-style="western"><surname>Shin</surname><given-names>M.G.</given-names></name><etal/></person-group><article-title>Placental growth factor regulates the generation of TH17 cells to link angiogenesis with autoimmunity</article-title><source>Nat. Immunol.</source><year>2019</year><volume>20</volume><fpage>1348</fpage><lpage>1359</lpage><pub-id pub-id-type="doi">10.1038/s41590-019-0456-4</pub-id><pub-id pub-id-type="pmid">31406382</pub-id></element-citation></ref><ref id="B139-ijms-21-08011"><label>139.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Harbour</surname><given-names>S.N.</given-names></name><name name-style="western"><surname>Maynard</surname><given-names>C.L.</given-names></name><name name-style="western"><surname>Zindl</surname><given-names>C.L.</given-names></name><name name-style="western"><surname>Schoeb</surname><given-names>T.R.</given-names></name><name name-style="western"><surname>Weaver</surname><given-names>C.T.</given-names></name></person-group><article-title>Th17 cells give rise to Th1 cells that are required for the pathogenesis of colitis</article-title><source>Proc. Natl. Acad. Sci. USA</source><year>2015</year><volume>112</volume><fpage>7061</fpage><lpage>7066</lpage><pub-id pub-id-type="doi">10.1073/pnas.1415675112</pub-id><pub-id pub-id-type="pmid">26038559</pub-id><pub-id pub-id-type="pmcid">PMC4460486</pub-id></element-citation></ref><ref id="B140-ijms-21-08011"><label>140.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Johnson</surname><given-names>M.O.</given-names></name><name name-style="western"><surname>Wolf</surname><given-names>M.M.</given-names></name><name name-style="western"><surname>Madden</surname><given-names>M.Z.</given-names></name><name name-style="western"><surname>Andrejeva</surname><given-names>G.</given-names></name><name name-style="western"><surname>Sugiura</surname><given-names>A.</given-names></name><name name-style="western"><surname>Contreras</surname><given-names>D.C.</given-names></name><name name-style="western"><surname>Maseda</surname><given-names>D.</given-names></name><name name-style="western"><surname>Liberti</surname><given-names>M.V.</given-names></name><name name-style="western"><surname>Paz</surname><given-names>K.</given-names></name><name name-style="western"><surname>Kishton</surname><given-names>R.J.</given-names></name><etal/></person-group><article-title>Distinct Regulation of Th17 and Th1 Cell Differentiation by Glutaminase-Dependent Metabolism</article-title><source>Cell</source><year>2018</year><volume>175</volume><fpage>1780</fpage><lpage>1795.e1719</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2018.10.001</pub-id><pub-id pub-id-type="pmid">30392958</pub-id><pub-id pub-id-type="pmcid">PMC6361668</pub-id></element-citation></ref><ref id="B141-ijms-21-08011"><label>141.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kono</surname><given-names>M.</given-names></name><name name-style="western"><surname>Yoshida</surname><given-names>N.</given-names></name><name name-style="western"><surname>Maeda</surname><given-names>K.</given-names></name><name name-style="western"><surname>Tsokos</surname><given-names>G.C.</given-names></name></person-group><article-title>Transcriptional factor ICER promotes glutaminolysis and the generation of Th17 cells</article-title><source>Proc. Natl. Acad. Sci. USA</source><year>2018</year><volume>115</volume><fpage>2478</fpage><lpage>2483</lpage><pub-id pub-id-type="doi">10.1073/pnas.1714717115</pub-id><pub-id pub-id-type="pmid">29463741</pub-id><pub-id pub-id-type="pmcid">PMC5877961</pub-id></element-citation></ref><ref id="B142-ijms-21-08011"><label>142.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Gibson</surname><given-names>S.A.</given-names></name><name name-style="western"><surname>Yang</surname><given-names>W.</given-names></name><name name-style="western"><surname>Yan</surname><given-names>Z.</given-names></name><name name-style="western"><surname>Qin</surname><given-names>H.</given-names></name><name name-style="western"><surname>Benveniste</surname><given-names>E.N.</given-names></name></person-group><article-title>CK2 Controls Th17 and Regulatory T Cell Differentiation Through Inhibition of FoxO1</article-title><source>J. Immunol.</source><year>2018</year><volume>201</volume><fpage>383</fpage><lpage>392</lpage><pub-id pub-id-type="doi">10.4049/jimmunol.1701592</pub-id><pub-id pub-id-type="pmid">29891553</pub-id><pub-id pub-id-type="pmcid">PMC6040220</pub-id></element-citation></ref><ref id="B143-ijms-21-08011"><label>143.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Karmaus</surname><given-names>P.W.F.</given-names></name><name name-style="western"><surname>Chen</surname><given-names>X.</given-names></name><name name-style="western"><surname>Lim</surname><given-names>S.A.</given-names></name><name name-style="western"><surname>Herrada</surname><given-names>A.A.</given-names></name><name name-style="western"><surname>Nguyen</surname><given-names>T.M.</given-names></name><name name-style="western"><surname>Xu</surname><given-names>B.</given-names></name><name name-style="western"><surname>Dhungana</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Rankin</surname><given-names>S.</given-names></name><name name-style="western"><surname>Chen</surname><given-names>W.</given-names></name><name name-style="western"><surname>Rosencrance</surname><given-names>C.</given-names></name><etal/></person-group><article-title>Metabolic heterogeneity underlies reciprocal fates of TH17 cell stemness and plasticity</article-title><source>Nature</source><year>2019</year><volume>565</volume><fpage>101</fpage><lpage>105</lpage><pub-id pub-id-type="doi">10.1038/s41586-018-0806-7</pub-id><pub-id pub-id-type="pmid">30568299</pub-id><pub-id pub-id-type="pmcid">PMC6420879</pub-id></element-citation></ref><ref id="B144-ijms-21-08011"><label>144.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Omenetti</surname><given-names>S.</given-names></name><name name-style="western"><surname>Bussi</surname><given-names>C.</given-names></name><name name-style="western"><surname>Metidji</surname><given-names>A.</given-names></name><name name-style="western"><surname>Iseppon</surname><given-names>A.</given-names></name><name name-style="western"><surname>Lee</surname><given-names>S.</given-names></name><name name-style="western"><surname>Tolaini</surname><given-names>M.</given-names></name><name name-style="western"><surname>Li</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Kelly</surname><given-names>G.</given-names></name><name name-style="western"><surname>Chakravarty</surname><given-names>P.</given-names></name><name name-style="western"><surname>Shoaie</surname><given-names>S.</given-names></name><etal/></person-group><article-title>The Intestine Harbors Functionally Distinct Homeostatic Tissue-Resident and Inflammatory Th17 Cells</article-title><source>Immunity</source><year>2019</year><volume>51</volume><fpage>77</fpage><lpage>89.e76</lpage><pub-id pub-id-type="doi">10.1016/j.immuni.2019.05.004</pub-id><pub-id pub-id-type="pmid">31229354</pub-id><pub-id pub-id-type="pmcid">PMC6642154</pub-id></element-citation></ref><ref id="B145-ijms-21-08011"><label>145.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Wang</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Godec</surname><given-names>J.</given-names></name><name name-style="western"><surname>Ben-Aissa</surname><given-names>K.</given-names></name><name name-style="western"><surname>Cui</surname><given-names>K.</given-names></name><name name-style="western"><surname>Zhao</surname><given-names>K.</given-names></name><name name-style="western"><surname>Pucsek</surname><given-names>A.B.</given-names></name><name name-style="western"><surname>Lee</surname><given-names>Y.K.</given-names></name><name name-style="western"><surname>Weaver</surname><given-names>C.T.</given-names></name><name name-style="western"><surname>Yagi</surname><given-names>R.</given-names></name><name name-style="western"><surname>Lazarevic</surname><given-names>V.</given-names></name></person-group><article-title>The transcription factors T-bet and Runx are required for the ontogeny of pathogenic interferon-gamma-producing T helper 17 cells</article-title><source>Immunity</source><year>2014</year><volume>40</volume><fpage>355</fpage><lpage>366</lpage><pub-id pub-id-type="doi">10.1016/j.immuni.2014.01.002</pub-id><pub-id pub-id-type="pmid">24530058</pub-id><pub-id pub-id-type="pmcid">PMC3965587</pub-id></element-citation></ref><ref id="B146-ijms-21-08011"><label>146.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Okada</surname><given-names>S.</given-names></name><name name-style="western"><surname>Markle</surname><given-names>J.G.</given-names></name><name name-style="western"><surname>Deenick</surname><given-names>E.K.</given-names></name><name name-style="western"><surname>Mele</surname><given-names>F.</given-names></name><name name-style="western"><surname>Averbuch</surname><given-names>D.</given-names></name><name name-style="western"><surname>Lagos</surname><given-names>M.</given-names></name><name name-style="western"><surname>Alzahrani</surname><given-names>M.</given-names></name><name name-style="western"><surname>Al-Muhsen</surname><given-names>S.</given-names></name><name name-style="western"><surname>Halwani</surname><given-names>R.</given-names></name><name name-style="western"><surname>Ma</surname><given-names>C.S.</given-names></name><etal/></person-group><article-title>IMMUNODEFICIENCIES. Impairment of immunity to Candida and Mycobacterium in humans with bi-allelic RORC mutations</article-title><source>Science</source><year>2015</year><volume>349</volume><fpage>606</fpage><lpage>613</lpage><pub-id pub-id-type="doi">10.1126/science.aaa4282</pub-id><pub-id pub-id-type="pmid">26160376</pub-id><pub-id pub-id-type="pmcid">PMC4668938</pub-id></element-citation></ref><ref id="B147-ijms-21-08011"><label>147.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Buckley</surname><given-names>R.H.</given-names></name></person-group><article-title>The hyper-IgE syndrome</article-title><source>Clin. Rev. Allergy Immunol.</source><year>2001</year><volume>20</volume><fpage>139</fpage><lpage>154</lpage><pub-id pub-id-type="pmid">11269224</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1385/CRIAI:20:1:139</pub-id></element-citation></ref><ref id="B148-ijms-21-08011"><label>148.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Holland</surname><given-names>S.M.</given-names></name><name name-style="western"><surname>DeLeo</surname><given-names>F.R.</given-names></name><name name-style="western"><surname>Elloumi</surname><given-names>H.Z.</given-names></name><name name-style="western"><surname>Hsu</surname><given-names>A.P.</given-names></name><name name-style="western"><surname>Uzel</surname><given-names>G.</given-names></name><name name-style="western"><surname>Brodsky</surname><given-names>N.</given-names></name><name name-style="western"><surname>Freeman</surname><given-names>A.F.</given-names></name><name name-style="western"><surname>Demidowich</surname><given-names>A.</given-names></name><name name-style="western"><surname>Davis</surname><given-names>J.</given-names></name><name name-style="western"><surname>Turner</surname><given-names>M.L.</given-names></name><etal/></person-group><article-title>STAT3 mutations in the hyper-IgE syndrome</article-title><source>N. Engl. J. Med.</source><year>2007</year><volume>357</volume><fpage>1608</fpage><lpage>1619</lpage><pub-id pub-id-type="pmid">17881745</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1056/NEJMoa073687</pub-id></element-citation></ref><ref id="B149-ijms-21-08011"><label>149.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Minegishi</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Saito</surname><given-names>M.</given-names></name><name name-style="western"><surname>Tsuchiya</surname><given-names>S.</given-names></name><name name-style="western"><surname>Tsuge</surname><given-names>I.</given-names></name><name name-style="western"><surname>Takada</surname><given-names>H.</given-names></name><name name-style="western"><surname>Hara</surname><given-names>T.</given-names></name><name name-style="western"><surname>Kawamura</surname><given-names>N.</given-names></name><name name-style="western"><surname>Ariga</surname><given-names>T.</given-names></name><name name-style="western"><surname>Pasic</surname><given-names>S.</given-names></name><name name-style="western"><surname>Stojkovic</surname><given-names>O.</given-names></name><etal/></person-group><article-title>Dominant-negative mutations in the DNA-binding domain of STAT3 cause hyper-IgE syndrome</article-title><source>Nature</source><year>2007</year><volume>448</volume><fpage>1058</fpage><lpage>1062</lpage><pub-id pub-id-type="pmid">17676033</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/nature06096</pub-id></element-citation></ref><ref id="B150-ijms-21-08011"><label>150.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Deng</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Li</surname><given-names>T.</given-names></name><name name-style="western"><surname>Xie</surname><given-names>X.</given-names></name><name name-style="western"><surname>Xia</surname><given-names>D.</given-names></name><name name-style="western"><surname>Ding</surname><given-names>L.</given-names></name><name name-style="western"><surname>Xiang</surname><given-names>H.</given-names></name><name name-style="western"><surname>Ma</surname><given-names>J.J.</given-names></name><name name-style="western"><surname>Li</surname><given-names>W.</given-names></name></person-group><article-title>Hyper IgE syndrome associated with novel and recurrent STAT3 mutations: Two case reports</article-title><source>Medicine</source><year>2019</year><volume>98</volume><fpage>e14003</fpage><pub-id pub-id-type="doi">10.1097/MD.0000000000014003</pub-id><pub-id pub-id-type="pmid">30732127</pub-id><pub-id pub-id-type="pmcid">PMC6380800</pub-id></element-citation></ref><ref id="B151-ijms-21-08011"><label>151.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Engelhardt</surname><given-names>K.R.</given-names></name><name name-style="western"><surname>McGhee</surname><given-names>S.</given-names></name><name name-style="western"><surname>Winkler</surname><given-names>S.</given-names></name><name name-style="western"><surname>Sassi</surname><given-names>A.</given-names></name><name name-style="western"><surname>Woellner</surname><given-names>C.</given-names></name><name name-style="western"><surname>Lopez-Herrera</surname><given-names>G.</given-names></name><name name-style="western"><surname>Chen</surname><given-names>A.</given-names></name><name name-style="western"><surname>Kim</surname><given-names>H.S.</given-names></name><name name-style="western"><surname>Lloret</surname><given-names>M.G.</given-names></name><name name-style="western"><surname>Schulze</surname><given-names>I.</given-names></name><etal/></person-group><article-title>Large deletions and point mutations involving the dedicator of cytokinesis 8 (DOCK8) in the autosomal-recessive form of hyper-IgE syndrome</article-title><source>J. Allergy Clin. Immunol.</source><year>2009</year><volume>124</volume><fpage>1289</fpage><lpage>1302.e1284</lpage><pub-id pub-id-type="doi">10.1016/j.jaci.2009.10.038</pub-id><pub-id pub-id-type="pmid">20004785</pub-id><pub-id pub-id-type="pmcid">PMC2818862</pub-id></element-citation></ref><ref id="B152-ijms-21-08011"><label>152.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Zhang</surname><given-names>Q.</given-names></name><name name-style="western"><surname>Davis</surname><given-names>J.C.</given-names></name><name name-style="western"><surname>Lamborn</surname><given-names>I.T.</given-names></name><name name-style="western"><surname>Freeman</surname><given-names>A.F.</given-names></name><name name-style="western"><surname>Jing</surname><given-names>H.</given-names></name><name name-style="western"><surname>Favreau</surname><given-names>A.J.</given-names></name><name name-style="western"><surname>Matthews</surname><given-names>H.F.</given-names></name><name name-style="western"><surname>Davis</surname><given-names>J.</given-names></name><name name-style="western"><surname>Turner</surname><given-names>M.L.</given-names></name><name name-style="western"><surname>Uzel</surname><given-names>G.</given-names></name><etal/></person-group><article-title>Combined immunodeficiency associated with DOCK8 mutations</article-title><source>N. Engl. J. Med.</source><year>2009</year><volume>361</volume><fpage>2046</fpage><lpage>2055</lpage><pub-id pub-id-type="doi">10.1056/NEJMoa0905506</pub-id><pub-id pub-id-type="pmid">19776401</pub-id><pub-id pub-id-type="pmcid">PMC2965730</pub-id></element-citation></ref><ref id="B153-ijms-21-08011"><label>153.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Dupuis</surname><given-names>S.</given-names></name><name name-style="western"><surname>Dargemont</surname><given-names>C.</given-names></name><name name-style="western"><surname>Fieschi</surname><given-names>C.</given-names></name><name name-style="western"><surname>Thomassin</surname><given-names>N.</given-names></name><name name-style="western"><surname>Rosenzweig</surname><given-names>S.</given-names></name><name name-style="western"><surname>Harris</surname><given-names>J.</given-names></name><name name-style="western"><surname>Holland</surname><given-names>S.M.</given-names></name><name name-style="western"><surname>Schreiber</surname><given-names>R.D.</given-names></name><name name-style="western"><surname>Casanova</surname><given-names>J.L.</given-names></name></person-group><article-title>Impairment of mycobacterial but not viral immunity by a germline human STAT1 mutation</article-title><source>Science</source><year>2001</year><volume>293</volume><fpage>300</fpage><lpage>303</lpage><pub-id pub-id-type="doi">10.1126/science.1061154</pub-id><pub-id pub-id-type="pmid">11452125</pub-id></element-citation></ref><ref id="B154-ijms-21-08011"><label>154.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Dupuis</surname><given-names>S.</given-names></name><name name-style="western"><surname>Jouanguy</surname><given-names>E.</given-names></name><name name-style="western"><surname>Al-Hajjar</surname><given-names>S.</given-names></name><name name-style="western"><surname>Fieschi</surname><given-names>C.</given-names></name><name name-style="western"><surname>Al-Mohsen</surname><given-names>I.Z.</given-names></name><name name-style="western"><surname>Al-Jumaah</surname><given-names>S.</given-names></name><name name-style="western"><surname>Yang</surname><given-names>K.</given-names></name><name name-style="western"><surname>Chapgier</surname><given-names>A.</given-names></name><name name-style="western"><surname>Eidenschenk</surname><given-names>C.</given-names></name><name name-style="western"><surname>Eid</surname><given-names>P.</given-names></name><etal/></person-group><article-title>Impaired response to interferon-alpha/beta and lethal viral disease in human STAT1 deficiency</article-title><source>Nat. Genet.</source><year>2003</year><volume>33</volume><fpage>388</fpage><lpage>391</lpage><pub-id pub-id-type="doi">10.1038/ng1097</pub-id><pub-id pub-id-type="pmid">12590259</pub-id></element-citation></ref><ref id="B155-ijms-21-08011"><label>155.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Liu</surname><given-names>L.</given-names></name><name name-style="western"><surname>Okada</surname><given-names>S.</given-names></name><name name-style="western"><surname>Kong</surname><given-names>X.F.</given-names></name><name name-style="western"><surname>Kreins</surname><given-names>A.Y.</given-names></name><name name-style="western"><surname>Cypowyj</surname><given-names>S.</given-names></name><name name-style="western"><surname>Abhyankar</surname><given-names>A.</given-names></name><name name-style="western"><surname>Toubiana</surname><given-names>J.</given-names></name><name name-style="western"><surname>Itan</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Audry</surname><given-names>M.</given-names></name><name name-style="western"><surname>Nitschke</surname><given-names>P.</given-names></name><etal/></person-group><article-title>Gain-of-function human STAT1 mutations impair IL-17 immunity and underlie chronic mucocutaneous candidiasis</article-title><source>J. Exp. Med.</source><year>2011</year><volume>208</volume><fpage>1635</fpage><lpage>1648</lpage><pub-id pub-id-type="doi">10.1084/jem.20110958</pub-id><pub-id pub-id-type="pmid">21727188</pub-id><pub-id pub-id-type="pmcid">PMC3149226</pub-id></element-citation></ref><ref id="B156-ijms-21-08011"><label>156.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Van de Veerdonk</surname><given-names>F.L.</given-names></name><name name-style="western"><surname>Plantinga</surname><given-names>T.S.</given-names></name><name name-style="western"><surname>Hoischen</surname><given-names>A.</given-names></name><name name-style="western"><surname>Smeekens</surname><given-names>S.P.</given-names></name><name name-style="western"><surname>Joosten</surname><given-names>L.A.</given-names></name><name name-style="western"><surname>Gilissen</surname><given-names>C.</given-names></name><name name-style="western"><surname>Arts</surname><given-names>P.</given-names></name><name name-style="western"><surname>Rosentul</surname><given-names>D.C.</given-names></name><name name-style="western"><surname>Carmichael</surname><given-names>A.J.</given-names></name><name name-style="western"><surname>Smits-van der Graaf</surname><given-names>C.A.</given-names></name><etal/></person-group><article-title>STAT1 mutations in autosomal dominant chronic mucocutaneous candidiasis</article-title><source>N. Engl. J. Med.</source><year>2011</year><volume>365</volume><fpage>54</fpage><lpage>61</lpage><pub-id pub-id-type="doi">10.1056/NEJMoa1100102</pub-id><pub-id pub-id-type="pmid">21714643</pub-id></element-citation></ref><ref id="B157-ijms-21-08011"><label>157.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Puel</surname><given-names>A.</given-names></name><name name-style="western"><surname>Cypowyj</surname><given-names>S.</given-names></name><name name-style="western"><surname>Bustamante</surname><given-names>J.</given-names></name><name name-style="western"><surname>Wright</surname><given-names>J.F.</given-names></name><name name-style="western"><surname>Liu</surname><given-names>L.</given-names></name><name name-style="western"><surname>Lim</surname><given-names>H.K.</given-names></name><name name-style="western"><surname>Migaud</surname><given-names>M.</given-names></name><name name-style="western"><surname>Israel</surname><given-names>L.</given-names></name><name name-style="western"><surname>Chrabieh</surname><given-names>M.</given-names></name><name name-style="western"><surname>Audry</surname><given-names>M.</given-names></name><etal/></person-group><article-title>Chronic mucocutaneous candidiasis in humans with inborn errors of interleukin-17 immunity</article-title><source>Science</source><year>2011</year><volume>332</volume><fpage>65</fpage><lpage>68</lpage><pub-id pub-id-type="doi">10.1126/science.1200439</pub-id><pub-id pub-id-type="pmid">21350122</pub-id><pub-id pub-id-type="pmcid">PMC3070042</pub-id></element-citation></ref><ref id="B158-ijms-21-08011"><label>158.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ben-Sasson</surname><given-names>S.Z.</given-names></name><name name-style="western"><surname>Hu-Li</surname><given-names>J.</given-names></name><name name-style="western"><surname>Quiel</surname><given-names>J.</given-names></name><name name-style="western"><surname>Cauchetaux</surname><given-names>S.</given-names></name><name name-style="western"><surname>Ratner</surname><given-names>M.</given-names></name><name name-style="western"><surname>Shapira</surname><given-names>I.</given-names></name><name name-style="western"><surname>Dinarello</surname><given-names>C.A.</given-names></name><name name-style="western"><surname>Paul</surname><given-names>W.E.</given-names></name></person-group><article-title>IL-1 acts directly on CD4 T cells to enhance their antigen-driven expansion and differentiation</article-title><source>Proc. Natl. Acad. Sci. USA</source><year>2009</year><volume>106</volume><fpage>7119</fpage><lpage>7124</lpage><pub-id pub-id-type="doi">10.1073/pnas.0902745106</pub-id><pub-id pub-id-type="pmid">19359475</pub-id><pub-id pub-id-type="pmcid">PMC2678417</pub-id></element-citation></ref><ref id="B159-ijms-21-08011"><label>159.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Masters</surname><given-names>S.L.</given-names></name><name name-style="western"><surname>Simon</surname><given-names>A.</given-names></name><name name-style="western"><surname>Aksentijevich</surname><given-names>I.</given-names></name><name name-style="western"><surname>Kastner</surname><given-names>D.L.</given-names></name></person-group><article-title>Horror autoinflammaticus: The molecular pathophysiology of autoinflammatory disease (*)</article-title><source>Annu. Rev. Immunol.</source><year>2009</year><volume>27</volume><fpage>621</fpage><lpage>668</lpage><pub-id pub-id-type="doi">10.1146/annurev.immunol.25.022106.141627</pub-id><pub-id pub-id-type="pmid">19302049</pub-id><pub-id pub-id-type="pmcid">PMC2996236</pub-id></element-citation></ref><ref id="B160-ijms-21-08011"><label>160.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ma</surname><given-names>H.L.</given-names></name><name name-style="western"><surname>Liang</surname><given-names>S.</given-names></name><name name-style="western"><surname>Li</surname><given-names>J.</given-names></name><name name-style="western"><surname>Napierata</surname><given-names>L.</given-names></name><name name-style="western"><surname>Brown</surname><given-names>T.</given-names></name><name name-style="western"><surname>Benoit</surname><given-names>S.</given-names></name><name name-style="western"><surname>Senices</surname><given-names>M.</given-names></name><name name-style="western"><surname>Gill</surname><given-names>D.</given-names></name><name name-style="western"><surname>Dunussi-Joannopoulos</surname><given-names>K.</given-names></name><name name-style="western"><surname>Collins</surname><given-names>M.</given-names></name><etal/></person-group><article-title>IL-22 is required for Th17 cell-mediated pathology in a mouse model of psoriasis-like skin inflammation</article-title><source>J. Clin. Investig.</source><year>2008</year><volume>118</volume><fpage>597</fpage><lpage>607</lpage><pub-id pub-id-type="doi">10.1172/JCI33263</pub-id><pub-id pub-id-type="pmid">18202747</pub-id><pub-id pub-id-type="pmcid">PMC2200300</pub-id></element-citation></ref><ref id="B161-ijms-21-08011"><label>161.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Torres</surname><given-names>T.</given-names></name><name name-style="western"><surname>Faria</surname><given-names>R.</given-names></name></person-group><article-title>Ustekinumab: The &#8220;New Kid on the Block&#8221; in the Treatment of Psoriatic Arthritis</article-title><source>Drug Dev. Res.</source><year>2015</year><volume>76</volume><fpage>428</fpage><lpage>431</lpage><pub-id pub-id-type="doi">10.1002/ddr.21279</pub-id><pub-id pub-id-type="pmid">26372543</pub-id></element-citation></ref><ref id="B162-ijms-21-08011"><label>162.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>McGeachy</surname><given-names>M.J.</given-names></name><name name-style="western"><surname>Cua</surname><given-names>D.J.</given-names></name><name name-style="western"><surname>Gaffen</surname><given-names>S.L.</given-names></name></person-group><article-title>The IL-17 Family of Cytokines in Health and Disease</article-title><source>Immunity</source><year>2019</year><volume>50</volume><fpage>892</fpage><lpage>906</lpage><pub-id pub-id-type="doi">10.1016/j.immuni.2019.03.021</pub-id><pub-id pub-id-type="pmid">30995505</pub-id><pub-id pub-id-type="pmcid">PMC6474359</pub-id></element-citation></ref><ref id="B163-ijms-21-08011"><label>163.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Huh</surname><given-names>J.R.</given-names></name><name name-style="western"><surname>Littman</surname><given-names>D.R.</given-names></name></person-group><article-title>Small molecule inhibitors of RORgammat: Targeting Th17 cells and other applications</article-title><source>Eur. J. Immunol.</source><year>2012</year><volume>42</volume><fpage>2232</fpage><lpage>2237</lpage><pub-id pub-id-type="doi">10.1002/eji.201242740</pub-id><pub-id pub-id-type="pmid">22949321</pub-id><pub-id pub-id-type="pmcid">PMC3609417</pub-id></element-citation></ref><ref id="B164-ijms-21-08011"><label>164.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Sakaguchi</surname><given-names>S.</given-names></name><name name-style="western"><surname>Sakaguchi</surname><given-names>N.</given-names></name><name name-style="western"><surname>Asano</surname><given-names>M.</given-names></name><name name-style="western"><surname>Itoh</surname><given-names>M.</given-names></name><name name-style="western"><surname>Toda</surname><given-names>M.</given-names></name></person-group><article-title>Immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor alpha-chains (CD25). Breakdown of a single mechanism of self-tolerance causes various autoimmune diseases</article-title><source>J. Immunol.</source><year>1995</year><volume>155</volume><fpage>1151</fpage><lpage>1164</lpage><pub-id pub-id-type="pmid">7636184</pub-id></element-citation></ref><ref id="B165-ijms-21-08011"><label>165.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Fontenot</surname><given-names>J.D.</given-names></name><name name-style="western"><surname>Gavin</surname><given-names>M.A.</given-names></name><name name-style="western"><surname>Rudensky</surname><given-names>A.Y.</given-names></name></person-group><article-title>Foxp3 programs the development and function of CD4+CD25+ regulatory T cells</article-title><source>Nat. Immunol.</source><year>2003</year><volume>4</volume><fpage>330</fpage><lpage>336</lpage><pub-id pub-id-type="doi">10.1038/ni904</pub-id><pub-id pub-id-type="pmid">12612578</pub-id></element-citation></ref><ref id="B166-ijms-21-08011"><label>166.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Hori</surname><given-names>S.</given-names></name><name name-style="western"><surname>Nomura</surname><given-names>T.</given-names></name><name name-style="western"><surname>Sakaguchi</surname><given-names>S.</given-names></name></person-group><article-title>Control of regulatory T cell development by the transcription factor Foxp3</article-title><source>Science</source><year>2003</year><volume>299</volume><fpage>1057</fpage><lpage>1061</lpage><pub-id pub-id-type="doi">10.1126/science.1079490</pub-id><pub-id pub-id-type="pmid">28115586</pub-id></element-citation></ref><ref id="B167-ijms-21-08011"><label>167.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Khattri</surname><given-names>R.</given-names></name><name name-style="western"><surname>Cox</surname><given-names>T.</given-names></name><name name-style="western"><surname>Yasayko</surname><given-names>S.A.</given-names></name><name name-style="western"><surname>Ramsdell</surname><given-names>F.</given-names></name></person-group><article-title>An essential role for Scurfin in CD4+CD25+ T regulatory cells</article-title><source>Nat. Immunol.</source><year>2003</year><volume>4</volume><fpage>337</fpage><lpage>342</lpage><pub-id pub-id-type="doi">10.1038/ni909</pub-id><pub-id pub-id-type="pmid">12612581</pub-id></element-citation></ref><ref id="B168-ijms-21-08011"><label>168.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Raffin</surname><given-names>C.</given-names></name><name name-style="western"><surname>Vo</surname><given-names>L.T.</given-names></name><name name-style="western"><surname>Bluestone</surname><given-names>J.A.</given-names></name></person-group><article-title>Treg cell-based therapies: Challenges and perspectives</article-title><source>Nat. Rev. Immunol.</source><year>2020</year><volume>20</volume><fpage>158</fpage><lpage>172</lpage><pub-id pub-id-type="doi">10.1038/s41577-019-0232-6</pub-id><pub-id pub-id-type="pmid">31811270</pub-id><pub-id pub-id-type="pmcid">PMC7814338</pub-id></element-citation></ref><ref id="B169-ijms-21-08011"><label>169.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Shevach</surname><given-names>E.M.</given-names></name><name name-style="western"><surname>Thornton</surname><given-names>A.M.</given-names></name></person-group><article-title>tTregs, pTregs, and iTregs: Similarities and differences</article-title><source>Immunol. Rev.</source><year>2014</year><volume>259</volume><fpage>88</fpage><lpage>102</lpage><pub-id pub-id-type="doi">10.1111/imr.12160</pub-id><pub-id pub-id-type="pmid">24712461</pub-id><pub-id pub-id-type="pmcid">PMC3982187</pub-id></element-citation></ref><ref id="B170-ijms-21-08011"><label>170.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kanamori</surname><given-names>M.</given-names></name><name name-style="western"><surname>Nakatsukasa</surname><given-names>H.</given-names></name><name name-style="western"><surname>Okada</surname><given-names>M.</given-names></name><name name-style="western"><surname>Lu</surname><given-names>Q.</given-names></name><name name-style="western"><surname>Yoshimura</surname><given-names>A.</given-names></name></person-group><article-title>Induced Regulatory T Cells: Their Development, Stability, and Applications</article-title><source>Trends Immunol.</source><year>2016</year><volume>37</volume><fpage>803</fpage><lpage>811</lpage><pub-id pub-id-type="doi">10.1016/j.it.2016.08.012</pub-id><pub-id pub-id-type="pmid">27623114</pub-id></element-citation></ref><ref id="B171-ijms-21-08011"><label>171.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Chen</surname><given-names>W.</given-names></name><name name-style="western"><surname>Jin</surname><given-names>W.</given-names></name><name name-style="western"><surname>Hardegen</surname><given-names>N.</given-names></name><name name-style="western"><surname>Lei</surname><given-names>K.J.</given-names></name><name name-style="western"><surname>Li</surname><given-names>L.</given-names></name><name name-style="western"><surname>Marinos</surname><given-names>N.</given-names></name><name name-style="western"><surname>McGrady</surname><given-names>G.</given-names></name><name name-style="western"><surname>Wahl</surname><given-names>S.M.</given-names></name></person-group><article-title>Conversion of peripheral CD4+CD25- naive T cells to CD4+CD25+ regulatory T cells by TGF-beta induction of transcription factor Foxp3</article-title><source>J. Exp. Med.</source><year>2003</year><volume>198</volume><fpage>1875</fpage><lpage>1886</lpage><pub-id pub-id-type="doi">10.1084/jem.20030152</pub-id><pub-id pub-id-type="pmid">14676299</pub-id><pub-id pub-id-type="pmcid">PMC2194145</pub-id></element-citation></ref><ref id="B172-ijms-21-08011"><label>172.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Fantini</surname><given-names>M.C.</given-names></name><name name-style="western"><surname>Becker</surname><given-names>C.</given-names></name><name name-style="western"><surname>Monteleone</surname><given-names>G.</given-names></name><name name-style="western"><surname>Pallone</surname><given-names>F.</given-names></name><name name-style="western"><surname>Galle</surname><given-names>P.R.</given-names></name><name name-style="western"><surname>Neurath</surname><given-names>M.F.</given-names></name></person-group><article-title>Cutting edge: TGF-beta induces a regulatory phenotype in CD4+CD25- T cells through Foxp3 induction and down-regulation of Smad7</article-title><source>J. Immunol.</source><year>2004</year><volume>172</volume><fpage>5149</fpage><lpage>5153</lpage><pub-id pub-id-type="doi">10.4049/jimmunol.172.9.5149</pub-id><pub-id pub-id-type="pmid">15100250</pub-id></element-citation></ref><ref id="B173-ijms-21-08011"><label>173.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Fu</surname><given-names>S.</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>N.</given-names></name><name name-style="western"><surname>Yopp</surname><given-names>A.C.</given-names></name><name name-style="western"><surname>Chen</surname><given-names>D.</given-names></name><name name-style="western"><surname>Mao</surname><given-names>M.</given-names></name><name name-style="western"><surname>Chen</surname><given-names>D.</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>H.</given-names></name><name name-style="western"><surname>Ding</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Bromberg</surname><given-names>J.S.</given-names></name></person-group><article-title>TGF-beta induces Foxp3 + T-regulatory cells from CD4 + CD25&#8212;Precursors</article-title><source>Am. J. Transpl.</source><year>2004</year><volume>4</volume><fpage>1614</fpage><lpage>1627</lpage><pub-id pub-id-type="doi">10.1111/j.1600-6143.2004.00566.x</pub-id><pub-id pub-id-type="pmid">15367216</pub-id></element-citation></ref><ref id="B174-ijms-21-08011"><label>174.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Zheng</surname><given-names>S.G.</given-names></name><name name-style="western"><surname>Wang</surname><given-names>J.H.</given-names></name><name name-style="western"><surname>Gray</surname><given-names>J.D.</given-names></name><name name-style="western"><surname>Soucier</surname><given-names>H.</given-names></name><name name-style="western"><surname>Horwitz</surname><given-names>D.A.</given-names></name></person-group><article-title>Natural and induced CD4+CD25+ cells educate CD4+CD25- cells to develop suppressive activity: The role of IL-2, TGF-beta, and IL-10</article-title><source>J. Immunol.</source><year>2004</year><volume>172</volume><fpage>5213</fpage><lpage>5221</lpage><pub-id pub-id-type="doi">10.4049/jimmunol.172.9.5213</pub-id><pub-id pub-id-type="pmid">15100259</pub-id></element-citation></ref><ref id="B175-ijms-21-08011"><label>175.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Schiering</surname><given-names>C.</given-names></name><name name-style="western"><surname>Krausgruber</surname><given-names>T.</given-names></name><name name-style="western"><surname>Chomka</surname><given-names>A.</given-names></name><name name-style="western"><surname>Frohlich</surname><given-names>A.</given-names></name><name name-style="western"><surname>Adelmann</surname><given-names>K.</given-names></name><name name-style="western"><surname>Wohlfert</surname><given-names>E.A.</given-names></name><name name-style="western"><surname>Pott</surname><given-names>J.</given-names></name><name name-style="western"><surname>Griseri</surname><given-names>T.</given-names></name><name name-style="western"><surname>Bollrath</surname><given-names>J.</given-names></name><name name-style="western"><surname>Hegazy</surname><given-names>A.N.</given-names></name><etal/></person-group><article-title>The alarmin IL-33 promotes regulatory T-cell function in the intestine</article-title><source>Nature</source><year>2014</year><volume>513</volume><fpage>564</fpage><lpage>568</lpage><pub-id pub-id-type="doi">10.1038/nature13577</pub-id><pub-id pub-id-type="pmid">25043027</pub-id><pub-id pub-id-type="pmcid">PMC4339042</pub-id></element-citation></ref><ref id="B176-ijms-21-08011"><label>176.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Sun</surname><given-names>C.M.</given-names></name><name name-style="western"><surname>Hall</surname><given-names>J.A.</given-names></name><name name-style="western"><surname>Blank</surname><given-names>R.B.</given-names></name><name name-style="western"><surname>Bouladoux</surname><given-names>N.</given-names></name><name name-style="western"><surname>Oukka</surname><given-names>M.</given-names></name><name name-style="western"><surname>Mora</surname><given-names>J.R.</given-names></name><name name-style="western"><surname>Belkaid</surname><given-names>Y.</given-names></name></person-group><article-title>Small intestine lamina propria dendritic cells promote de novo generation of Foxp3 T reg cells via retinoic acid</article-title><source>J. Exp. Med.</source><year>2007</year><volume>204</volume><fpage>1775</fpage><lpage>1785</lpage><pub-id pub-id-type="doi">10.1084/jem.20070602</pub-id><pub-id pub-id-type="pmid">17620362</pub-id><pub-id pub-id-type="pmcid">PMC2118682</pub-id></element-citation></ref><ref id="B177-ijms-21-08011"><label>177.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Coombes</surname><given-names>J.L.</given-names></name><name name-style="western"><surname>Siddiqui</surname><given-names>K.R.</given-names></name><name name-style="western"><surname>Arancibia-Carcamo</surname><given-names>C.V.</given-names></name><name name-style="western"><surname>Hall</surname><given-names>J.</given-names></name><name name-style="western"><surname>Sun</surname><given-names>C.M.</given-names></name><name name-style="western"><surname>Belkaid</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Powrie</surname><given-names>F.</given-names></name></person-group><article-title>A functionally specialized population of mucosal CD103+ DCs induces Foxp3+ regulatory T cells via a TGF-beta and retinoic acid-dependent mechanism</article-title><source>J. Exp. Med.</source><year>2007</year><volume>204</volume><fpage>1757</fpage><lpage>1764</lpage><pub-id pub-id-type="doi">10.1084/jem.20070590</pub-id><pub-id pub-id-type="pmid">17620361</pub-id><pub-id pub-id-type="pmcid">PMC2118683</pub-id></element-citation></ref><ref id="B178-ijms-21-08011"><label>178.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Lathrop</surname><given-names>S.K.</given-names></name><name name-style="western"><surname>Bloom</surname><given-names>S.M.</given-names></name><name name-style="western"><surname>Rao</surname><given-names>S.M.</given-names></name><name name-style="western"><surname>Nutsch</surname><given-names>K.</given-names></name><name name-style="western"><surname>Lio</surname><given-names>C.W.</given-names></name><name name-style="western"><surname>Santacruz</surname><given-names>N.</given-names></name><name name-style="western"><surname>Peterson</surname><given-names>D.A.</given-names></name><name name-style="western"><surname>Stappenbeck</surname><given-names>T.S.</given-names></name><name name-style="western"><surname>Hsieh</surname><given-names>C.S.</given-names></name></person-group><article-title>Peripheral education of the immune system by colonic commensal microbiota</article-title><source>Nature</source><year>2011</year><volume>478</volume><fpage>250</fpage><lpage>254</lpage><pub-id pub-id-type="doi">10.1038/nature10434</pub-id><pub-id pub-id-type="pmid">21937990</pub-id><pub-id pub-id-type="pmcid">PMC3192908</pub-id></element-citation></ref><ref id="B179-ijms-21-08011"><label>179.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Thornton</surname><given-names>A.M.</given-names></name><name name-style="western"><surname>Korty</surname><given-names>P.E.</given-names></name><name name-style="western"><surname>Tran</surname><given-names>D.Q.</given-names></name><name name-style="western"><surname>Wohlfert</surname><given-names>E.A.</given-names></name><name name-style="western"><surname>Murray</surname><given-names>P.E.</given-names></name><name name-style="western"><surname>Belkaid</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Shevach</surname><given-names>E.M.</given-names></name></person-group><article-title>Expression of Helios, an Ikaros transcription factor family member, differentiates thymic-derived from peripherally induced Foxp3+ T regulatory cells</article-title><source>J. Immunol.</source><year>2010</year><volume>184</volume><fpage>3433</fpage><lpage>3441</lpage><pub-id pub-id-type="doi">10.4049/jimmunol.0904028</pub-id><pub-id pub-id-type="pmid">20181882</pub-id><pub-id pub-id-type="pmcid">PMC3725574</pub-id></element-citation></ref><ref id="B180-ijms-21-08011"><label>180.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Yadav</surname><given-names>M.</given-names></name><name name-style="western"><surname>Louvet</surname><given-names>C.</given-names></name><name name-style="western"><surname>Davini</surname><given-names>D.</given-names></name><name name-style="western"><surname>Gardner</surname><given-names>J.M.</given-names></name><name name-style="western"><surname>Martinez-Llordella</surname><given-names>M.</given-names></name><name name-style="western"><surname>Bailey-Bucktrout</surname><given-names>S.</given-names></name><name name-style="western"><surname>Anthony</surname><given-names>B.A.</given-names></name><name name-style="western"><surname>Sverdrup</surname><given-names>F.M.</given-names></name><name name-style="western"><surname>Head</surname><given-names>R.</given-names></name><name name-style="western"><surname>Kuster</surname><given-names>D.J.</given-names></name><etal/></person-group><article-title>Neuropilin-1 distinguishes natural and inducible regulatory T cells among regulatory T cell subsets in vivo</article-title><source>J. Exp. Med.</source><year>2012</year><volume>209</volume><fpage>1713</fpage><lpage>1722</lpage><pub-id pub-id-type="doi">10.1084/jem.20120822</pub-id><pub-id pub-id-type="pmid">22966003</pub-id><pub-id pub-id-type="pmcid">PMC3457729</pub-id></element-citation></ref><ref id="B181-ijms-21-08011"><label>181.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Floess</surname><given-names>S.</given-names></name><name name-style="western"><surname>Freyer</surname><given-names>J.</given-names></name><name name-style="western"><surname>Siewert</surname><given-names>C.</given-names></name><name name-style="western"><surname>Baron</surname><given-names>U.</given-names></name><name name-style="western"><surname>Olek</surname><given-names>S.</given-names></name><name name-style="western"><surname>Polansky</surname><given-names>J.</given-names></name><name name-style="western"><surname>Schlawe</surname><given-names>K.</given-names></name><name name-style="western"><surname>Chang</surname><given-names>H.D.</given-names></name><name name-style="western"><surname>Bopp</surname><given-names>T.</given-names></name><name name-style="western"><surname>Schmitt</surname><given-names>E.</given-names></name><etal/></person-group><article-title>Epigenetic control of the foxp3 locus in regulatory T cells</article-title><source>PLoS Biol.</source><year>2007</year><volume>5</volume><elocation-id>e38</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pbio.0050038</pub-id><pub-id pub-id-type="pmid">17298177</pub-id><pub-id pub-id-type="pmcid">PMC1783672</pub-id></element-citation></ref><ref id="B182-ijms-21-08011"><label>182.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Polansky</surname><given-names>J.K.</given-names></name><name name-style="western"><surname>Kretschmer</surname><given-names>K.</given-names></name><name name-style="western"><surname>Freyer</surname><given-names>J.</given-names></name><name name-style="western"><surname>Floess</surname><given-names>S.</given-names></name><name name-style="western"><surname>Garbe</surname><given-names>A.</given-names></name><name name-style="western"><surname>Baron</surname><given-names>U.</given-names></name><name name-style="western"><surname>Olek</surname><given-names>S.</given-names></name><name name-style="western"><surname>Hamann</surname><given-names>A.</given-names></name><name name-style="western"><surname>von Boehmer</surname><given-names>H.</given-names></name><name name-style="western"><surname>Huehn</surname><given-names>J.</given-names></name></person-group><article-title>DNA methylation controls Foxp3 gene expression</article-title><source>Eur. J. Immunol.</source><year>2008</year><volume>38</volume><fpage>1654</fpage><lpage>1663</lpage><pub-id pub-id-type="doi">10.1002/eji.200838105</pub-id><pub-id pub-id-type="pmid">18493985</pub-id></element-citation></ref><ref id="B183-ijms-21-08011"><label>183.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ohnmacht</surname><given-names>C.</given-names></name><name name-style="western"><surname>Park</surname><given-names>J.H.</given-names></name><name name-style="western"><surname>Cording</surname><given-names>S.</given-names></name><name name-style="western"><surname>Wing</surname><given-names>J.B.</given-names></name><name name-style="western"><surname>Atarashi</surname><given-names>K.</given-names></name><name name-style="western"><surname>Obata</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Gaboriau-Routhiau</surname><given-names>V.</given-names></name><name name-style="western"><surname>Marques</surname><given-names>R.</given-names></name><name name-style="western"><surname>Dulauroy</surname><given-names>S.</given-names></name><name name-style="western"><surname>Fedoseeva</surname><given-names>M.</given-names></name><etal/></person-group><article-title>MUCOSAL IMMUNOLOGY. The microbiota regulates type 2 immunity through RORgammat(+) T cells</article-title><source>Science</source><year>2015</year><volume>349</volume><fpage>989</fpage><lpage>993</lpage><pub-id pub-id-type="doi">10.1126/science.aac4263</pub-id><pub-id pub-id-type="pmid">26160380</pub-id></element-citation></ref><ref id="B184-ijms-21-08011"><label>184.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Sefik</surname><given-names>E.</given-names></name><name name-style="western"><surname>Geva-Zatorsky</surname><given-names>N.</given-names></name><name name-style="western"><surname>Oh</surname><given-names>S.</given-names></name><name name-style="western"><surname>Konnikova</surname><given-names>L.</given-names></name><name name-style="western"><surname>Zemmour</surname><given-names>D.</given-names></name><name name-style="western"><surname>McGuire</surname><given-names>A.M.</given-names></name><name name-style="western"><surname>Burzyn</surname><given-names>D.</given-names></name><name name-style="western"><surname>Ortiz-Lopez</surname><given-names>A.</given-names></name><name name-style="western"><surname>Lobera</surname><given-names>M.</given-names></name><name name-style="western"><surname>Yang</surname><given-names>J.</given-names></name><etal/></person-group><article-title>MUCOSAL IMMUNOLOGY. Individual intestinal symbionts induce a distinct population of RORgamma(+) regulatory T cells</article-title><source>Science</source><year>2015</year><volume>349</volume><fpage>993</fpage><lpage>997</lpage><pub-id pub-id-type="doi">10.1126/science.aaa9420</pub-id><pub-id pub-id-type="pmid">26272906</pub-id><pub-id pub-id-type="pmcid">PMC4700932</pub-id></element-citation></ref><ref id="B185-ijms-21-08011"><label>185.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Takimoto</surname><given-names>T.</given-names></name><name name-style="western"><surname>Wakabayashi</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Sekiya</surname><given-names>T.</given-names></name><name name-style="western"><surname>Inoue</surname><given-names>N.</given-names></name><name name-style="western"><surname>Morita</surname><given-names>R.</given-names></name><name name-style="western"><surname>Ichiyama</surname><given-names>K.</given-names></name><name name-style="western"><surname>Takahashi</surname><given-names>R.</given-names></name><name name-style="western"><surname>Asakawa</surname><given-names>M.</given-names></name><name name-style="western"><surname>Muto</surname><given-names>G.</given-names></name><name name-style="western"><surname>Mori</surname><given-names>T.</given-names></name><etal/></person-group><article-title>Smad2 and Smad3 are redundantly essential for the TGF-beta-mediated regulation of regulatory T plasticity and Th1 development</article-title><source>J. Immunol.</source><year>2010</year><volume>185</volume><fpage>842</fpage><lpage>855</lpage><pub-id pub-id-type="doi">10.4049/jimmunol.0904100</pub-id><pub-id pub-id-type="pmid">20548029</pub-id></element-citation></ref><ref id="B186-ijms-21-08011"><label>186.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Zorn</surname><given-names>E.</given-names></name><name name-style="western"><surname>Nelson</surname><given-names>E.A.</given-names></name><name name-style="western"><surname>Mohseni</surname><given-names>M.</given-names></name><name name-style="western"><surname>Porcheray</surname><given-names>F.</given-names></name><name name-style="western"><surname>Kim</surname><given-names>H.</given-names></name><name name-style="western"><surname>Litsa</surname><given-names>D.</given-names></name><name name-style="western"><surname>Bellucci</surname><given-names>R.</given-names></name><name name-style="western"><surname>Raderschall</surname><given-names>E.</given-names></name><name name-style="western"><surname>Canning</surname><given-names>C.</given-names></name><name name-style="western"><surname>Soiffer</surname><given-names>R.J.</given-names></name><etal/></person-group><article-title>IL-2 regulates FOXP3 expression in human CD4+CD25+ regulatory T cells through a STAT-dependent mechanism and induces the expansion of these cells in vivo</article-title><source>Blood</source><year>2006</year><volume>108</volume><fpage>1571</fpage><lpage>1579</lpage><pub-id pub-id-type="doi">10.1182/blood-2006-02-004747</pub-id><pub-id pub-id-type="pmid">16645171</pub-id><pub-id pub-id-type="pmcid">PMC1895505</pub-id></element-citation></ref><ref id="B187-ijms-21-08011"><label>187.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Burchill</surname><given-names>M.A.</given-names></name><name name-style="western"><surname>Yang</surname><given-names>J.</given-names></name><name name-style="western"><surname>Vogtenhuber</surname><given-names>C.</given-names></name><name name-style="western"><surname>Blazar</surname><given-names>B.R.</given-names></name><name name-style="western"><surname>Farrar</surname><given-names>M.A.</given-names></name></person-group><article-title>IL-2 receptor beta-dependent STAT5 activation is required for the development of Foxp3+ regulatory T cells</article-title><source>J. Immunol.</source><year>2007</year><volume>178</volume><fpage>280</fpage><lpage>290</lpage><pub-id pub-id-type="doi">10.4049/jimmunol.178.1.280</pub-id><pub-id pub-id-type="pmid">17182565</pub-id></element-citation></ref><ref id="B188-ijms-21-08011"><label>188.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Rudra</surname><given-names>D.</given-names></name><name name-style="western"><surname>Egawa</surname><given-names>T.</given-names></name><name name-style="western"><surname>Chong</surname><given-names>M.M.</given-names></name><name name-style="western"><surname>Treuting</surname><given-names>P.</given-names></name><name name-style="western"><surname>Littman</surname><given-names>D.R.</given-names></name><name name-style="western"><surname>Rudensky</surname><given-names>A.Y.</given-names></name></person-group><article-title>Runx-CBFbeta complexes control expression of the transcription factor Foxp3 in regulatory T cells</article-title><source>Nat. Immunol.</source><year>2009</year><volume>10</volume><fpage>1170</fpage><lpage>1177</lpage><pub-id pub-id-type="doi">10.1038/ni.1795</pub-id><pub-id pub-id-type="pmid">19767756</pub-id><pub-id pub-id-type="pmcid">PMC2764816</pub-id></element-citation></ref><ref id="B189-ijms-21-08011"><label>189.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Sekiya</surname><given-names>T.</given-names></name><name name-style="western"><surname>Kashiwagi</surname><given-names>I.</given-names></name><name name-style="western"><surname>Inoue</surname><given-names>N.</given-names></name><name name-style="western"><surname>Morita</surname><given-names>R.</given-names></name><name name-style="western"><surname>Hori</surname><given-names>S.</given-names></name><name name-style="western"><surname>Waldmann</surname><given-names>H.</given-names></name><name name-style="western"><surname>Rudensky</surname><given-names>A.Y.</given-names></name><name name-style="western"><surname>Ichinose</surname><given-names>H.</given-names></name><name name-style="western"><surname>Metzger</surname><given-names>D.</given-names></name><name name-style="western"><surname>Chambon</surname><given-names>P.</given-names></name><etal/></person-group><article-title>The nuclear orphan receptor Nr4a2 induces Foxp3 and regulates differentiation of CD4+ T cells</article-title><source>Nat. Commun.</source><year>2011</year><volume>2</volume><fpage>269</fpage><pub-id pub-id-type="doi">10.1038/ncomms1272</pub-id><pub-id pub-id-type="pmid">21468021</pub-id><pub-id pub-id-type="pmcid">PMC3104557</pub-id></element-citation></ref><ref id="B190-ijms-21-08011"><label>190.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kerdiles</surname><given-names>Y.M.</given-names></name><name name-style="western"><surname>Stone</surname><given-names>E.L.</given-names></name><name name-style="western"><surname>Beisner</surname><given-names>D.R.</given-names></name><name name-style="western"><surname>McGargill</surname><given-names>M.A.</given-names></name><name name-style="western"><surname>Ch&#8217;en</surname><given-names>I.L.</given-names></name><name name-style="western"><surname>Stockmann</surname><given-names>C.</given-names></name><name name-style="western"><surname>Katayama</surname><given-names>C.D.</given-names></name><name name-style="western"><surname>Hedrick</surname><given-names>S.M.</given-names></name></person-group><article-title>Foxo transcription factors control regulatory T cell development and function</article-title><source>Immunity</source><year>2010</year><volume>33</volume><fpage>890</fpage><lpage>904</lpage><pub-id pub-id-type="doi">10.1016/j.immuni.2010.12.002</pub-id><pub-id pub-id-type="pmid">21167754</pub-id><pub-id pub-id-type="pmcid">PMC3034255</pub-id></element-citation></ref><ref id="B191-ijms-21-08011"><label>191.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kitagawa</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Ohkura</surname><given-names>N.</given-names></name><name name-style="western"><surname>Kidani</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Vandenbon</surname><given-names>A.</given-names></name><name name-style="western"><surname>Hirota</surname><given-names>K.</given-names></name><name name-style="western"><surname>Kawakami</surname><given-names>R.</given-names></name><name name-style="western"><surname>Yasuda</surname><given-names>K.</given-names></name><name name-style="western"><surname>Motooka</surname><given-names>D.</given-names></name><name name-style="western"><surname>Nakamura</surname><given-names>S.</given-names></name><name name-style="western"><surname>Kondo</surname><given-names>M.</given-names></name><etal/></person-group><article-title>Guidance of regulatory T cell development by Satb1-dependent super-enhancer establishment</article-title><source>Nat. Immunol.</source><year>2017</year><volume>18</volume><fpage>173</fpage><lpage>183</lpage><pub-id pub-id-type="doi">10.1038/ni.3646</pub-id><pub-id pub-id-type="pmid">27992401</pub-id><pub-id pub-id-type="pmcid">PMC5582804</pub-id></element-citation></ref><ref id="B192-ijms-21-08011"><label>192.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Getnet</surname><given-names>D.</given-names></name><name name-style="western"><surname>Grosso</surname><given-names>J.F.</given-names></name><name name-style="western"><surname>Goldberg</surname><given-names>M.V.</given-names></name><name name-style="western"><surname>Harris</surname><given-names>T.J.</given-names></name><name name-style="western"><surname>Yen</surname><given-names>H.R.</given-names></name><name name-style="western"><surname>Bruno</surname><given-names>T.C.</given-names></name><name name-style="western"><surname>Durham</surname><given-names>N.M.</given-names></name><name name-style="western"><surname>Hipkiss</surname><given-names>E.L.</given-names></name><name name-style="western"><surname>Pyle</surname><given-names>K.J.</given-names></name><name name-style="western"><surname>Wada</surname><given-names>S.</given-names></name><etal/></person-group><article-title>A role for the transcription factor Helios in human CD4(+)CD25(+) regulatory T cells</article-title><source>Mol. Immunol.</source><year>2010</year><volume>47</volume><fpage>1595</fpage><lpage>1600</lpage><pub-id pub-id-type="doi">10.1016/j.molimm.2010.02.001</pub-id><pub-id pub-id-type="pmid">20226531</pub-id><pub-id pub-id-type="pmcid">PMC3060613</pub-id></element-citation></ref><ref id="B193-ijms-21-08011"><label>193.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Shevach</surname><given-names>E.M.</given-names></name></person-group><article-title>Mechanisms of foxp3+ T regulatory cell-mediated suppression</article-title><source>Immunity</source><year>2009</year><volume>30</volume><fpage>636</fpage><lpage>645</lpage><pub-id pub-id-type="doi">10.1016/j.immuni.2009.04.010</pub-id><pub-id pub-id-type="pmid">19464986</pub-id></element-citation></ref><ref id="B194-ijms-21-08011"><label>194.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Spolski</surname><given-names>R.</given-names></name><name name-style="western"><surname>Li</surname><given-names>P.</given-names></name><name name-style="western"><surname>Leonard</surname><given-names>W.J.</given-names></name></person-group><article-title>Biology and regulation of IL-2: From molecular mechanisms to human therapy</article-title><source>Nat. Rev. Immunol.</source><year>2018</year><volume>18</volume><fpage>648</fpage><lpage>659</lpage><pub-id pub-id-type="doi">10.1038/s41577-018-0046-y</pub-id><pub-id pub-id-type="pmid">30089912</pub-id></element-citation></ref><ref id="B195-ijms-21-08011"><label>195.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Liu</surname><given-names>Z.</given-names></name><name name-style="western"><surname>Gerner</surname><given-names>M.Y.</given-names></name><name name-style="western"><surname>Van Panhuys</surname><given-names>N.</given-names></name><name name-style="western"><surname>Levine</surname><given-names>A.G.</given-names></name><name name-style="western"><surname>Rudensky</surname><given-names>A.Y.</given-names></name><name name-style="western"><surname>Germain</surname><given-names>R.N.</given-names></name></person-group><article-title>Immune homeostasis enforced by co-localized effector and regulatory T cells</article-title><source>Nature</source><year>2015</year><volume>528</volume><fpage>225</fpage><lpage>230</lpage><pub-id pub-id-type="doi">10.1038/nature16169</pub-id><pub-id pub-id-type="pmid">26605524</pub-id><pub-id pub-id-type="pmcid">PMC4702500</pub-id></element-citation></ref><ref id="B196-ijms-21-08011"><label>196.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Onishi</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Fehervari</surname><given-names>Z.</given-names></name><name name-style="western"><surname>Yamaguchi</surname><given-names>T.</given-names></name><name name-style="western"><surname>Sakaguchi</surname><given-names>S.</given-names></name></person-group><article-title>Foxp3+ natural regulatory T cells preferentially form aggregates on dendritic cells in vitro and actively inhibit their maturation</article-title><source>Proc. Natl. Acad. Sci. USA</source><year>2008</year><volume>105</volume><fpage>10113</fpage><lpage>10118</lpage><pub-id pub-id-type="doi">10.1073/pnas.0711106105</pub-id><pub-id pub-id-type="pmid">18635688</pub-id><pub-id pub-id-type="pmcid">PMC2481354</pub-id></element-citation></ref><ref id="B197-ijms-21-08011"><label>197.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Grossman</surname><given-names>W.J.</given-names></name><name name-style="western"><surname>Verbsky</surname><given-names>J.W.</given-names></name><name name-style="western"><surname>Barchet</surname><given-names>W.</given-names></name><name name-style="western"><surname>Colonna</surname><given-names>M.</given-names></name><name name-style="western"><surname>Atkinson</surname><given-names>J.P.</given-names></name><name name-style="western"><surname>Ley</surname><given-names>T.J.</given-names></name></person-group><article-title>Human T regulatory cells can use the perforin pathway to cause autologous target cell death</article-title><source>Immunity</source><year>2004</year><volume>21</volume><fpage>589</fpage><lpage>601</lpage><pub-id pub-id-type="doi">10.1016/j.immuni.2004.09.002</pub-id><pub-id pub-id-type="pmid">15485635</pub-id></element-citation></ref><ref id="B198-ijms-21-08011"><label>198.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Akkaya</surname><given-names>B.</given-names></name><name name-style="western"><surname>Oya</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Akkaya</surname><given-names>M.</given-names></name><name name-style="western"><surname>Al Souz</surname><given-names>J.</given-names></name><name name-style="western"><surname>Holstein</surname><given-names>A.H.</given-names></name><name name-style="western"><surname>Kamenyeva</surname><given-names>O.</given-names></name><name name-style="western"><surname>Kabat</surname><given-names>J.</given-names></name><name name-style="western"><surname>Matsumura</surname><given-names>R.</given-names></name><name name-style="western"><surname>Dorward</surname><given-names>D.W.</given-names></name><name name-style="western"><surname>Glass</surname><given-names>D.D.</given-names></name><etal/></person-group><article-title>Regulatory T cells mediate specific suppression by depleting peptide-MHC class II from dendritic cells</article-title><source>Nat. Immunol.</source><year>2019</year><volume>20</volume><fpage>218</fpage><lpage>231</lpage><pub-id pub-id-type="doi">10.1038/s41590-018-0280-2</pub-id><pub-id pub-id-type="pmid">30643268</pub-id><pub-id pub-id-type="pmcid">PMC6402611</pub-id></element-citation></ref><ref id="B199-ijms-21-08011"><label>199.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Bennett</surname><given-names>C.L.</given-names></name><name name-style="western"><surname>Christie</surname><given-names>J.</given-names></name><name name-style="western"><surname>Ramsdell</surname><given-names>F.</given-names></name><name name-style="western"><surname>Brunkow</surname><given-names>M.E.</given-names></name><name name-style="western"><surname>Ferguson</surname><given-names>P.J.</given-names></name><name name-style="western"><surname>Whitesell</surname><given-names>L.</given-names></name><name name-style="western"><surname>Kelly</surname><given-names>T.E.</given-names></name><name name-style="western"><surname>Saulsbury</surname><given-names>F.T.</given-names></name><name name-style="western"><surname>Chance</surname><given-names>P.F.</given-names></name><name name-style="western"><surname>Ochs</surname><given-names>H.D.</given-names></name></person-group><article-title>The immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome (IPEX) is caused by mutations of FOXP3</article-title><source>Nat. Genet.</source><year>2001</year><volume>27</volume><fpage>20</fpage><lpage>21</lpage><pub-id pub-id-type="doi">10.1038/83713</pub-id><pub-id pub-id-type="pmid">11137993</pub-id></element-citation></ref><ref id="B200-ijms-21-08011"><label>200.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Brunkow</surname><given-names>M.E.</given-names></name><name name-style="western"><surname>Jeffery</surname><given-names>E.W.</given-names></name><name name-style="western"><surname>Hjerrild</surname><given-names>K.A.</given-names></name><name name-style="western"><surname>Paeper</surname><given-names>B.</given-names></name><name name-style="western"><surname>Clark</surname><given-names>L.B.</given-names></name><name name-style="western"><surname>Yasayko</surname><given-names>S.A.</given-names></name><name name-style="western"><surname>Wilkinson</surname><given-names>J.E.</given-names></name><name name-style="western"><surname>Galas</surname><given-names>D.</given-names></name><name name-style="western"><surname>Ziegler</surname><given-names>S.F.</given-names></name><name name-style="western"><surname>Ramsdell</surname><given-names>F.</given-names></name></person-group><article-title>Disruption of a new forkhead/winged-helix protein, scurfin, results in the fatal lymphoproliferative disorder of the scurfy mouse</article-title><source>Nat. Genet.</source><year>2001</year><volume>27</volume><fpage>68</fpage><lpage>73</lpage><pub-id pub-id-type="doi">10.1038/83784</pub-id><pub-id pub-id-type="pmid">11138001</pub-id></element-citation></ref><ref id="B201-ijms-21-08011"><label>201.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Wildin</surname><given-names>R.S.</given-names></name><name name-style="western"><surname>Ramsdell</surname><given-names>F.</given-names></name><name name-style="western"><surname>Peake</surname><given-names>J.</given-names></name><name name-style="western"><surname>Faravelli</surname><given-names>F.</given-names></name><name name-style="western"><surname>Casanova</surname><given-names>J.L.</given-names></name><name name-style="western"><surname>Buist</surname><given-names>N.</given-names></name><name name-style="western"><surname>Levy-Lahad</surname><given-names>E.</given-names></name><name name-style="western"><surname>Mazzella</surname><given-names>M.</given-names></name><name name-style="western"><surname>Goulet</surname><given-names>O.</given-names></name><name name-style="western"><surname>Perroni</surname><given-names>L.</given-names></name><etal/></person-group><article-title>X-linked neonatal diabetes mellitus, enteropathy and endocrinopathy syndrome is the human equivalent of mouse scurfy</article-title><source>Nat. Genet.</source><year>2001</year><volume>27</volume><fpage>18</fpage><lpage>20</lpage><pub-id pub-id-type="doi">10.1038/83707</pub-id><pub-id pub-id-type="pmid">11137992</pub-id></element-citation></ref><ref id="B202-ijms-21-08011"><label>202.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Van Gool</surname><given-names>F.</given-names></name><name name-style="western"><surname>Nguyen</surname><given-names>M.L.T.</given-names></name><name name-style="western"><surname>Mumbach</surname><given-names>M.R.</given-names></name><name name-style="western"><surname>Satpathy</surname><given-names>A.T.</given-names></name><name name-style="western"><surname>Rosenthal</surname><given-names>W.L.</given-names></name><name name-style="western"><surname>Giacometti</surname><given-names>S.</given-names></name><name name-style="western"><surname>Le</surname><given-names>D.T.</given-names></name><name name-style="western"><surname>Liu</surname><given-names>W.</given-names></name><name name-style="western"><surname>Brusko</surname><given-names>T.M.</given-names></name><name name-style="western"><surname>Anderson</surname><given-names>M.S.</given-names></name><etal/></person-group><article-title>A Mutation in the Transcription Factor Foxp3 Drives T Helper 2 Effector Function in Regulatory T Cells</article-title><source>Immunity</source><year>2019</year><volume>50</volume><fpage>362</fpage><lpage>377.e366</lpage><pub-id pub-id-type="doi">10.1016/j.immuni.2018.12.016</pub-id><pub-id pub-id-type="pmid">30709738</pub-id><pub-id pub-id-type="pmcid">PMC6476426</pub-id></element-citation></ref><ref id="B203-ijms-21-08011"><label>203.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Chang</surname><given-names>J.H.</given-names></name><name name-style="western"><surname>Hu</surname><given-names>H.</given-names></name><name name-style="western"><surname>Jin</surname><given-names>J.</given-names></name><name name-style="western"><surname>Puebla-Osorio</surname><given-names>N.</given-names></name><name name-style="western"><surname>Xiao</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Gilbert</surname><given-names>B.E.</given-names></name><name name-style="western"><surname>Brink</surname><given-names>R.</given-names></name><name name-style="western"><surname>Ullrich</surname><given-names>S.E.</given-names></name><name name-style="western"><surname>Sun</surname><given-names>S.C.</given-names></name></person-group><article-title>TRAF3 regulates the effector function of regulatory T cells and humoral immune responses</article-title><source>J. Exp. Med.</source><year>2014</year><volume>211</volume><fpage>137</fpage><lpage>151</lpage><pub-id pub-id-type="doi">10.1084/jem.20131019</pub-id><pub-id pub-id-type="pmid">24378539</pub-id><pub-id pub-id-type="pmcid">PMC3892978</pub-id></element-citation></ref><ref id="B204-ijms-21-08011"><label>204.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Zhang</surname><given-names>R.</given-names></name><name name-style="western"><surname>Huynh</surname><given-names>A.</given-names></name><name name-style="western"><surname>Whitcher</surname><given-names>G.</given-names></name><name name-style="western"><surname>Chang</surname><given-names>J.</given-names></name><name name-style="western"><surname>Maltzman</surname><given-names>J.S.</given-names></name><name name-style="western"><surname>Turka</surname><given-names>L.A.</given-names></name></person-group><article-title>An obligate cell-intrinsic function for CD28 in Tregs</article-title><source>J. Clin. Investig.</source><year>2013</year><volume>123</volume><fpage>580</fpage><lpage>593</lpage><pub-id pub-id-type="doi">10.1172/JCI65013</pub-id><pub-id pub-id-type="pmid">23281398</pub-id><pub-id pub-id-type="pmcid">PMC3561819</pub-id></element-citation></ref><ref id="B205-ijms-21-08011"><label>205.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Miyazaki</surname><given-names>M.</given-names></name><name name-style="western"><surname>Miyazaki</surname><given-names>K.</given-names></name><name name-style="western"><surname>Chen</surname><given-names>S.</given-names></name><name name-style="western"><surname>Itoi</surname><given-names>M.</given-names></name><name name-style="western"><surname>Miller</surname><given-names>M.</given-names></name><name name-style="western"><surname>Lu</surname><given-names>L.F.</given-names></name><name name-style="western"><surname>Varki</surname><given-names>N.</given-names></name><name name-style="western"><surname>Chang</surname><given-names>A.N.</given-names></name><name name-style="western"><surname>Broide</surname><given-names>D.H.</given-names></name><name name-style="western"><surname>Murre</surname><given-names>C.</given-names></name></person-group><article-title>Id2 and Id3 maintain the regulatory T cell pool to suppress inflammatory disease</article-title><source>Nat. Immunol.</source><year>2014</year><volume>15</volume><fpage>767</fpage><lpage>776</lpage><pub-id pub-id-type="doi">10.1038/ni.2928</pub-id><pub-id pub-id-type="pmid">24973820</pub-id><pub-id pub-id-type="pmcid">PMC4365819</pub-id></element-citation></ref><ref id="B206-ijms-21-08011"><label>206.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Chang</surname><given-names>J.H.</given-names></name><name name-style="western"><surname>Xiao</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Hu</surname><given-names>H.</given-names></name><name name-style="western"><surname>Jin</surname><given-names>J.</given-names></name><name name-style="western"><surname>Yu</surname><given-names>J.</given-names></name><name name-style="western"><surname>Zhou</surname><given-names>X.</given-names></name><name name-style="western"><surname>Wu</surname><given-names>X.</given-names></name><name name-style="western"><surname>Johnson</surname><given-names>H.M.</given-names></name><name name-style="western"><surname>Akira</surname><given-names>S.</given-names></name><name name-style="western"><surname>Pasparakis</surname><given-names>M.</given-names></name><etal/></person-group><article-title>Ubc13 maintains the suppressive function of regulatory T cells and prevents their conversion into effector-like T cells</article-title><source>Nat. Immunol.</source><year>2012</year><volume>13</volume><fpage>481</fpage><lpage>490</lpage><pub-id pub-id-type="doi">10.1038/ni.2267</pub-id><pub-id pub-id-type="pmid">22484734</pub-id><pub-id pub-id-type="pmcid">PMC3361639</pub-id></element-citation></ref><ref id="B207-ijms-21-08011"><label>207.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Layman</surname><given-names>A.A.K.</given-names></name><name name-style="western"><surname>Deng</surname><given-names>G.</given-names></name><name name-style="western"><surname>O&#8217;Leary</surname><given-names>C.E.</given-names></name><name name-style="western"><surname>Tadros</surname><given-names>S.</given-names></name><name name-style="western"><surname>Thomas</surname><given-names>R.M.</given-names></name><name name-style="western"><surname>Dybas</surname><given-names>J.M.</given-names></name><name name-style="western"><surname>Moser</surname><given-names>E.K.</given-names></name><name name-style="western"><surname>Wells</surname><given-names>A.D.</given-names></name><name name-style="western"><surname>Doliba</surname><given-names>N.M.</given-names></name><name name-style="western"><surname>Oliver</surname><given-names>P.M.</given-names></name></person-group><article-title>Ndfip1 restricts mTORC1 signalling and glycolysis in regulatory T cells to prevent autoinflammatory disease</article-title><source>Nat. Commun.</source><year>2017</year><volume>8</volume><fpage>15677</fpage><pub-id pub-id-type="doi">10.1038/ncomms15677</pub-id><pub-id pub-id-type="pmid">28580955</pub-id><pub-id pub-id-type="pmcid">PMC5465375</pub-id></element-citation></ref><ref id="B208-ijms-21-08011"><label>208.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Oh</surname><given-names>H.</given-names></name><name name-style="western"><surname>Grinberg-Bleyer</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Liao</surname><given-names>W.</given-names></name><name name-style="western"><surname>Maloney</surname><given-names>D.</given-names></name><name name-style="western"><surname>Wang</surname><given-names>P.</given-names></name><name name-style="western"><surname>Wu</surname><given-names>Z.</given-names></name><name name-style="western"><surname>Wang</surname><given-names>J.</given-names></name><name name-style="western"><surname>Bhatt</surname><given-names>D.M.</given-names></name><name name-style="western"><surname>Heise</surname><given-names>N.</given-names></name><name name-style="western"><surname>Schmid</surname><given-names>R.M.</given-names></name><etal/></person-group><article-title>An NF-kappaB Transcription-Factor-Dependent Lineage-Specific Transcriptional Program Promotes Regulatory T Cell Identity and Function</article-title><source>Immunity</source><year>2017</year><volume>47</volume><fpage>450</fpage><lpage>465.e455</lpage><pub-id pub-id-type="doi">10.1016/j.immuni.2017.08.010</pub-id><pub-id pub-id-type="pmid">28889947</pub-id><pub-id pub-id-type="pmcid">PMC5679261</pub-id></element-citation></ref><ref id="B209-ijms-21-08011"><label>209.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Sebastian</surname><given-names>M.</given-names></name><name name-style="western"><surname>Lopez-Ocasio</surname><given-names>M.</given-names></name><name name-style="western"><surname>Metidji</surname><given-names>A.</given-names></name><name name-style="western"><surname>Rieder</surname><given-names>S.A.</given-names></name><name name-style="western"><surname>Shevach</surname><given-names>E.M.</given-names></name><name name-style="western"><surname>Thornton</surname><given-names>A.M.</given-names></name></person-group><article-title>Helios Controls a Limited Subset of Regulatory T Cell Functions</article-title><source>J. Immunol.</source><year>2016</year><volume>196</volume><fpage>144</fpage><lpage>155</lpage><pub-id pub-id-type="doi">10.4049/jimmunol.1501704</pub-id><pub-id pub-id-type="pmid">26582951</pub-id><pub-id pub-id-type="pmcid">PMC4685018</pub-id></element-citation></ref><ref id="B210-ijms-21-08011"><label>210.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Carpenter</surname><given-names>A.C.</given-names></name><name name-style="western"><surname>Wohlfert</surname><given-names>E.</given-names></name><name name-style="western"><surname>Chopp</surname><given-names>L.B.</given-names></name><name name-style="western"><surname>Vacchio</surname><given-names>M.S.</given-names></name><name name-style="western"><surname>Nie</surname><given-names>J.</given-names></name><name name-style="western"><surname>Zhao</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Shetty</surname><given-names>J.</given-names></name><name name-style="western"><surname>Xiao</surname><given-names>Q.</given-names></name><name name-style="western"><surname>Deng</surname><given-names>C.</given-names></name><name name-style="western"><surname>Tran</surname><given-names>B.</given-names></name><etal/></person-group><article-title>Control of Regulatory T Cell Differentiation by the Transcription Factors Thpok and LRF</article-title><source>J. Immunol.</source><year>2017</year><volume>199</volume><fpage>1716</fpage><lpage>1728</lpage><pub-id pub-id-type="doi">10.4049/jimmunol.1700181</pub-id><pub-id pub-id-type="pmid">28754678</pub-id><pub-id pub-id-type="pmcid">PMC5576567</pub-id></element-citation></ref><ref id="B211-ijms-21-08011"><label>211.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>DuPage</surname><given-names>M.</given-names></name><name name-style="western"><surname>Chopra</surname><given-names>G.</given-names></name><name name-style="western"><surname>Quiros</surname><given-names>J.</given-names></name><name name-style="western"><surname>Rosenthal</surname><given-names>W.L.</given-names></name><name name-style="western"><surname>Morar</surname><given-names>M.M.</given-names></name><name name-style="western"><surname>Holohan</surname><given-names>D.</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>R.</given-names></name><name name-style="western"><surname>Turka</surname><given-names>L.</given-names></name><name name-style="western"><surname>Marson</surname><given-names>A.</given-names></name><name name-style="western"><surname>Bluestone</surname><given-names>J.A.</given-names></name></person-group><article-title>The chromatin-modifying enzyme Ezh2 is critical for the maintenance of regulatory T cell identity after activation</article-title><source>Immunity</source><year>2015</year><volume>42</volume><fpage>227</fpage><lpage>238</lpage><pub-id pub-id-type="doi">10.1016/j.immuni.2015.01.007</pub-id><pub-id pub-id-type="pmid">25680271</pub-id><pub-id pub-id-type="pmcid">PMC4347854</pub-id></element-citation></ref><ref id="B212-ijms-21-08011"><label>212.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Roychoudhuri</surname><given-names>R.</given-names></name><name name-style="western"><surname>Hirahara</surname><given-names>K.</given-names></name><name name-style="western"><surname>Mousavi</surname><given-names>K.</given-names></name><name name-style="western"><surname>Clever</surname><given-names>D.</given-names></name><name name-style="western"><surname>Klebanoff</surname><given-names>C.A.</given-names></name><name name-style="western"><surname>Bonelli</surname><given-names>M.</given-names></name><name name-style="western"><surname>Sciume</surname><given-names>G.</given-names></name><name name-style="western"><surname>Zare</surname><given-names>H.</given-names></name><name name-style="western"><surname>Vahedi</surname><given-names>G.</given-names></name><name name-style="western"><surname>Dema</surname><given-names>B.</given-names></name><etal/></person-group><article-title>BACH2 represses effector programs to stabilize T(reg)-mediated immune homeostasis</article-title><source>Nature</source><year>2013</year><volume>498</volume><fpage>506</fpage><lpage>510</lpage><pub-id pub-id-type="doi">10.1038/nature12199</pub-id><pub-id pub-id-type="pmid">23728300</pub-id><pub-id pub-id-type="pmcid">PMC3710737</pub-id></element-citation></ref><ref id="B213-ijms-21-08011"><label>213.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kim</surname><given-names>E.H.</given-names></name><name name-style="western"><surname>Gasper</surname><given-names>D.J.</given-names></name><name name-style="western"><surname>Lee</surname><given-names>S.H.</given-names></name><name name-style="western"><surname>Plisch</surname><given-names>E.H.</given-names></name><name name-style="western"><surname>Svaren</surname><given-names>J.</given-names></name><name name-style="western"><surname>Suresh</surname><given-names>M.</given-names></name></person-group><article-title>Bach2 regulates homeostasis of Foxp3+ regulatory T cells and protects against fatal lung disease in mice</article-title><source>J. Immunol.</source><year>2014</year><volume>192</volume><fpage>985</fpage><lpage>995</lpage><pub-id pub-id-type="doi">10.4049/jimmunol.1302378</pub-id><pub-id pub-id-type="pmid">24367030</pub-id><pub-id pub-id-type="pmcid">PMC3946995</pub-id></element-citation></ref><ref id="B214-ijms-21-08011"><label>214.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kondo</surname><given-names>M.</given-names></name><name name-style="western"><surname>Tanaka</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Kuwabara</surname><given-names>T.</given-names></name><name name-style="western"><surname>Naito</surname><given-names>T.</given-names></name><name name-style="western"><surname>Kohwi-Shigematsu</surname><given-names>T.</given-names></name><name name-style="western"><surname>Watanabe</surname><given-names>A.</given-names></name></person-group><article-title>SATB1 Plays a Critical Role in Establishment of Immune Tolerance</article-title><source>J. Immunol.</source><year>2016</year><volume>196</volume><fpage>563</fpage><lpage>572</lpage><pub-id pub-id-type="doi">10.4049/jimmunol.1501429</pub-id><pub-id pub-id-type="pmid">26667169</pub-id></element-citation></ref><ref id="B215-ijms-21-08011"><label>215.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Cretney</surname><given-names>E.</given-names></name><name name-style="western"><surname>Xin</surname><given-names>A.</given-names></name><name name-style="western"><surname>Shi</surname><given-names>W.</given-names></name><name name-style="western"><surname>Minnich</surname><given-names>M.</given-names></name><name name-style="western"><surname>Masson</surname><given-names>F.</given-names></name><name name-style="western"><surname>Miasari</surname><given-names>M.</given-names></name><name name-style="western"><surname>Belz</surname><given-names>G.T.</given-names></name><name name-style="western"><surname>Smyth</surname><given-names>G.K.</given-names></name><name name-style="western"><surname>Busslinger</surname><given-names>M.</given-names></name><name name-style="western"><surname>Nutt</surname><given-names>S.L.</given-names></name><etal/></person-group><article-title>The transcription factors Blimp-1 and IRF4 jointly control the differentiation and function of effector regulatory T cells</article-title><source>Nat. Immunol.</source><year>2011</year><volume>12</volume><fpage>304</fpage><lpage>311</lpage><pub-id pub-id-type="doi">10.1038/ni.2006</pub-id><pub-id pub-id-type="pmid">21378976</pub-id></element-citation></ref><ref id="B216-ijms-21-08011"><label>216.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Yang</surname><given-names>K.</given-names></name><name name-style="western"><surname>Blanco</surname><given-names>D.B.</given-names></name><name name-style="western"><surname>Neale</surname><given-names>G.</given-names></name><name name-style="western"><surname>Vogel</surname><given-names>P.</given-names></name><name name-style="western"><surname>Avila</surname><given-names>J.</given-names></name><name name-style="western"><surname>Clish</surname><given-names>C.B.</given-names></name><name name-style="western"><surname>Wu</surname><given-names>C.</given-names></name><name name-style="western"><surname>Shrestha</surname><given-names>S.</given-names></name><name name-style="western"><surname>Rankin</surname><given-names>S.</given-names></name><name name-style="western"><surname>Long</surname><given-names>L.</given-names></name><etal/></person-group><article-title>Homeostatic control of metabolic and functional fitness of Treg cells by LKB1 signalling</article-title><source>Nature</source><year>2017</year><volume>548</volume><fpage>602</fpage><lpage>606</lpage><pub-id pub-id-type="doi">10.1038/nature23665</pub-id><pub-id pub-id-type="pmid">28847007</pub-id><pub-id pub-id-type="pmcid">PMC5804356</pub-id></element-citation></ref><ref id="B217-ijms-21-08011"><label>217.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Yu</surname><given-names>D.</given-names></name><name name-style="western"><surname>Rao</surname><given-names>S.</given-names></name><name name-style="western"><surname>Tsai</surname><given-names>L.M.</given-names></name><name name-style="western"><surname>Lee</surname><given-names>S.K.</given-names></name><name name-style="western"><surname>He</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Sutcliffe</surname><given-names>E.L.</given-names></name><name name-style="western"><surname>Srivastava</surname><given-names>M.</given-names></name><name name-style="western"><surname>Linterman</surname><given-names>M.</given-names></name><name name-style="western"><surname>Zheng</surname><given-names>L.</given-names></name><name name-style="western"><surname>Simpson</surname><given-names>N.</given-names></name><etal/></person-group><article-title>The transcriptional repressor Bcl-6 directs T follicular helper cell lineage commitment</article-title><source>Immunity</source><year>2009</year><volume>31</volume><fpage>457</fpage><lpage>468</lpage><pub-id pub-id-type="doi">10.1016/j.immuni.2009.07.002</pub-id><pub-id pub-id-type="pmid">19631565</pub-id></element-citation></ref><ref id="B218-ijms-21-08011"><label>218.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Nurieva</surname><given-names>R.I.</given-names></name><name name-style="western"><surname>Chung</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Martinez</surname><given-names>G.J.</given-names></name><name name-style="western"><surname>Yang</surname><given-names>X.O.</given-names></name><name name-style="western"><surname>Tanaka</surname><given-names>S.</given-names></name><name name-style="western"><surname>Matskevitch</surname><given-names>T.D.</given-names></name><name name-style="western"><surname>Wang</surname><given-names>Y.H.</given-names></name><name name-style="western"><surname>Dong</surname><given-names>C.</given-names></name></person-group><article-title>Bcl6 mediates the development of T follicular helper cells</article-title><source>Science</source><year>2009</year><volume>325</volume><fpage>1001</fpage><lpage>1005</lpage><pub-id pub-id-type="doi">10.1126/science.1176676</pub-id><pub-id pub-id-type="pmid">19628815</pub-id><pub-id pub-id-type="pmcid">PMC2857334</pub-id></element-citation></ref><ref id="B219-ijms-21-08011"><label>219.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Johnston</surname><given-names>R.J.</given-names></name><name name-style="western"><surname>Poholek</surname><given-names>A.C.</given-names></name><name name-style="western"><surname>DiToro</surname><given-names>D.</given-names></name><name name-style="western"><surname>Yusuf</surname><given-names>I.</given-names></name><name name-style="western"><surname>Eto</surname><given-names>D.</given-names></name><name name-style="western"><surname>Barnett</surname><given-names>B.</given-names></name><name name-style="western"><surname>Dent</surname><given-names>A.L.</given-names></name><name name-style="western"><surname>Craft</surname><given-names>J.</given-names></name><name name-style="western"><surname>Crotty</surname><given-names>S.</given-names></name></person-group><article-title>Bcl6 and Blimp-1 are reciprocal and antagonistic regulators of T follicular helper cell differentiation</article-title><source>Science</source><year>2009</year><volume>325</volume><fpage>1006</fpage><lpage>1010</lpage><pub-id pub-id-type="doi">10.1126/science.1175870</pub-id><pub-id pub-id-type="pmid">19608860</pub-id><pub-id pub-id-type="pmcid">PMC2766560</pub-id></element-citation></ref><ref id="B220-ijms-21-08011"><label>220.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Vinuesa</surname><given-names>C.G.</given-names></name><name name-style="western"><surname>Linterman</surname><given-names>M.A.</given-names></name><name name-style="western"><surname>Yu</surname><given-names>D.</given-names></name><name name-style="western"><surname>MacLennan</surname><given-names>I.C.</given-names></name></person-group><article-title>Follicular Helper T Cells</article-title><source>Annu. Rev. Immunol.</source><year>2016</year><volume>34</volume><fpage>335</fpage><lpage>368</lpage><pub-id pub-id-type="doi">10.1146/annurev-immunol-041015-055605</pub-id><pub-id pub-id-type="pmid">26907215</pub-id></element-citation></ref><ref id="B221-ijms-21-08011"><label>221.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Roco</surname><given-names>J.A.</given-names></name><name name-style="western"><surname>Mesin</surname><given-names>L.</given-names></name><name name-style="western"><surname>Binder</surname><given-names>S.C.</given-names></name><name name-style="western"><surname>Nefzger</surname><given-names>C.</given-names></name><name name-style="western"><surname>Gonzalez-Figueroa</surname><given-names>P.</given-names></name><name name-style="western"><surname>Canete</surname><given-names>P.F.</given-names></name><name name-style="western"><surname>Ellyard</surname><given-names>J.</given-names></name><name name-style="western"><surname>Shen</surname><given-names>Q.</given-names></name><name name-style="western"><surname>Robert</surname><given-names>P.A.</given-names></name><name name-style="western"><surname>Cappello</surname><given-names>J.</given-names></name><etal/></person-group><article-title>Class-Switch Recombination Occurs Infrequently in Germinal Centers</article-title><source>Immunity</source><year>2019</year><volume>51</volume><fpage>337</fpage><lpage>350.e337</lpage><pub-id pub-id-type="doi">10.1016/j.immuni.2019.07.001</pub-id><pub-id pub-id-type="pmid">31375460</pub-id><pub-id pub-id-type="pmcid">PMC6914312</pub-id></element-citation></ref><ref id="B222-ijms-21-08011"><label>222.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Nurieva</surname><given-names>R.I.</given-names></name><name name-style="western"><surname>Chung</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Hwang</surname><given-names>D.</given-names></name><name name-style="western"><surname>Yang</surname><given-names>X.O.</given-names></name><name name-style="western"><surname>Kang</surname><given-names>H.S.</given-names></name><name name-style="western"><surname>Ma</surname><given-names>L.</given-names></name><name name-style="western"><surname>Wang</surname><given-names>Y.H.</given-names></name><name name-style="western"><surname>Watowich</surname><given-names>S.S.</given-names></name><name name-style="western"><surname>Jetten</surname><given-names>A.M.</given-names></name><name name-style="western"><surname>Tian</surname><given-names>Q.</given-names></name><etal/></person-group><article-title>Generation of T follicular helper cells is mediated by interleukin-21 but independent of T helper 1, 2, or 17 cell lineages</article-title><source>Immunity</source><year>2008</year><volume>29</volume><fpage>138</fpage><lpage>149</lpage><pub-id pub-id-type="doi">10.1016/j.immuni.2008.05.009</pub-id><pub-id pub-id-type="pmid">18599325</pub-id><pub-id pub-id-type="pmcid">PMC2556461</pub-id></element-citation></ref><ref id="B223-ijms-21-08011"><label>223.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Lu</surname><given-names>K.T.</given-names></name><name name-style="western"><surname>Kanno</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Cannons</surname><given-names>J.L.</given-names></name><name name-style="western"><surname>Handon</surname><given-names>R.</given-names></name><name name-style="western"><surname>Bible</surname><given-names>P.</given-names></name><name name-style="western"><surname>Elkahloun</surname><given-names>A.G.</given-names></name><name name-style="western"><surname>Anderson</surname><given-names>S.M.</given-names></name><name name-style="western"><surname>Wei</surname><given-names>L.</given-names></name><name name-style="western"><surname>Sun</surname><given-names>H.</given-names></name><name name-style="western"><surname>O&#8217;Shea</surname><given-names>J.J.</given-names></name><etal/></person-group><article-title>Functional and epigenetic studies reveal multistep differentiation and plasticity of in vitro-generated and in vivo-derived follicular T helper cells</article-title><source>Immunity</source><year>2011</year><volume>35</volume><fpage>622</fpage><lpage>632</lpage><pub-id pub-id-type="doi">10.1016/j.immuni.2011.07.015</pub-id><pub-id pub-id-type="pmid">22018472</pub-id><pub-id pub-id-type="pmcid">PMC3235706</pub-id></element-citation></ref><ref id="B224-ijms-21-08011"><label>224.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Fazilleau</surname><given-names>N.</given-names></name><name name-style="western"><surname>McHeyzer-Williams</surname><given-names>L.J.</given-names></name><name name-style="western"><surname>Rosen</surname><given-names>H.</given-names></name><name name-style="western"><surname>McHeyzer-Williams</surname><given-names>M.G.</given-names></name></person-group><article-title>The function of follicular helper T cells is regulated by the strength of T cell antigen receptor binding</article-title><source>Nat. Immunol.</source><year>2009</year><volume>10</volume><fpage>375</fpage><lpage>384</lpage><pub-id pub-id-type="doi">10.1038/ni.1704</pub-id><pub-id pub-id-type="pmid">19252493</pub-id><pub-id pub-id-type="pmcid">PMC2712297</pub-id></element-citation></ref><ref id="B225-ijms-21-08011"><label>225.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Spolski</surname><given-names>R.</given-names></name><name name-style="western"><surname>Leonard</surname><given-names>W.J.</given-names></name></person-group><article-title>Interleukin-21: A double-edged sword with therapeutic potential</article-title><source>Nat. Rev. Drug Discov.</source><year>2014</year><volume>13</volume><fpage>379</fpage><lpage>395</lpage><pub-id pub-id-type="doi">10.1038/nrd4296</pub-id><pub-id pub-id-type="pmid">24751819</pub-id></element-citation></ref><ref id="B226-ijms-21-08011"><label>226.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>DiToro</surname><given-names>D.</given-names></name><name name-style="western"><surname>Winstead</surname><given-names>C.J.</given-names></name><name name-style="western"><surname>Pham</surname><given-names>D.</given-names></name><name name-style="western"><surname>Witte</surname><given-names>S.</given-names></name><name name-style="western"><surname>Andargachew</surname><given-names>R.</given-names></name><name name-style="western"><surname>Singer</surname><given-names>J.R.</given-names></name><name name-style="western"><surname>Wilson</surname><given-names>C.G.</given-names></name><name name-style="western"><surname>Zindl</surname><given-names>C.L.</given-names></name><name name-style="western"><surname>Luther</surname><given-names>R.J.</given-names></name><name name-style="western"><surname>Silberger</surname><given-names>D.J.</given-names></name><etal/></person-group><article-title>Differential IL-2 expression defines developmental fates of follicular versus nonfollicular helper T cells</article-title><source>Science</source><year>2018</year><volume>361</volume><fpage>eaao2933</fpage><pub-id pub-id-type="doi">10.1126/science.aao2933</pub-id><pub-id pub-id-type="pmid">30213884</pub-id><pub-id pub-id-type="pmcid">PMC6501592</pub-id></element-citation></ref><ref id="B227-ijms-21-08011"><label>227.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Crotty</surname><given-names>S.</given-names></name></person-group><article-title>T follicular helper cell differentiation, function, and roles in disease</article-title><source>Immunity</source><year>2014</year><volume>41</volume><fpage>529</fpage><lpage>542</lpage><pub-id pub-id-type="doi">10.1016/j.immuni.2014.10.004</pub-id><pub-id pub-id-type="pmid">25367570</pub-id><pub-id pub-id-type="pmcid">PMC4223692</pub-id></element-citation></ref><ref id="B228-ijms-21-08011"><label>228.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ma</surname><given-names>C.S.</given-names></name><name name-style="western"><surname>Deenick</surname><given-names>E.K.</given-names></name><name name-style="western"><surname>Batten</surname><given-names>M.</given-names></name><name name-style="western"><surname>Tangye</surname><given-names>S.G.</given-names></name></person-group><article-title>The origins, function, and regulation of T follicular helper cells</article-title><source>J. Exp. Med.</source><year>2012</year><volume>209</volume><fpage>1241</fpage><lpage>1253</lpage><pub-id pub-id-type="doi">10.1084/jem.20120994</pub-id><pub-id pub-id-type="pmid">22753927</pub-id><pub-id pub-id-type="pmcid">PMC3405510</pub-id></element-citation></ref><ref id="B229-ijms-21-08011"><label>229.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Liu</surname><given-names>X.</given-names></name><name name-style="western"><surname>Chen</surname><given-names>X.</given-names></name><name name-style="western"><surname>Zhong</surname><given-names>B.</given-names></name><name name-style="western"><surname>Wang</surname><given-names>A.</given-names></name><name name-style="western"><surname>Wang</surname><given-names>X.</given-names></name><name name-style="western"><surname>Chu</surname><given-names>F.</given-names></name><name name-style="western"><surname>Nurieva</surname><given-names>R.I.</given-names></name><name name-style="western"><surname>Yan</surname><given-names>X.</given-names></name><name name-style="western"><surname>Chen</surname><given-names>P.</given-names></name><name name-style="western"><surname>van der Flier</surname><given-names>L.G.</given-names></name><etal/></person-group><article-title>Transcription factor achaete-scute homologue 2 initiates follicular T-helper-cell development</article-title><source>Nature</source><year>2014</year><volume>507</volume><fpage>513</fpage><lpage>518</lpage><pub-id pub-id-type="doi">10.1038/nature12910</pub-id><pub-id pub-id-type="pmid">24463518</pub-id><pub-id pub-id-type="pmcid">PMC4012617</pub-id></element-citation></ref><ref id="B230-ijms-21-08011"><label>230.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Xiao</surname><given-names>N.M.</given-names></name><name name-style="western"><surname>Eto</surname><given-names>D.</given-names></name><name name-style="western"><surname>Elly</surname><given-names>C.</given-names></name><name name-style="western"><surname>Peng</surname><given-names>G.Y.</given-names></name><name name-style="western"><surname>Crotty</surname><given-names>S.</given-names></name><name name-style="western"><surname>Liu</surname><given-names>Y.C.</given-names></name></person-group><article-title>The E3 ubiquitin ligase Itch is required for the differentiation of follicular helper T cells</article-title><source>Nat. Immunol.</source><year>2014</year><volume>15</volume><fpage>657</fpage><lpage>666</lpage><pub-id pub-id-type="doi">10.1038/ni.2912</pub-id><pub-id pub-id-type="pmid">24859451</pub-id><pub-id pub-id-type="pmcid">PMC4289613</pub-id></element-citation></ref><ref id="B231-ijms-21-08011"><label>231.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Zhu</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Zhao</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Zou</surname><given-names>L.</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>D.</given-names></name><name name-style="western"><surname>Aki</surname><given-names>D.</given-names></name><name name-style="western"><surname>Liu</surname><given-names>Y.C.</given-names></name></person-group><article-title>The E3 ligase VHL promotes follicular helper T cell differentiation via glycolytic-epigenetic control</article-title><source>J. Exp. Med.</source><year>2019</year><volume>216</volume><fpage>1664</fpage><lpage>1681</lpage><pub-id pub-id-type="doi">10.1084/jem.20190337</pub-id><pub-id pub-id-type="pmid">31123085</pub-id><pub-id pub-id-type="pmcid">PMC6605754</pub-id></element-citation></ref><ref id="B232-ijms-21-08011"><label>232.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Liu</surname><given-names>Z.</given-names></name><name name-style="western"><surname>Zhu</surname><given-names>L.</given-names></name><name name-style="western"><surname>Lu</surname><given-names>Z.</given-names></name><name name-style="western"><surname>Chen</surname><given-names>H.</given-names></name><name name-style="western"><surname>Fan</surname><given-names>L.</given-names></name><name name-style="western"><surname>Xue</surname><given-names>Q.</given-names></name><name name-style="western"><surname>Shi</surname><given-names>J.</given-names></name><name name-style="western"><surname>Li</surname><given-names>M.</given-names></name><name name-style="western"><surname>Li</surname><given-names>H.</given-names></name><name name-style="western"><surname>Gong</surname><given-names>J.</given-names></name><etal/></person-group><article-title>IL-37 Represses the Autoimmunity in Myasthenia Gravis via Directly Targeting Follicular Th and B Cells</article-title><source>J. Immunol.</source><year>2020</year><volume>204</volume><fpage>1736</fpage><lpage>1745</lpage><pub-id pub-id-type="doi">10.4049/jimmunol.1901176</pub-id><pub-id pub-id-type="pmid">32111731</pub-id></element-citation></ref><ref id="B233-ijms-21-08011"><label>233.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Cho</surname><given-names>S.H.</given-names></name><name name-style="western"><surname>Raybuck</surname><given-names>A.L.</given-names></name><name name-style="western"><surname>Blagih</surname><given-names>J.</given-names></name><name name-style="western"><surname>Kemboi</surname><given-names>E.</given-names></name><name name-style="western"><surname>Haase</surname><given-names>V.H.</given-names></name><name name-style="western"><surname>Jones</surname><given-names>R.G.</given-names></name><name name-style="western"><surname>Boothby</surname><given-names>M.R.</given-names></name></person-group><article-title>Hypoxia-inducible factors in CD4(+) T cells promote metabolism, switch cytokine secretion, and T cell help in humoral immunity</article-title><source>Proc. Natl. Acad. Sci. USA</source><year>2019</year><volume>116</volume><fpage>8975</fpage><lpage>8984</lpage><pub-id pub-id-type="doi">10.1073/pnas.1811702116</pub-id><pub-id pub-id-type="pmid">30988188</pub-id><pub-id pub-id-type="pmcid">PMC6500120</pub-id></element-citation></ref><ref id="B234-ijms-21-08011"><label>234.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Liu</surname><given-names>T.</given-names></name><name name-style="western"><surname>Yang</surname><given-names>Q.</given-names></name><name name-style="western"><surname>Cao</surname><given-names>Y.J.</given-names></name><name name-style="western"><surname>Yuan</surname><given-names>W.M.</given-names></name><name name-style="western"><surname>Lei</surname><given-names>A.H.</given-names></name><name name-style="western"><surname>Zhou</surname><given-names>P.</given-names></name><name name-style="western"><surname>Zhou</surname><given-names>W.</given-names></name><name name-style="western"><surname>Liu</surname><given-names>Y.D.</given-names></name><name name-style="western"><surname>Shi</surname><given-names>M.H.</given-names></name><name name-style="western"><surname>Yang</surname><given-names>Q.</given-names></name><etal/></person-group><article-title>Cyclooxygenase-1 Regulates the Development of Follicular Th Cells via Prostaglandin E2</article-title><source>J. Immunol.</source><year>2019</year><volume>203</volume><fpage>864</fpage><lpage>872</lpage><pub-id pub-id-type="doi">10.4049/jimmunol.1801674</pub-id><pub-id pub-id-type="pmid">31243090</pub-id></element-citation></ref><ref id="B235-ijms-21-08011"><label>235.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Vacchio</surname><given-names>M.S.</given-names></name><name name-style="western"><surname>Ciucci</surname><given-names>T.</given-names></name><name name-style="western"><surname>Gao</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Watanabe</surname><given-names>M.</given-names></name><name name-style="western"><surname>Balmaceno-Criss</surname><given-names>M.</given-names></name><name name-style="western"><surname>McGinty</surname><given-names>M.T.</given-names></name><name name-style="western"><surname>Huang</surname><given-names>A.</given-names></name><name name-style="western"><surname>Xiao</surname><given-names>Q.</given-names></name><name name-style="western"><surname>McConkey</surname><given-names>C.</given-names></name><name name-style="western"><surname>Zhao</surname><given-names>Y.</given-names></name><etal/></person-group><article-title>A Thpok-Directed Transcriptional Circuitry Promotes Bcl6 and Maf Expression to Orchestrate T Follicular Helper Differentiation</article-title><source>Immunity</source><year>2019</year><volume>51</volume><fpage>465</fpage><lpage>478.e466</lpage><pub-id pub-id-type="doi">10.1016/j.immuni.2019.06.023</pub-id><pub-id pub-id-type="pmid">31422869</pub-id><pub-id pub-id-type="pmcid">PMC6904114</pub-id></element-citation></ref><ref id="B236-ijms-21-08011"><label>236.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Xu</surname><given-names>W.</given-names></name><name name-style="western"><surname>Zhao</surname><given-names>X.</given-names></name><name name-style="western"><surname>Wang</surname><given-names>X.</given-names></name><name name-style="western"><surname>Feng</surname><given-names>H.</given-names></name><name name-style="western"><surname>Gou</surname><given-names>M.</given-names></name><name name-style="western"><surname>Jin</surname><given-names>W.</given-names></name><name name-style="western"><surname>Wang</surname><given-names>X.</given-names></name><name name-style="western"><surname>Liu</surname><given-names>X.</given-names></name><name name-style="western"><surname>Dong</surname><given-names>C.</given-names></name></person-group><article-title>The Transcription Factor Tox2 Drives T Follicular Helper Cell Development via Regulating Chromatin Accessibility</article-title><source>Immunity</source><year>2019</year><volume>51</volume><fpage>826</fpage><lpage>839.e825</lpage><pub-id pub-id-type="doi">10.1016/j.immuni.2019.10.006</pub-id><pub-id pub-id-type="pmid">31732165</pub-id></element-citation></ref><ref id="B237-ijms-21-08011"><label>237.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Takahashi</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Dutta</surname><given-names>P.R.</given-names></name><name name-style="western"><surname>Cerasoli</surname><given-names>D.M.</given-names></name><name name-style="western"><surname>Kelsoe</surname><given-names>G.</given-names></name></person-group><article-title>In situ studies of the primary immune response to (4-hydroxy-3-nitrophenyl)acetyl. V. Affinity maturation develops in two stages of clonal selection</article-title><source>J. Exp. Med.</source><year>1998</year><volume>187</volume><fpage>885</fpage><lpage>895</lpage><pub-id pub-id-type="doi">10.1084/jem.187.6.885</pub-id><pub-id pub-id-type="pmid">9500791</pub-id><pub-id pub-id-type="pmcid">PMC2212188</pub-id></element-citation></ref><ref id="B238-ijms-21-08011"><label>238.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Han</surname><given-names>S.</given-names></name><name name-style="western"><surname>Hathcock</surname><given-names>K.</given-names></name><name name-style="western"><surname>Zheng</surname><given-names>B.</given-names></name><name name-style="western"><surname>Kepler</surname><given-names>T.B.</given-names></name><name name-style="western"><surname>Hodes</surname><given-names>R.</given-names></name><name name-style="western"><surname>Kelsoe</surname><given-names>G.</given-names></name></person-group><article-title>Cellular interaction in germinal centers. Roles of CD40 ligand and B7-2 in established germinal centers</article-title><source>J. Immunol.</source><year>1995</year><volume>155</volume><fpage>556</fpage><lpage>567</lpage><pub-id pub-id-type="pmid">7541819</pub-id></element-citation></ref><ref id="B239-ijms-21-08011"><label>239.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Zotos</surname><given-names>D.</given-names></name><name name-style="western"><surname>Coquet</surname><given-names>J.M.</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Light</surname><given-names>A.</given-names></name><name name-style="western"><surname>D&#8217;Costa</surname><given-names>K.</given-names></name><name name-style="western"><surname>Kallies</surname><given-names>A.</given-names></name><name name-style="western"><surname>Corcoran</surname><given-names>L.M.</given-names></name><name name-style="western"><surname>Godfrey</surname><given-names>D.I.</given-names></name><name name-style="western"><surname>Toellner</surname><given-names>K.M.</given-names></name><name name-style="western"><surname>Smyth</surname><given-names>M.J.</given-names></name><etal/></person-group><article-title>IL-21 regulates germinal center B cell differentiation and proliferation through a B cell-intrinsic mechanism</article-title><source>J. Exp. Med.</source><year>2010</year><volume>207</volume><fpage>365</fpage><lpage>378</lpage><pub-id pub-id-type="doi">10.1084/jem.20091777</pub-id><pub-id pub-id-type="pmid">20142430</pub-id><pub-id pub-id-type="pmcid">PMC2822601</pub-id></element-citation></ref><ref id="B240-ijms-21-08011"><label>240.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Linterman</surname><given-names>M.A.</given-names></name><name name-style="western"><surname>Beaton</surname><given-names>L.</given-names></name><name name-style="western"><surname>Yu</surname><given-names>D.</given-names></name><name name-style="western"><surname>Ramiscal</surname><given-names>R.R.</given-names></name><name name-style="western"><surname>Srivastava</surname><given-names>M.</given-names></name><name name-style="western"><surname>Hogan</surname><given-names>J.J.</given-names></name><name name-style="western"><surname>Verma</surname><given-names>N.K.</given-names></name><name name-style="western"><surname>Smyth</surname><given-names>M.J.</given-names></name><name name-style="western"><surname>Rigby</surname><given-names>R.J.</given-names></name><name name-style="western"><surname>Vinuesa</surname><given-names>C.G.</given-names></name></person-group><article-title>IL-21 acts directly on B cells to regulate Bcl-6 expression and germinal center responses</article-title><source>J. Exp. Med.</source><year>2010</year><volume>207</volume><fpage>353</fpage><lpage>363</lpage><pub-id pub-id-type="doi">10.1084/jem.20091738</pub-id><pub-id pub-id-type="pmid">20142429</pub-id><pub-id pub-id-type="pmcid">PMC2822609</pub-id></element-citation></ref><ref id="B241-ijms-21-08011"><label>241.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Van Besouw</surname><given-names>N.M.</given-names></name><name name-style="western"><surname>Mendoza Rojas</surname><given-names>A.</given-names></name><name name-style="western"><surname>Baan</surname><given-names>C.C.</given-names></name></person-group><article-title>The role of follicular T helper cells in the humoral alloimmune response after clinical organ transplantation</article-title><source>HLA</source><year>2019</year><volume>94</volume><fpage>407</fpage><lpage>414</lpage><pub-id pub-id-type="doi">10.1111/tan.13671</pub-id><pub-id pub-id-type="pmid">31423738</pub-id><pub-id pub-id-type="pmcid">PMC6852567</pub-id></element-citation></ref><ref id="B242-ijms-21-08011"><label>242.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Gowthaman</surname><given-names>U.</given-names></name><name name-style="western"><surname>Chen</surname><given-names>J.S.</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>B.</given-names></name><name name-style="western"><surname>Flynn</surname><given-names>W.F.</given-names></name><name name-style="western"><surname>Lu</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Song</surname><given-names>W.</given-names></name><name name-style="western"><surname>Joseph</surname><given-names>J.</given-names></name><name name-style="western"><surname>Gertie</surname><given-names>J.A.</given-names></name><name name-style="western"><surname>Xu</surname><given-names>L.</given-names></name><name name-style="western"><surname>Collet</surname><given-names>M.A.</given-names></name><etal/></person-group><article-title>Identification of a T follicular helper cell subset that drives anaphylactic IgE</article-title><source>Science</source><year>2019</year><volume>365</volume><fpage>eaaw6433</fpage><pub-id pub-id-type="doi">10.1126/science.aaw6433</pub-id><pub-id pub-id-type="pmid">31371561</pub-id><pub-id pub-id-type="pmcid">PMC6901029</pub-id></element-citation></ref><ref id="B243-ijms-21-08011"><label>243.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Simpson</surname><given-names>N.</given-names></name><name name-style="western"><surname>Gatenby</surname><given-names>P.A.</given-names></name><name name-style="western"><surname>Wilson</surname><given-names>A.</given-names></name><name name-style="western"><surname>Malik</surname><given-names>S.</given-names></name><name name-style="western"><surname>Fulcher</surname><given-names>D.A.</given-names></name><name name-style="western"><surname>Tangye</surname><given-names>S.G.</given-names></name><name name-style="western"><surname>Manku</surname><given-names>H.</given-names></name><name name-style="western"><surname>Vyse</surname><given-names>T.J.</given-names></name><name name-style="western"><surname>Roncador</surname><given-names>G.</given-names></name><name name-style="western"><surname>Huttley</surname><given-names>G.A.</given-names></name><etal/></person-group><article-title>Expansion of circulating T cells resembling follicular helper T cells is a fixed phenotype that identifies a subset of severe systemic lupus erythematosus</article-title><source>Arthritis Rheum.</source><year>2010</year><volume>62</volume><fpage>234</fpage><lpage>244</lpage><pub-id pub-id-type="doi">10.1002/art.25032</pub-id><pub-id pub-id-type="pmid">20039395</pub-id></element-citation></ref><ref id="B244-ijms-21-08011"><label>244.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Faliti</surname><given-names>C.E.</given-names></name><name name-style="western"><surname>Gualtierotti</surname><given-names>R.</given-names></name><name name-style="western"><surname>Rottoli</surname><given-names>E.</given-names></name><name name-style="western"><surname>Gerosa</surname><given-names>M.</given-names></name><name name-style="western"><surname>Perruzza</surname><given-names>L.</given-names></name><name name-style="western"><surname>Romagnani</surname><given-names>A.</given-names></name><name name-style="western"><surname>Pellegrini</surname><given-names>G.</given-names></name><name name-style="western"><surname>De Ponte Conti</surname><given-names>B.</given-names></name><name name-style="western"><surname>Rossi</surname><given-names>R.L.</given-names></name><name name-style="western"><surname>Idzko</surname><given-names>M.</given-names></name><etal/></person-group><article-title>P2X7 receptor restrains pathogenic Tfh cell generation in systemic lupus erythematosus</article-title><source>J. Exp. Med.</source><year>2019</year><volume>216</volume><fpage>317</fpage><lpage>336</lpage><pub-id pub-id-type="doi">10.1084/jem.20171976</pub-id><pub-id pub-id-type="pmid">30655308</pub-id><pub-id pub-id-type="pmcid">PMC6363434</pub-id></element-citation></ref><ref id="B245-ijms-21-08011"><label>245.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Psianou</surname><given-names>K.</given-names></name><name name-style="western"><surname>Panagoulias</surname><given-names>I.</given-names></name><name name-style="western"><surname>Papanastasiou</surname><given-names>A.D.</given-names></name><name name-style="western"><surname>de Lastic</surname><given-names>A.L.</given-names></name><name name-style="western"><surname>Rodi</surname><given-names>M.</given-names></name><name name-style="western"><surname>Spantidea</surname><given-names>P.I.</given-names></name><name name-style="western"><surname>Degn</surname><given-names>S.E.</given-names></name><name name-style="western"><surname>Georgiou</surname><given-names>P.</given-names></name><name name-style="western"><surname>Mouzaki</surname><given-names>A.</given-names></name></person-group><article-title>Clinical and immunological parameters of Sjogren&#8217;s syndrome</article-title><source>Autoimmun. Rev.</source><year>2018</year><volume>17</volume><fpage>1053</fpage><lpage>1064</lpage><pub-id pub-id-type="doi">10.1016/j.autrev.2018.05.005</pub-id><pub-id pub-id-type="pmid">30103041</pub-id></element-citation></ref><ref id="B246-ijms-21-08011"><label>246.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Morita</surname><given-names>R.</given-names></name><name name-style="western"><surname>Schmitt</surname><given-names>N.</given-names></name><name name-style="western"><surname>Bentebibel</surname><given-names>S.E.</given-names></name><name name-style="western"><surname>Ranganathan</surname><given-names>R.</given-names></name><name name-style="western"><surname>Bourdery</surname><given-names>L.</given-names></name><name name-style="western"><surname>Zurawski</surname><given-names>G.</given-names></name><name name-style="western"><surname>Foucat</surname><given-names>E.</given-names></name><name name-style="western"><surname>Dullaers</surname><given-names>M.</given-names></name><name name-style="western"><surname>Oh</surname><given-names>S.</given-names></name><name name-style="western"><surname>Sabzghabaei</surname><given-names>N.</given-names></name><etal/></person-group><article-title>Human blood CXCR5(+)CD4(+) T cells are counterparts of T follicular cells and contain specific subsets that differentially support antibody secretion</article-title><source>Immunity</source><year>2011</year><volume>34</volume><fpage>108</fpage><lpage>121</lpage><pub-id pub-id-type="doi">10.1016/j.immuni.2010.12.012</pub-id><pub-id pub-id-type="pmid">21215658</pub-id><pub-id pub-id-type="pmcid">PMC3046815</pub-id></element-citation></ref><ref id="B247-ijms-21-08011"><label>247.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Deng</surname><given-names>J.</given-names></name><name name-style="western"><surname>Wei</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Fonseca</surname><given-names>V.R.</given-names></name><name name-style="western"><surname>Graca</surname><given-names>L.</given-names></name><name name-style="western"><surname>Yu</surname><given-names>D.</given-names></name></person-group><article-title>T follicular helper cells and T follicular regulatory cells in rheumatic diseases</article-title><source>Nat. Rev. Rheumatol.</source><year>2019</year><volume>15</volume><fpage>475</fpage><lpage>490</lpage><pub-id pub-id-type="doi">10.1038/s41584-019-0254-2</pub-id><pub-id pub-id-type="pmid">31289377</pub-id></element-citation></ref><ref id="B248-ijms-21-08011"><label>248.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ma</surname><given-names>C.S.</given-names></name><name name-style="western"><surname>Avery</surname><given-names>D.T.</given-names></name><name name-style="western"><surname>Chan</surname><given-names>A.</given-names></name><name name-style="western"><surname>Batten</surname><given-names>M.</given-names></name><name name-style="western"><surname>Bustamante</surname><given-names>J.</given-names></name><name name-style="western"><surname>Boisson-Dupuis</surname><given-names>S.</given-names></name><name name-style="western"><surname>Arkwright</surname><given-names>P.D.</given-names></name><name name-style="western"><surname>Kreins</surname><given-names>A.Y.</given-names></name><name name-style="western"><surname>Averbuch</surname><given-names>D.</given-names></name><name name-style="western"><surname>Engelhard</surname><given-names>D.</given-names></name><etal/></person-group><article-title>Functional STAT3 deficiency compromises the generation of human T follicular helper cells</article-title><source>Blood</source><year>2012</year><volume>119</volume><fpage>3997</fpage><lpage>4008</lpage><pub-id pub-id-type="doi">10.1182/blood-2011-11-392985</pub-id><pub-id pub-id-type="pmid">22403255</pub-id><pub-id pub-id-type="pmcid">PMC3355712</pub-id></element-citation></ref><ref id="B249-ijms-21-08011"><label>249.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Lee</surname><given-names>W.I.</given-names></name><name name-style="western"><surname>Torgerson</surname><given-names>T.R.</given-names></name><name name-style="western"><surname>Schumacher</surname><given-names>M.J.</given-names></name><name name-style="western"><surname>Yel</surname><given-names>L.</given-names></name><name name-style="western"><surname>Zhu</surname><given-names>Q.</given-names></name><name name-style="western"><surname>Ochs</surname><given-names>H.D.</given-names></name></person-group><article-title>Molecular analysis of a large cohort of patients with the hyper immunoglobulin M (IgM) syndrome</article-title><source>Blood</source><year>2005</year><volume>105</volume><fpage>1881</fpage><lpage>1890</lpage><pub-id pub-id-type="doi">10.1182/blood-2003-12-4420</pub-id><pub-id pub-id-type="pmid">15358621</pub-id></element-citation></ref><ref id="B250-ijms-21-08011"><label>250.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Du</surname><given-names>X.</given-names></name><name name-style="western"><surname>Tang</surname><given-names>W.</given-names></name><name name-style="western"><surname>Chen</surname><given-names>X.</given-names></name><name name-style="western"><surname>Zeng</surname><given-names>T.</given-names></name><name name-style="western"><surname>Wang</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Chen</surname><given-names>Z.</given-names></name><name name-style="western"><surname>Xu</surname><given-names>T.</given-names></name><name name-style="western"><surname>Zhou</surname><given-names>L.</given-names></name><name name-style="western"><surname>Tang</surname><given-names>X.</given-names></name><name name-style="western"><surname>An</surname><given-names>Y.</given-names></name><etal/></person-group><article-title>Clinical, genetic and immunological characteristics of 40 Chinese patients with CD40 ligand deficiency</article-title><source>Scand. J. Immunol.</source><year>2019</year><volume>90</volume><fpage>e12798</fpage><pub-id pub-id-type="doi">10.1111/sji.12798</pub-id><pub-id pub-id-type="pmid">31179555</pub-id></element-citation></ref><ref id="B251-ijms-21-08011"><label>251.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Bossaller</surname><given-names>L.</given-names></name><name name-style="western"><surname>Burger</surname><given-names>J.</given-names></name><name name-style="western"><surname>Draeger</surname><given-names>R.</given-names></name><name name-style="western"><surname>Grimbacher</surname><given-names>B.</given-names></name><name name-style="western"><surname>Knoth</surname><given-names>R.</given-names></name><name name-style="western"><surname>Plebani</surname><given-names>A.</given-names></name><name name-style="western"><surname>Durandy</surname><given-names>A.</given-names></name><name name-style="western"><surname>Baumann</surname><given-names>U.</given-names></name><name name-style="western"><surname>Schlesier</surname><given-names>M.</given-names></name><name name-style="western"><surname>Welcher</surname><given-names>A.A.</given-names></name><etal/></person-group><article-title>ICOS deficiency is associated with a severe reduction of CXCR5+CD4 germinal center Th cells</article-title><source>J. Immunol.</source><year>2006</year><volume>177</volume><fpage>4927</fpage><lpage>4932</lpage><pub-id pub-id-type="doi">10.4049/jimmunol.177.7.4927</pub-id><pub-id pub-id-type="pmid">16982935</pub-id></element-citation></ref><ref id="B252-ijms-21-08011"><label>252.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Strutt</surname><given-names>T.M.</given-names></name><name name-style="western"><surname>McKinstry</surname><given-names>K.K.</given-names></name><name name-style="western"><surname>Dibble</surname><given-names>J.P.</given-names></name><name name-style="western"><surname>Winchell</surname><given-names>C.</given-names></name><name name-style="western"><surname>Kuang</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Curtis</surname><given-names>J.D.</given-names></name><name name-style="western"><surname>Huston</surname><given-names>G.</given-names></name><name name-style="western"><surname>Dutton</surname><given-names>R.W.</given-names></name><name name-style="western"><surname>Swain</surname><given-names>S.L.</given-names></name></person-group><article-title>Memory CD4+ T cells induce innate responses independently of pathogen</article-title><source>Nat. Med.</source><year>2010</year><volume>16</volume><fpage>558</fpage><lpage>564</lpage><pub-id pub-id-type="doi">10.1038/nm.2142</pub-id><pub-id pub-id-type="pmid">20436484</pub-id><pub-id pub-id-type="pmcid">PMC2927232</pub-id></element-citation></ref><ref id="B253-ijms-21-08011"><label>253.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kawabe</surname><given-names>T.</given-names></name><name name-style="western"><surname>Jankovic</surname><given-names>D.</given-names></name><name name-style="western"><surname>Kawabe</surname><given-names>S.</given-names></name><name name-style="western"><surname>Huang</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Lee</surname><given-names>P.H.</given-names></name><name name-style="western"><surname>Yamane</surname><given-names>H.</given-names></name><name name-style="western"><surname>Zhu</surname><given-names>J.</given-names></name><name name-style="western"><surname>Sher</surname><given-names>A.</given-names></name><name name-style="western"><surname>Germain</surname><given-names>R.N.</given-names></name><name name-style="western"><surname>Paul</surname><given-names>W.E.</given-names></name></person-group><article-title>Memory-phenotype CD4(+) T cells spontaneously generated under steady-state conditions exert innate TH1-like effector function</article-title><source>Sci. Immunol.</source><year>2017</year><volume>2</volume><pub-id pub-id-type="doi">10.1126/sciimmunol.aam9304</pub-id><pub-id pub-id-type="pmcid">PMC5568832</pub-id><pub-id pub-id-type="pmid">28783663</pub-id></element-citation></ref><ref id="B254-ijms-21-08011"><label>254.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Yu</surname><given-names>F.</given-names></name><name name-style="western"><surname>Sharma</surname><given-names>S.</given-names></name><name name-style="western"><surname>Edwards</surname><given-names>J.</given-names></name><name name-style="western"><surname>Feigenbaum</surname><given-names>L.</given-names></name><name name-style="western"><surname>Zhu</surname><given-names>J.</given-names></name></person-group><article-title>Dynamic expression of transcription factors T-bet and GATA-3 by regulatory T cells maintains immunotolerance</article-title><source>Nat. Immunol.</source><year>2015</year><volume>16</volume><fpage>197</fpage><lpage>206</lpage><pub-id pub-id-type="doi">10.1038/ni.3053</pub-id><pub-id pub-id-type="pmid">25501630</pub-id><pub-id pub-id-type="pmcid">PMC4297509</pub-id></element-citation></ref><ref id="B255-ijms-21-08011"><label>255.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Zhou</surname><given-names>L.</given-names></name><name name-style="western"><surname>Chong</surname><given-names>M.M.</given-names></name><name name-style="western"><surname>Littman</surname><given-names>D.R.</given-names></name></person-group><article-title>Plasticity of CD4+ T cell lineage differentiation</article-title><source>Immunity</source><year>2009</year><volume>30</volume><fpage>646</fpage><lpage>655</lpage><pub-id pub-id-type="doi">10.1016/j.immuni.2009.05.001</pub-id><pub-id pub-id-type="pmid">19464987</pub-id></element-citation></ref><ref id="B256-ijms-21-08011"><label>256.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Sakaguchi</surname><given-names>S.</given-names></name><name name-style="western"><surname>Vignali</surname><given-names>D.A.</given-names></name><name name-style="western"><surname>Rudensky</surname><given-names>A.Y.</given-names></name><name name-style="western"><surname>Niec</surname><given-names>R.E.</given-names></name><name name-style="western"><surname>Waldmann</surname><given-names>H.</given-names></name></person-group><article-title>The plasticity and stability of regulatory T cells</article-title><source>Nat. Rev. Immunol.</source><year>2013</year><volume>13</volume><fpage>461</fpage><lpage>467</lpage><pub-id pub-id-type="doi">10.1038/nri3464</pub-id><pub-id pub-id-type="pmid">23681097</pub-id></element-citation></ref><ref id="B257-ijms-21-08011"><label>257.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Stubbington</surname><given-names>M.J.T.</given-names></name><name name-style="western"><surname>Rozenblatt-Rosen</surname><given-names>O.</given-names></name><name name-style="western"><surname>Regev</surname><given-names>A.</given-names></name><name name-style="western"><surname>Teichmann</surname><given-names>S.A.</given-names></name></person-group><article-title>Single-cell transcriptomics to explore the immune system in health and disease</article-title><source>Science</source><year>2017</year><volume>358</volume><fpage>58</fpage><lpage>63</lpage><pub-id pub-id-type="doi">10.1126/science.aan6828</pub-id><pub-id pub-id-type="pmid">28983043</pub-id><pub-id pub-id-type="pmcid">PMC5654495</pub-id></element-citation></ref><ref id="B258-ijms-21-08011"><label>258.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ledford</surname><given-names>H.</given-names></name></person-group><article-title>Quest to use CRISPR against disease gains ground</article-title><source>Nature</source><year>2020</year><volume>577</volume><fpage>156</fpage><pub-id pub-id-type="doi">10.1038/d41586-019-03919-0</pub-id><pub-id pub-id-type="pmid">31911695</pub-id></element-citation></ref><ref id="B259-ijms-21-08011"><label>259.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Renaud</surname><given-names>J.P.</given-names></name><name name-style="western"><surname>Chari</surname><given-names>A.</given-names></name><name name-style="western"><surname>Ciferri</surname><given-names>C.</given-names></name><name name-style="western"><surname>Liu</surname><given-names>W.T.</given-names></name><name name-style="western"><surname>Remigy</surname><given-names>H.W.</given-names></name><name name-style="western"><surname>Stark</surname><given-names>H.</given-names></name><name name-style="western"><surname>Wiesmann</surname><given-names>C.</given-names></name></person-group><article-title>Cryo-EM in drug discovery: Achievements, limitations and prospects</article-title><source>Nat. Rev. Drug Discov.</source><year>2018</year><volume>17</volume><fpage>471</fpage><lpage>492</lpage><pub-id pub-id-type="doi">10.1038/nrd.2018.77</pub-id><pub-id pub-id-type="pmid">29880918</pub-id></element-citation></ref><ref id="B260-ijms-21-08011"><label>260.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Bendall</surname><given-names>S.C.</given-names></name><name name-style="western"><surname>Simonds</surname><given-names>E.F.</given-names></name><name name-style="western"><surname>Qiu</surname><given-names>P.</given-names></name><name name-style="western"><surname>El-ad</surname><given-names>D.A.</given-names></name><name name-style="western"><surname>Krutzik</surname><given-names>P.O.</given-names></name><name name-style="western"><surname>Finck</surname><given-names>R.</given-names></name><name name-style="western"><surname>Bruggner</surname><given-names>R.V.</given-names></name><name name-style="western"><surname>Melamed</surname><given-names>R.</given-names></name><name name-style="western"><surname>Trejo</surname><given-names>A.</given-names></name><name name-style="western"><surname>Ornatsky</surname><given-names>O.I.</given-names></name><etal/></person-group><article-title>Single-cell mass cytometry of differential immune and drug responses across a human hematopoietic continuum</article-title><source>Science</source><year>2011</year><volume>332</volume><fpage>687</fpage><lpage>696</lpage><pub-id pub-id-type="doi">10.1126/science.1198704</pub-id><pub-id pub-id-type="pmid">21551058</pub-id><pub-id pub-id-type="pmcid">PMC3273988</pub-id></element-citation></ref><ref id="B261-ijms-21-08011"><label>261.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Germain</surname><given-names>R.N.</given-names></name><name name-style="western"><surname>Robey</surname><given-names>E.A.</given-names></name><name name-style="western"><surname>Cahalan</surname><given-names>M.D.</given-names></name></person-group><article-title>A decade of imaging cellular motility and interaction dynamics in the immune system</article-title><source>Science</source><year>2012</year><volume>336</volume><fpage>1676</fpage><lpage>1681</lpage><pub-id pub-id-type="doi">10.1126/science.1221063</pub-id><pub-id pub-id-type="pmid">22745423</pub-id><pub-id pub-id-type="pmcid">PMC3405774</pub-id></element-citation></ref><ref id="B262-ijms-21-08011"><label>262.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Qi</surname><given-names>H.</given-names></name><name name-style="western"><surname>Kastenmuller</surname><given-names>W.</given-names></name><name name-style="western"><surname>Germain</surname><given-names>R.N.</given-names></name></person-group><article-title>Spatiotemporal basis of innate and adaptive immunity in secondary lymphoid tissue</article-title><source>Annu. Rev. Cell Dev. Biol.</source><year>2014</year><volume>30</volume><fpage>141</fpage><lpage>167</lpage><pub-id pub-id-type="doi">10.1146/annurev-cellbio-100913-013254</pub-id><pub-id pub-id-type="pmid">25150013</pub-id></element-citation></ref><ref id="B263-ijms-21-08011"><label>263.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Tang</surname><given-names>J.</given-names></name><name name-style="western"><surname>van Panhuys</surname><given-names>N.</given-names></name><name name-style="western"><surname>Kastenmuller</surname><given-names>W.</given-names></name><name name-style="western"><surname>Germain</surname><given-names>R.N.</given-names></name></person-group><article-title>The future of immunoimaging&#8212;Deeper, bigger, more precise, and definitively more colorful</article-title><source>Eur. J. Immunol.</source><year>2013</year><volume>43</volume><fpage>1407</fpage><lpage>1412</lpage><pub-id pub-id-type="doi">10.1002/eji.201243119</pub-id><pub-id pub-id-type="pmid">23568494</pub-id><pub-id pub-id-type="pmcid">PMC3748132</pub-id></element-citation></ref><ref id="B264-ijms-21-08011"><label>264.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Schreiner</surname><given-names>D.</given-names></name><name name-style="western"><surname>King</surname><given-names>C.G.</given-names></name></person-group><article-title>CD4+ Memory T Cells at Home in the Tissue: Mechanisms for Health and Disease</article-title><source>Front. Immunol.</source><year>2018</year><volume>9</volume><fpage>2394</fpage><pub-id pub-id-type="doi">10.3389/fimmu.2018.02394</pub-id><pub-id pub-id-type="pmid">30386342</pub-id><pub-id pub-id-type="pmcid">PMC6198086</pub-id></element-citation></ref><ref id="B265-ijms-21-08011"><label>265.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Jameson</surname><given-names>S.C.</given-names></name><name name-style="western"><surname>Masopust</surname><given-names>D.</given-names></name></person-group><article-title>Understanding Subset Diversity in T Cell Memory</article-title><source>Immunity</source><year>2018</year><volume>48</volume><fpage>214</fpage><lpage>226</lpage><pub-id pub-id-type="doi">10.1016/j.immuni.2018.02.010</pub-id><pub-id pub-id-type="pmid">29466754</pub-id><pub-id pub-id-type="pmcid">PMC5863745</pub-id></element-citation></ref></ref-list></back><floats-group><fig id="ijms-21-08011-f001" orientation="portrait" position="float"><label>Figure 1</label><caption><p>The development and functions of CD4 T helper (Th) and innate lymphoid cell (ILC) subsets. Na&#239;ve CD4 T cells can differentiate into Th1, Th2, Th17, Tfh (follicular T helper), and Treg (T regulatory) subsets upon T cell receptor (TCR) activation in different cytokine milieu. T cells may also become cytotoxic CD4 T cells (CD4-CTLs) that kill their target cells in major histocompatibility complex class II (MHCII)-restricted manner. ILC1, ILC2, and ILC3 subsets are the innate counterparts of Th1, Th2, and Th17 cells and they are involved in type 1, type 2, and type 3 immune responses, respectively. ILC1, ILC2, and ILC3 subsets develop from ILC progenitors (ILCPs), which are distinct from progenitors that give rise to natural killer (NK) cells and lymphoid tissue inducers (LTis).</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="float" orientation="portrait" xlink:href="ijms-21-08011-g001.jpg"/></fig><fig id="ijms-21-08011-f002" orientation="portrait" position="float"><label>Figure 2</label><caption><p>Crosstalk between ILC2s and Th2 cells during type 2 immune responses. Upon stimulation by helminth products or allergens, epithelial and/or stromal cells may produce inflammatory cytokines including IL-33, IL-25, and TSLP, which are capable of activating ILC2s. By producing type 2 effector cytokines, such as IL-4 and IL-13, ILC2s may promote the migration of dendritic cells (DCs) into draining lymph nodes to induce Th2 cell differentiation. Some ILC2s also express MHCII, which allows them to directly interact with Th2 cells through antigen presentation. Thus, ILC2s could promote the further differentiation of early Th2 cells; on the other hand, Th2 cells may expand ILC2s through IL-2 production. Effector cytokines including IL-4 and IL-13 produced by Th2 cells, may also indirectly induce the expansion of ILC2s through stimulating epithelial cells to produce ILC2-activating inflammatory cytokines such as IL-25 and TSLP.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="float" orientation="portrait" xlink:href="ijms-21-08011-g002.jpg"/></fig></floats-group></article></pmc-articleset>